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Chapter 1 | General introduction, aim and thesis outline
Patients undergoing abdominal surgery run the risk of postoperative complications. The 
three most frequent major complications are represented by:
1) incisional hernia (IH);
2) postoperative ileus (POI);
3) colorectal anastomotic leakage (CAL).
The cause of developing a surgical complication is mostly multifactorial. Several patient-
related risk factors for all three complications such as age, gender, prior abdominal 
surgery, comorbidities, immune deficiency, and emergency surgery cannot be con-
trolled [1]. Risk factors that can be influenced are nutritional status, obesity, smoking, 
and experience of the surgeon among others. Nevertheless, surgical complications also 
frequently happen to patients without any obvious reason.
DEFINITION AND INCIDENCE
Incisional hernia (IH):
IH can be defined as any abdominal wall gap with or without bulging in the area of 
a postoperative scar perceptible or palpable by clinical examination or imaging [2]. IH 
is a very common complication after abdominal surgery, with an incidence ranging 
between 10-23% [3]. The highest rates of IH occur after midline abdominal incisions for 
conventional (‘open’) colorectal or vascular surgery. IH is associated with pain, discom-
fort, decreased quality of life, incarceration and even strangulation [3].
Prolonged postoperative ileus (PPOI):
POI, a transit cessation of bowel mobility occur in each patient undergoing abdominal 
surgery due to a normal physiologic response. But after major abdominal surgery PPOI 
has an incidence of up to 14.9-19% which contributes to postoperative morbidity [4,5]. 
Postoperative inhibition of motility of the gastro-intestinal tract leads to symptoms like 
nausea, vomiting, abdominal pain, delayed passage of flatus and stool, and the inability 
to tolerate solid food. Patients are considered to have PPOI if they do not tolerate solid 
food for at least 24 hours and experience absence of flatus over 24 hours, occurring on 
or after day 5 postoperatively [6].
Colorectal anastomotic leakage (CAL):
CAL is the most severe complication of abdominal surgery and represents a defect of the 
intestinal wall integrity at the anastomotic site. A pelvic abscess close to the anastomosis 
is also considered as CAL [7]. Because CAL results in 3-32% of the cases to mortality and 
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severe morbidity, including reoperation, intensive care admittance, abscess drainage 
and stoma construction [8-10], CAL is the most feared complication with an incidence 
of 5.9% (after colon resection) and 9.3% (after rectum resection) in The Netherlands in 
2014 [8]. As a consequence, CAL also leads to reduced quality of life, a higher cancer 
recurrence and doubled hospital charges [9].
THE ROLE OF THE INFLAMMATORy RESPONSE
Surgical injury induces a hemodynamic, metabolic, and systemic inflammatory response 
with rise of systemic and local cytokine release. The initial pro-inflammatory immune re-
sponse in the intraoperative and early postoperative periods is initiated by macrophages 
and monocytes at the initial site of injury. The pro-inflammatory cytokines including 
tumor necrosis factor (TNF)-α and IL (interleukin)-1β stimulate the production of IL-6. 
The postoperative inflammatory response plays a major role in all above-mentioned 
surgical complications. The crucial role of macrophages with regard to postoperative 
complications was not discovered until recent decades.
MACROPHAGES
Macrophages can derive from monocytes, one of the major groups of white blood 
cells. These are initially characterized by their ability to perform phagocytosis. When 
macrophages are stimulated for example by foreign substances, they will increase 
their capacity of phagocytosis and intracellular digestion and exhibit enhanced meta-
bolic and lysosomal enzyme activity. Macrophages are remarkably plastic and can even 
change their functional phenotype depending on the environmental cues they receive. 
Macrophages are also secretory cells that produce cytokines that stimulate in defensive 
and reparative functions. Activation of macrophages is critical in the acute phase of 
wound healing [11, 12]. Macrophages can be roughly divided into pro-inflammatory 
macrophages, also called M1 macrophages, and anti-inflammatory macrophages, also 
called M2 macrophages or repair macrophages [13, 14]. M1 macrophages secrete high 
levels of pro-inflammatory cytokines e.g. TNF-α, IL-6, IL-1β and generate reactive oxygen 
and nitrogen species via activation of inducible nitric oxide synthase (iNOS). Conversely, 
M2 macrophages activate arginase 1 that blocks iNOS activity and therefore inhibits 
nitric oxide production. They also secrete anti-inflammatory cytokines e.g. IL-10, TGF-β, 
IL-4 essential for inflammatory response resolution. The balance between M1 and M2 
plays a critical role in the phagocytosis of pathogens, the clearance of apoptotic cells 
and the healing and remodeling of injured tissues.
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BIOMATERIALS
Biomaterials such as hernia meshes and tissue adhesives can be used to prevent surgical 
complications for example IH and CAL. A biomaterial is made of natural or synthetic 
material that is suitable for introduction into living tissue to replace or repair tissue. 
The surface properties and the material itself play an important role for the foreign 
body response. Host reactions following implantation of biomaterials include injury, 
blood-material interactions, provisional matrix formation, acute inflammation, chronic 
inflammation, granulation tissue development, foreign body reaction, and fibrosis/
fibrous capsule development [11]. The inflammatory response is very important follow-
ing surgical tissue damage and material implantation or application, every biomaterial 
induces an inflammatory foreign body response.
PREVENTION AND DETECTION
IH can be prevented by using a small tissue bites suture technique of 5 mm instead 
of large bites of 1 cm every 1 cm, as shown in a randomized controlled trial [3]. For 
example obese patients or patients with an aorta aneurysm are at high risk to develop 
complications after surgery such as IH and wound infection. The mechanisms to explain 
an increased tendency for wound complications in obese patients are various. Vascular 
insufficiency and oxidative stress of the tissue causes decrease in collagen synthesis and 
limits an adequate inflammatory response [15]. Obese patients always have a low-grade 
inflammatory response in the obese tissue and therefore a more pro-inflammatory 
profile [15,16]. Because of the higher complication risk in this specific patient category 
it is desirable to prevent IH by primary mesh augmentation [17]. Although every indi-
vidual patient has a unique response to biomaterials is would be ideal to investigate this 
response prior to surgery.
Different strategies have been explored to prevent POI. Surgical procedures trigger 
two different phases of POI: an early neurogenic phase and a late inflammatory phase. 
This inflammatory phase is considered to be a more relevant factor in gastrointestinal 
dismotility [18]. In this phase, local macrophages, activated by intestinal manipulation, 
induce an inflammatory response that results in muscle dysfunction, also inducing the 
infiltration of inflammatory cells, including neutrophils into the intestinal muscularis 
layer. Therefore, systemic inflammatory markers, such as interleukin-1 (IL-1), IL-6 , TNF-α, 
and CRP, might be valuable for the early detection of POI. Pharmacological manage-
ment with μ-opioid receptor antagonists and serotonin receptor agonists appeared 
to significantly shorten the duration of ileus. Another strategy is stimulation of the 
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gastro-intestinal motility by chewing gum that induces cephalo-vagal stimulation and 
activating the cholinergic anti-inflammatory pathway by activating the vagal nerve [19, 
20]. Early detection of PPOI prevents a high postoperative morbidity.
If a patient develops CAL, the cause is mostly multifactorial. Roughly, CAL can be due 
to technical failure or impaired anastomotic healing. Although the surgical technique 
is improved in the last decades, the incidence of CAL is not clearly decreased, aging of 
the patient population and the application of chemoradiotherapy for rectal carcinoma 
representing important factors. Some factors can be influenced, but most patient-
related risk factors cannot be changed. Therefore there is more need to understand the 
pathophysiology of anastomotic healing and there should be more attention for the 
prevention of leakage by optimizing the surgical technique. Moreover, when CAL hap-
pens detection in an early phase is needed to prevent from worse.
AIM AND OUTLINE OF THIS THESIS
Even anno 2017 it is still necessary to explore new strategies to prevent complications 
in abdominal surgery. Also with new surgical techniques, for example the use of staplers 
for colorectal anastomosis, prevention of CAL is still an issue. In addition, early detection 
of a complication is necessary to prevent from worse. This also requires more attention 
and research since detection of leakage is still mainly based on clinical observation and 
the experience of the surgeon. Research on more advanced technical and/ or digital 
solutions to objectively assess and quantify leakage is strongly needed. The aim of this 
thesis was to develop different strategies that may facilitate prevention, prediction, and 
diagnosis of different important abdominal surgical complications such as CAL, POI, IH, 
and infectious  complications.
In Part 1, Chapters 2-6, of this thesis, prediction and detection of complications are 
evaluated in patients who are not at risk to develop a surgical complication.
In Chapter 2 it is investigated whether aortoiliac calcification is linked to CAL by mea-
suring the calcified plaques in the various abdominal arteries.
In Chapter 3 the perioperative bowel perfusion is evaluated with a miniaturized Dy-
namic Light Scattering device, to determine whether anastomotic perfusion correlates 
with the anastomotic healing process.
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In Chapter 4 a clinical study is presented in which it is examined whether it is possible 
to detect POI and infectious complications in an early stage.
In Chapter 5 an overview of the current evidence regarding clinical endpoints, early 
detection, and differential diagnosis of POI will be presented.
In Part 2, Chapters 6-8, the focus is on the prevention of surgical complications.
In Chapter 6 the hypothesis that perioperative nicotine administration may reduce 
postoperative opioid use and prevent postoperative nausea and vomiting is discussed.
In Chapter 7 the focus is on the prevention of CAL. The possibility to use hyperbaric 
oxygen treatment to prevent CAL is evaluated.
In Chapter 8 another innovative approach to prevent CAL and improve colorectal 
wound healing will be presented. Here, a study is presented with adipose tissue-derived 
stem cells (ACS) cultured in high density to compose an ASC-sheet. This sheet will be 
applied on the colorectal anastomosis in a CAL rat model.
In Chapter 9 the prevention of CAL with cyanoacrylate tissue adhesive will be evaluated 
in a systematic review.
In Part 3, Chapters 10-14, prevention of surgical complications in patients at risk is 
investigated.
In Chapter 10 different tissue adhesives in the prevention of CAL in a bacterially con-
taminated environment are investigated.
In Chapter 11 the same tissue adhesives will be used in a new developed IBD-colectomy 
model in the rat. Here, the same adhesives are evaluated but then in a different high-risk 
situation.
In Chapter 12 cyanoacrylate glue will be tested in an ischemic porcine and CAL model.
In Chapter 13 the effect of common used biomaterials on polarization of macrophages 
in healthy subjects will be reviewed.
In Chapter 14 the response of macrophages will be examined in more detail in a devel-
oped culture model with human primary macrophages from patients with or without 
16
obesity to evaluate the acute response of macrophages to biomaterials in this specific 
patient group.
In Chapter 15 the findings of this thesis will be discussed.
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ABSTRACT
Background
Anastomotic leakage in bowel surgery remains a devastating complication. Various risk 
factors have been uncovered, however, high anastomotic leakage rates are still being 
reported. This study describes the use of calcification markers of the central abdominal 
arteries as a prognostic factor for colorectal anastomotic leakage.
Methods
This case-control study includes clinical data from three different hospitals. Calcium 
volume and calcium score of the aortoiliac tract were determined by CT-scan analysis. 
Cases were all patients with anastomotic leakage after a left-sided anastomosis (n=30). 
Three controls were randomly matched for each case. Only patients with a contrast-
enhanced pre-operative CT-scan were included.
Results
The measurements of the calcium score and calcium volume of the different trajectories 
showed that there was one significant difference with regard to the right external iliac 
artery. Multiple regression analysis showed a significant different negative odds ratio of 
the presence of calcium in the right external iliac artery.
Conclusion
This study demonstrates that calcium volume and calcium score of the aortoiliac trajec-
tory does not correlate with the risk of colorectal anastomotic leakage after a left-sided 
anastomosis.
23
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INTRODUCTION
The occurrence of anastomotic leakage (AL) after colorectal surgery remains a severe 
complication leading to high morbidity and mortality. Literature has identified the 
main risk factors for colorectal anastomotic leakage: male gender, pre-operative ra-
diotherapy, low anastomosis (<10cm from the anal verge), high BMI, high comorbidity, 
ligation above the left colonic artery, advanced age, and a history of vascular disease 
[1-8]. Despite the accumulation of knowledge and the improvements brought by novel 
surgical techniques, the incidence of AL remains high, approximately 8-18% [4, 9-14].
Sufficient tissue perfusion is an important factor for anastomotic healing. Several ex-
perimental and clinical studies showed a correlation between a higher risk of AL when 
the oxygenation rate of the cut anastomotic edges did not rise during operation [15-18]. 
In these studies the oxygen saturation of the anastomosis was measured with different 
tools like near-infrared reflection spectroscopy or by custom-made electrodes. These 
studies conclude that perioperative low oxygen values lead to a higher risk of anasto-
motic leakage. Karliczek et al. used visible light spectroscopy to measure the oxygen 
values during colorectal surgery, they investigated that leaking anastomoses showed 
less rising oxygen values during operation than normal anastomoses [15].
Smoking, high BMI, hypertension and hypercholesterolemia are risk factors for AL but 
also for atherosclerosis [19]. An atherosclerotic plaque is made up of fat, cholesterol, 
and calcium, hardening and narrowing the arteries with limitation of oxygen-rich blood 
flow. Atherosclerosis is correlated with tissue ischemia and anastomotic leakage caused 
by poor microcirculation [20-25]. The calcium in the atherosclerotic plaques in the 
arteries can be scored on computed tomography (CT) by dedicated scoring software. 
The Agatston calcium score, which is the most validated and most frequently used scor-
ing system as a predictor in previous studies, is the product of the density factor and 
the area of the calcified plaques (mm2) [26]. The calcium volume score represents an 
actual volume of calcium in the artery and reduces calcium measurement variability 
between scans [27]. The presence of calcium is considered to stabilise the plaque, which 
decreases the chance of plaque rupture and subsequent ischemic disease [28]. Never-
theless, several studies have shown a correlation between the calcium score and cardiac 
events [26, 29]. Patients with high Agatston scores have a higher frequency of cardiac 
adverse events whereas a calcium score of zero portrays a very low risk for short term 
and midterm cardiac events [30, 31]. A correlation has also been described between 
higher Agatston score, calcium mass, and calcium volume in various abdominal arteries 
and the risk of AL after colorectal surgery [32].
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In this case-control study we investigated whether the calcium score using Agatston or 
volume score also can be used as a predictive factor for left-sided colorectal anastomotic 
leakage, based on enhanced CT measurements.
METHODS
Study population
During 2009 and 2011 all patients undergoing a primary left sided colorectal anastomo-
sis, who preoperatively received a contrast enhanced abdominal CT-scan with a 5mm 
slice thickness, were included. Data was obtained from the following teaching hospitals; 
the Erasmus University Medical Center Rotterdam (EMC), Albert Schweitzer hospital 
Dordrecht (ASD), and the University Medical Center Groningen (UMCG). In this retro-
spective case-control study cases were patients who had radiographically confirmed 
anastomotic leakage within 30 days postoperatively. At least 3 controls per case were 
randomly selected and matched by sex, age, ASA classification, diverting stoma and 
operation, some cases having 4 controls.
Data collection included age, sex, body mass index (BMI), American Society of Anaes-
thesiologists (ASA) score, medication use, smoking, alcohol use, operative procedure, 
postoperative complications and postoperative course.
This study was approved by the Medical Ethical Committee of the Erasmus University 
Medical Center, Rotterdam, Netherlands, in accordance with the Dutch law on medical 
research in humans. Permit number MEC-2011-121.
Measurements of calcium score and calcium volume
Two different types of CT-scanner were used in this study. UMCG and EMC used Siemens 
Somatom Sensation 16 or 64 (Forcheim, Germany) and ASD used Philips Brilliance 40 or 
64(Eindhoven, The Netherlands). The calcium scores and volumes were retrospectively 
determined by two researchers, with Siemens software (Syngo.via® 2009-2012, serial 
number 100106, Siemens AG, Germany). The score was determined for the total aor-
toiliac trajectory starting from the T12-L1 disk space (just above the superior mesenteric 
artery) up to the internal iliac arteries, with a convolution kernel (CK) of 30f, slice thick-
ness of 5mm, and kV of 120 as described by Komen et al. [32, 33]. The calcium score 
and calcium volume were determined at a threshold level of 500 Hounsfield Units (HU) 
according to Komen et al. We used a higher threshold, than standard 130 HU, because of 
the intra-arterial contrast.
25
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Calcium score and volume were determined on the CT-scan at 7 different segments in 
the aortoiliacal trajectory. The presence of atherosclerotic plaques were computed at 
several segments: in the abdominal aorta (starting from vertebra T12-L1 up to the aortic 
bifurcation), the left and right common iliac arteries, the left and right internal iliac arter-
ies, and the left and right external iliac arteries. These segments are representative for 
the entire aortoiliac trajectory and are important for the vascularisation of the colon 
and rectum. The vascularisation of the descending colon, sigmoid colon and rectum, 
which have an important role in the perfusion of the left-side anastomosis, partly arise 
from the inferior mesenteric artery (IMA). The origin of the IMA is at the ventral side of 
the abdominal aorta. The IMA is branching into the left colic artery, the sigmoid arteries, 
and the superior rectal artery. Vascularisation of the rectum originates from the superior, 
middle and inferior rectal arteries. The latter originates from the internal iliac artery 
(hypogastric artery) [34].
Statistical analysis
The statistical analysis was carried out using the Statistical Product and Service Solu-
tions (SPSS Inc., Chicago, USA, version 20.0 for Windows). Univariate analysis between 
the groups with or without AL was done by the median and mean values of the Mann-
Whitney U test or chi-square test. Data in the tables on the calcium score and volume are 
displayed in the original scale of measurement. However, these data were normalized by 
a logarithmic transformation prior to formal analysis. To determine whether there were 
significant differences between calcium score and calcium volume in relation to AL or no 
AL we performed multiple regression by generalized linear models. All reported p values 
were two-sided; a p value < 0.05 was considered to indicate statistical significance.
RESULTS
In total 36 cases and 167 controls were included in the database, six cases and 62 con-
trols were excluded from further analyses because they could not be matched properly, 
implicating 135 patients (30 cases and 105 controls) were included. Table 1 illustrates 
the demographic, clinical, and operative characteristics of the included patients.
Univariate analysis of the patient and operative characteristics showed significant differ-
ences in cardiac comorbidity and packed cell use during or after the operation between 
patients with or without AL. The mortality rate in the group with AL was not significantly 
different to the group without AL (p  = 0.533; Table 2). Significant differences were found 
for postoperative bleeding, wound infection, postoperative ileus, intra-abdominal ab-
scess, and urinary tract infection in the AL group, (p < 0.05; Table 2).
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Table 1. Patient and operation characteristics
(30 cases)  (105 controls)
p valueAnastomotic leakage (%) No anastomotic leakage (%)
Patient characteristics      
Age (yrs) 64.50 ± 11.6 66.49 ± 11.4 0.412
Gender 0.508
Male 16 (53.3) 58 (55.2)
Female 14 (46.7) 47 (44.8)
BMI (kg/m2) 28.25 ± 6.7 26.88 ± 4.88 0.227
ASA scoreα 0.897
1 5 (19.2) 20 (20.6)
2 16 (61.5) 62 (63.9)
3 5 (19.2) 15 (15.5)
4 0 0
Comorbidity
Cardiac comorbidity 9 (30.0) 14 (13.3) 0.035
Peripheral vascular disease 1 (3.3) 8 (7.6) 0.364
Diabetes Mellitus 3 (10) 12 (11.4) 0.563
Smoking (current)α 9 (33.3) 29 (30.9) 0.490
Medication
Use of steroids 1 (3.3) 6 (5.7) 0.513
Use of statinsα 5 (17.9) 13 (12.5) 0.324
Use of antihypertensivaα 10 (33.3) 39 (37.5) 0.424
Neoadjuvant radiotherapy 2 (6.9) 6 (5.7) 0.566
Operation characteristics
Surgeon vs. resident 21 (70.0) 76 (73.1) 0.452
Type of operation 0.442
Sigmoid Resection 17 (56.7) 48 (45.7)
Low Anterior Resection 7 (23.3) 32 (30.5)
Rectosigmoid resection 3 (10) 15 (14.3)
Hemicolectomy left 1 (3.3) 8 (7.6)
Other 2 (6.7) 2 (1.9)
Approachα 0.184
Laparotomy 22 (75.9) 68 (64.8)
Laparoscopy  7 (24.1) 37 (35.2)
Stapled vs. hand suturedα 0.098
Sutured 15 (51.7) 38 (36.2)
Stapled 14 (48.3) 67 (63.8)
Conversionα 5 (26) 14 (74) 0.205
27
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Table 3 presents the mean and standard deviation (SD) of the calcium score and calcium 
volume of the different trajectories. The measurements show that there is only one sig-
nificant difference in one trajectory (right external iliac artery), indicating that patients 
without anastomotic leakage had a significant higher calcium volume in that specific 
trajectory.
Multiple regression analysis showed significant differences in the odds ratio for AL after 
higher calcium score in the right external iliac artery (Table 4). Negative odds ratio indi-
cates a negative relationship between the probability of anastomotic leakage and the 
calcium score or calcium volume.
Table 2. Postoperative complications
 
( 30 cases)  (105 controls)
p valueAnastomotic leakage (%) No anastomotic leakage  (%)
Complications      
Postoperative ileus 7 (23.3) 9 (8.6) 0.035
Dehiscence of laparotomy wound 2 (6.7) 3 (2.9) 0.308
Wound infection 7 (23.3) 5 (4.8) 0.005
Intra-abdominal abscess* 12 (40) 2 (1.9) 0.000
Urinary tract infection 2 (6.7) 0 (0) 0.048
Pneumonia 3 (10) 3 (2.9) 0.123
Bleeding 3 (10) 1 (1) 0.034
Mortality** 1 (3.3) 2 (1.9) 0.533
* not close to anastomosis     ** (<30days post-operative)
Table 1. Patient and operation characteristics (continued)
( 30 cases)  (105 controls)
p valueAnastomotic leakage (%) No anastomotic leakage (%)
Anastomotic configurationα 0.315
Side-end 5 (17.2) 31 (35.6)
Side-side 5 (17.2) 10 (11.5)
End-side 2 (6.9) 5 (5.7)
End-end 17 (58.6) 41 (47.1)
Stomaα 4 (14.3) 15 (17.9) 0.455
Packed cellsα 25 (100) 36 (43.9) 0.000
Prophylactic drainageα 20 (69) 51 (49.5) 0.073
α The numbers do not add up to 135 because of occasional missing data
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Table 4. Multiple regression by generalized linear models calcium volume and calcium score
500HU Calcium Volume Calcium Score
Trajectory odds ratio p value odds ratio p value
Total trajectory 0.03 0.710 0.03 0.704
Aorta 0.04 0.558 0.03 0.710
Left common iliac artery 0.01 0.897 0.01 0.862
Left internal iliac artery -0.17 0.116 -0.04 0.694
Left external iliac artery -0.25 0.117 -0.09 0.410
Right common iliac artery 0.10 0.227 0.05 0.524
Right internal iliac artery -0.12 0.371 -0.12 0.279
Right external iliac artery -0.25 0.043 -0.15 0.163
Left and right common iliac arteries 0.04 0.607 0.04 0.162
Left and right internal iliac arteries -0.09 0.437 -0.08 0.376
Table 3.  Calcium volume and calcium score of the different trajectories 500 HU
Trajectory n
Calcium Volume Calcium Score
Mean SD p value Mean SD p value
Total trajectory 30 4.98 2.77 0.712 5.50 2.88 0.707
104 4.75 2.95 5.26 3.12
Aorta abdominalis 30 4.42 2.85 0.561 4.93 2.93 0.713
104 4.06 3.04 4.70 3.10
Iliac artery
Left common 30 2.25 2.34 0.898 2.75 2.55 0.863
104 2.18 2.42 2.65 2.76
Right common 30 2.86 2.35 0.112 3.36 2.62 0.697
104 2.26 2.41 3.01 2.75
Left internal 30 1.12 1.72 0.109 1.49 2.12 0.412
104 1.85 2.33 1.66 2.14
Left external 30 0.66 1.44 0.227 0.99 1.75 0.527
104 1.32 2.09 1.34 2.17
Right internal 30 0.81 1.70 0.372 1.06 1.97 0.279
104 1.12 1.67 1.50 1.96
Right external 30 0.69 1.67 0.036 0.93 1.91 0.159
104 1.62 2.22 1.58 2.30
Left and right common 30 2.55 0.43 0.610 3.06 2.59 0.615
104 2.22 2.42 2.83 2.76
Left and right internal 30 0.97 1.71 0.440 1.28 2.05 0.378
104 1.49 1.00 1.58 2.05
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DISCUSSION
Anastomotic leakage remains one of the most feared complications after colorectal sur-
gery. There are several well-known risk factors for colorectal anastomotic leakage, such 
as high BMI, advanced age, high level of comorbidity and a history of cardiovascular 
disease. All these risk factors are also correlated to atherosclerosis. However, atheroscle-
rosis alone has not been identified as a risk factor for colorectal anastomotic leakage.
The results of our study suggest that the abdominal calcium score and calcium volume 
in aortoiliac trajectory are not correlated with anastomotic leakage in left-sided colon 
anastomoses. We did not find any indications that calcium measurements correlate to 
the onset of AL. Although, the collected data give a good reflection of reality because of 
the use of different CT-scanners in both local and university hospitals.
It is well known that left-sided anastomoses are associated with higher AL percent-
ages when compared to more proximal anastomoses [35, 36]. However, in this study we 
showed that the calcium scores in the atherosclerotic plaques of patients with AL, are 
not higher than in patients without AL for the same type of surgery.
Our results are in line with previous research by Kornmann et al., who scored the stenosis 
caused by arteriosclerotic lesions in the visceral arteries. They studied 242 patients who 
underwent colorectal anastomosis. The authors suggested that asymptomatic visceral 
artery occlusive disease is not a risk factor for anastomotic leakage [37]. This is maybe 
caused by the presence of a sufficient collateral network [38].
Komen et al. investigated that patients with higher calcium scores in the common iliacal 
arteries had an increased leakage risk of colorectal anastomosis. This study also men-
tioned that the calcium score of the left internal iliac is significantly higher in patients 
with colorectal AL, however the reason for this finding remained unclear [32].
In this present study we used the same measurement method of the calcium score as 
described by Komen et al. [32]. In the current study we could not measure the calcium 
mass, due to the lack of software support on this value for the different types of CT-
scanners. Although the calcium volume and calcium score correlate very well with the 
calcium mass, Komen et al. showed a better correlation between the calcium mass and 
AL than the calcium score and AL [32]. It is possibly due to the smaller study population 
in Komens’ study.
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Measuring the calcium volume and calcium score with a threshold of 500HU is higher 
than usual because of the contrast enhanced CT scan. Because of the intra-arterial con-
trast we probably missed some calcifications but this is the same in the AL group as in 
the non-AL group. This will not have any influence on the results. This will also explain 
the low scores of calcium mass and calcium volume compared to other studies.
From the results obtained in this study, we conclude that abdominal atherosclerotic cal-
cifications expressed as calcium score and calcium volume is not useful for preoperative 
risk assessment for left-sided anastomoses. This study indicates that calcified atheroscle-
rosis in the large abdominal arteries does not influence the perfusion of the anastomotic 
edges. It is known that coronary calcified plaques represents approximately 20% of the 
total plaque, the other 80% is lipid-rich plaque or fibrous plaque [27]. This may indicate 
that the calcified plaques are not representative enough for the total atherosclerosis in 
the abdominal arteries.
Future research regarding the relationship between abdominal atherosclerosis and the 
risk of colorectal anastomotic leakage should concentrate on the relationship between 
abdominal calcifications and the severity of abdominal artery lumen stenosis and the 
perfusion of the colon during surgery. Furthermore, visualization of the collateral net-
work around the anastomosis may provide extra information on the onset of ischemia 
leading to AL.
CONCLUSION
This study demonstrates that the abdominal calcium score and calcium volume in the 
aortoiliac trajectory are not correlated with anastomotic leakage in left-sided colon 
anastomosis.
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ABSTRACT
Introduction
Perioperative bowel perfusion (local-hemodynamic index, LHI) was measured with a 
miniaturized Dynamic Light Scattering (mDLS) device, aiming to determine whether 
anastomotic perfusion correlates with the anastomotic healing process, and whether 
LHI measurement assists detection of anastomotic leakage (AL) in colorectal surgery.
Methods
A partial colectomy was performed in 21 male Wistar rats. Colonic and anastomotic LHI 
were recorded during operation. On postoperative day (POD)-3, the rats were examined 
for AL manifestations. Anastomotic LHI was recorded before determining anastomotic 
bursting pressure (ABP). The postoperative LHI measurements were repeated in another 
15 rats with experimental colitis. Clinical manifestations and anastomotic LHI were also 
determined on POD3. Diagnostic value of LHI measurement was analyzed with the 
combined data from both experiments.
Results
Intraoperative LHI measurement showed no correlation with the ABP on POD3. Postop-
erative anastomotic LHI on POD3 was significantly correlated with ABP in the normal 
rats (R2=0.52, p<0.001) and in the colitis rats (R2=0.63, p=0.0012). Anastomotic LHI on 
POD3 had high accuracy for identifying ABP < 50 mmHg (AUC=0.86, SE=0.065, p<0.001). 
A cut-off point of 1236 yielded a sensitivity of 100% and a specificity of 65%. On POD3, 
rats with LHI<1236 had significantly higher dehiscence rate (40% vs. 0%), more weight 
loss, higher abscess severity and lower ABP (p<0.05 respectively); worse anastomotic 
inflammation and collagen deposition were also found in the histological examination.
Conclusion
Our data suggest that postoperative evaluation of anastomotic microcirculation with the 
mDLS device assists the detection of anastomotic leakage in gastrointestinal surgery.
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INTRODUCTION
Despite successful resection of the primary disease, an uncomplicated healing pro-
cess after construction of an anastomosis is crucial after colorectal surgery. Failure in 
anastomotic healing results in anastomotic leakage (AL), which is a serious short-term 
complication contributing to one-third of all postoperative mortality after colorectal 
surgery [1]. When AL strikes, nonsterile intraluminal content leaks into the abdominal 
or pelvic cavity, which causes infection or peritonitis and may lead to sepsis, multiple-
organ failure, and even death if not detected and treated on time [2]. Because of these 
catastrophic outcomes, early detection of AL is the crucial intervention.
Conventionally, surgeons select patients suspicious for AL for radiological examinations 
based on abnormal postoperative manifestations. But those “abnormal” manifestations 
(e.g. fever, leukocytosis, tachycardia, tachypnea) are remarkably common after abdomi-
nal surgery, occurring in a substantial number of uncomplicated recoveries [3]. To date, 
AL is usually detected between day 5 and day 8 or even later after surgery, [4] and more 
than half of the detected leakages require reoperation [5,6]. Surgeons are of the opinion 
that many leakage cases are not detected until too late with the current strategy.
Similar to other types of wounds, one direct consequence of an anastomotic wound is 
tissue ischemia, which has been considered as a risk factor of AL [7-9]. In skin wounds, 
tissue perfusion can be conveniently revealed by repeated evaluation or even real-time 
monitoring with laser Doppler imaging device, flowmetry, or other techniques [10,11]. 
Unfortunately, evaluation of anastomotic perfusion is not a simple task, and to date, it is 
still confined to intraoperative measurement because of the large sizes of most devices 
[12-14]. Monitoring of postoperative anastomotic circulation is not feasible unless a 
much smaller device is available, which patients may carry during hospitalization or 
even afterward.
Recent developments in laser technology include a novel miniaturized dynamic light 
scattering (mDLS) device, which can be used to carry out postoperative evaluation 
of anastomotic microcirculation. However, whether the perfusion data correlate with 
anastomotic healing remains a fundamental question to be answered prior to further 
application of the device. To this end, this study was designed to determine whether 
blood flow measurement with the mDLS device may aid in the diagnosis of failed anas-
tomotic healing. The perioperative local hemodynamic index (LHI) was recorded during 
rat colectomy and analyzed afterward to determine its diagnostic value.
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METHODS
Male Wistar rats were purchased from a licensed breeder (Harlan Laboratories, Boxmeer, 
Netherlands). All rats were bred under specific pathogen-free conditions. Rat chow and 
water were supplied ad libitum. The Ethical Committee on Animal Experimentation of 
Erasmus University Rotterdam approved the protocol.
LHI monitoring device and data extraction
The LHIs were measured with a mDLS device (Elfor, Elfi-Tech Ltd., Rehovot, Israel). The 
device consists of 3 parts: an mDLS sensor, a data-collecting device, and a data-analyzing 
system (ie, real-time monitoring software). The mDLS sensor consists of a vertical-cavity 
surface-emitting laser (wavelength 852.4 ± 2 nm; continuous wave; peak energy 0.7 
mW) and an optoelectronic detection system and is linked to a data-collecting device 
via flexible wires. When measuring, one can choose to send the recorded data directly to 
the computer program via Bluetooth or USB link for real-time monitoring. At the same 
time, the data are also saved on an SD card, which can be analyzed afterward (Figure 1).
Figure 1. The miniaturized dynamic light scattering (mDLS) device, software interface and local hemody-
namic index (LHI) data. A. The mDLS sensor: (1) 10-cent euro coin; (2) the sensor, size = 10 × 10 × 1 mm3 . B. 
The mDLS device, size: 8 × 5 × 1.5 cm3 . C. Interface of the real-time monitoring software. D. Raw LHI data 
recorded by the device. E. LHI data extracted from raw data, 1 to 5 kHz
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This device measures LHI with laser-speckle analysis of moving red blood cells (RBCs)
[15]. The measurement is based on time-dependent analysis of the scattered coherent 
light from an ensemble of moving RBCs and can be used for an assessment of local 
blood shear rate and blood flow [15]. Based on the estimated blood shear rate contri-
butions to the overall signal, different blood flow components into the measured laser 
speckle signal can also be extracted. In this study, the data with a frequency between 1 
and 5 kHz, which represent RBC movement in capillaries and are of the most relevance 
to tissue perfusion, were analyzed [16,17]. A detailed description of the algorithm of LHI 
measurement and calculation is provided in the supplementary data.
In this study, we measured LHI at different time points during the rat colectomy (Figure 
2). Blinded measurements (ie, measuring without real-time monitoring) were used to 
ensure the highest level of objectiveness. During each measurement, the sensor was 
covered with a sterile transparent plastic bag to prevent contamination. Afterward, the 
raw data were uploaded and converted into LHIs (1-5 kHz) with the offline software. The 
median value of each LHI measurement was used for statistical analysis.
Evaluation of a correlation between LHI and anastomotic healing
The rats were anesthetized with an isoflurane/O2 mask. Partial colectomy was performed 
according to the methods described in our previous study [18]. The baseline LHI data of 
the ascending and descending colon were first recorded at the site of the intended cut-
ting edges (Figure 2). Subsequently, the major part of the colon was resected, followed 
by a full-thickness end-to-end anastomosis (ie, continuous suture with 12 stitches) with 
Dafilon 8/0 (B. Braun, Germany) under the microscope. Then, the LHI of the upper and 
lower anastomotic edges were measured. After the LHI measurement on top of the 
anastomosis (Figure 2), the abdominal wall was closed.
Figure 2. Schematic overview of the rat colon and the locations of perfusion measurement, anterior view. 
A. Before colectomy. B. After colectomy. Anatomy: (a) cecum, (b) terminal ileum, (c) rectum and anus. Pro-
cedure: (1) The baseline local hemodynamic index (LHI) is first measured before colectomy at the intended 
cutting edges (ie, indicated with orange dots); (2) a major part of the colon (ie, indicated in gray) is resected; 
(3) the anastomosis (red arrow) is constructed, and the LHI is measured again. Adapted from Wu et al (2015) 
with permission [19].
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Because a standard colectomy yields a relatively low rate of AL, [18] we used an insuf-
ficiently sutured anastomosis in 3 rats to achieve a higher rate of AL, according to the 
leakage model developed. In these rats, 5 interrupted stitches were used instead of 12 
stitches to construct a technically insufficient anastomosis, and the other procedures 
remained the same as in the aforementioned partial colectomy.
Postoperative LHI measurements in a colitis-colectomy model
To verify whether the findings from the previous experiment also exist in a colon disease 
model, postoperative anastomotic LHI measurements were repeated in rats with colitis. 
Colitis was induced by transanal injection of 0.25 mL 2,4,6-trinitrobenzenesulfonic acid 
(TNBS, 10 mg diluted in 25% ethanol) under anesthesia according to the previously 
published TNBS-colitis model [19]. One week later, colectomy was performed with the 
aforementioned technique, and the anastomosis was constructed with a continuous 
suture with 12 stitches.
Follow-up and postoperative evaluation
The rat abdomen was examined on postoperative day (POD) 3. We first checked for signs 
of AL, including abscess formation and anastomotic dehiscence. The abscess severity 
was determined by an abscess scoring system, [20,21] and adhesion formation was 
evaluated using the Zühlke score, [22] anastomotic LHI having been determined with 
the device. The anastomotic bursting pressure (ABP) was determined after the measure-
ment using the methods described in our previous study [18]. The anastomotic segment 
was harvested and stained with hematoxylin and eosin. The slides were scored using the 
Ehrlich and Hunt numerical scale as modified by Phillips et al. [23].
Statistical analysis
Statistical analysis was performed with GraphPad Prism 6.0 (GraphPad Software, Inc, CA). 
Data are presented as mean ± standard deviation, unless stated otherwise. The Mann-
Whitney test, t test, Pearson correlation test, and receiver operating characteristic (ROC) 
analysis were used. All reported p values were 2 sided; a p value <0.05 was considered to 
indicate statistical significance.
RESULTS
Perioperative LHI and anastomotic healing in normal rats
A total of 21 rats (450-550 g) were used. Weight loss and diarrhea after operation were 
observed in all rats. Two deaths occurred after surgery with no signs of AL during au-
topsy.
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The baseline LHI was similar between the ascending and descending colon. Although 
LHI changes were observed during colectomy, the average LHI remained stable at both 
cutting edges. A LHI similar to the baseline was found at the anastomotic site after con-
struction (p > 0.05, Pearson correlation test). None of the intraoperative LHI measure-
ments showed a significant correlation with ABP on POD3 (Figure 3).
Figure 3. Local hemodynamic index (LHI) during colectomy and correlations between intraoperative LHI 
and the anastomotic bursting pressure (ABP) in normal rats. Only rats with the 12-suture anastomosis were 
included, n = 12-15; three rats with the 5-suture anastomosis were excluded for analysis. (A) The baseline 
LHI was similar between the intended upper and lower cutting edges, which remained stable during the 
operation; similar LHI to the baseline was found at the anastomotic site (p > 0.05 respectively), values are 
mean (± S.E.), paired Mann-Whitney test. (B) None of the intraoperative LHI showed a significant correlation 
with ABP (p > 0.05 respectively). Each numbered time point in Figure A corresponds to the average of the 
intraoperative LHI values in the numbered figures in Figure B respectively.
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The correlation between postoperative LHI and ABP on POD3 was statistically significant 
(R2 = 0.52; p < .001, Pearson correlation test). Further linear regression analysis showed 
that Y = 0.044X + 1.0 (Y is the ABP; X is the anastomotic LHI on POD3; Figure 4).
Validating the LHI measurements in a colitis-colectomy model
Based on the results of the previous experiment, postoperative LHI measurements were 
repeated in 15 rats with colitis after colectomy. One death occurred after surgery, and 
no sign of AL was observed during autopsy. Similarly, LHI on POD3 yielded a significant 
correlation with ABP in the colitic rats after colectomy (R2 = 0.63; p = 0.0012; Pearson 
Figure 4. Correlation between the postoperative local hemodynamic index (LHI) and the anastomotic 
bursting pressure (ABP) on postoperative day (POD) 3. The X-axis is the anastomotic LHI on POD 3. The 
Y-axis is the ABP on POD 3. (A) In the normal rats, the linear regression analysis showed that Y = 0.044*X + 
1.0, R2 = 0.52, p < 0.001, n = 18. (B) In the colitis rats, Y = 0.088*X - 22.22, R2 = 0.63, p = 0.0012, n = 13. (C) The 
correlation between the LHI and ABP remained significant when data of the normal and colitic rats were 
combined, Y = 0.043*X + 8.04, R2 = 0.49, p<0.001, n = 31. (D) ROC analysis showed LHI on POD3 had high 
accuracy for identifying ABP < 50 mmHg. Area under curve (AUC) = 0.86, S.E. = 0.065, 95%CI = 0.74 to 0.99, 
p<0.001, n = 31.
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correlation test). Further linear regression analysis showed that Y = 0.088 × X − 22.22; 
P = 0.0012 (Y stands for ABP; X stands for LHI; Figure 4).
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Figure 5. Comparison of clinical and histological outcomes between the insufficient perfusion group (IPG, 
n = 20) and the sufficient perfusion group (SPG, n = 11). (A) Anastomotic dehiscence rate was 40% (8/20) in 
the insufficient perfusion group and 0% (0/11) in the sufficient perfusion group, p = 0.028, Chi-square test. (B) 
Comparison of weight loss yielded a p = 0.048, t test. (C) Comparison of anastomotic bursting pressure (ABP) 
resulted in p < 0.001, Mann-Whitney test. (D) A significantly higher abscess score was found in the insufficient 
perfusion group than that in the sufficient perfusion group, p = 0.034, Mann-Whitney test. (E) In histological 
evaluations, the insufficient perfusion group showed a significantly worse status of inflammatory infiltration 
and collagen deposition, p < 0.05 respectively, Mann-Whitney test. * indicates p < 0.05, *** indicates p < 0.001. 
In (B-E) values are mean (± S.E.).
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Diagnostic value of postoperative LHI measurement
Combining the data from the 2 experiments, we still observed a significant correlation 
between LHI and ABP (Figure 4). Moreover, we found that the postoperative LHI showed 
high accuracy in detecting failed anastomotic healing. Based on our previous rat ex-
periments, ABP <50 mm Hg was set to determine if an anastomosis was mechanically 
insufficient [24]. As is shown in Figure 4, anastomotic LHI on POD3 had high accuracy for 
identifying ABP <50 mm Hg. Area under the curve was 0.86 (standard error = 0.065; 95% 
confidence interval [CI] = 0.74 to 0.99; p < 0.001). Further analysis showed that a cutoff 
point of 1236 yielded a sensitivity of 100% (95% CI = 77%-100%) and a specificity of 65% 
(95% CI = 28%-86%), a positive predictive value of 70% and a negative predictive value 
of 100%, and an accuracy of 81%.
To enable comparisons between rats with sufficient/ insufficient anastomotic LHI on POD3, 
the rats were further assigned to 2 groups based on perfusion. Rats with a higher anasto-
motic LHI than the cutoff point (ie, 1236) were assigned to a sufficient-perfusion group (n = 
11), including 10 normal rats and 1 rat with colitis, and the other rats were divided into an 
insufficient-perfusion group (n = 20), including 5 normal rats with the 12-suture anastomo-
sis, all 3 normal rats with the 5-suture anastomosis, and 12 rats with colitis.
In total, 8 animals had an anastomotic dehiscence, all from the insufficient-perfusion 
group. Significantly higher weight loss (39.8 ± 11.4 g vs 29.3 ± 16.9 g; p = 0.048; t test) 
and higher abscess score (2.3 ± 1.4 vs 1.2 ± 0.8; P = .034; Mann-Whitney test) were found 
in the insufficient-perfusion group as well when compared with the sufficient-perfusion 
group (Figure 5). An average bursting pressure of 38.2 ± 26.4 mm Hg was seen in the 
insufficient-perfusion group, which was significantly lower than that in the sufficient-
perfusion group (98.7 ± 34.0 mm Hg; p < 0.001; Mann-Whitney test; Figure 5). On histo-
logical evaluation, the insufficient-perfusion group showed a significantly worse status 
of inflammatory infiltration and collagen deposition (p < 0.05; MannWhitney test).
DISCUSSION
Evaluation of anastomotic perfusion may be a reliable strategy to reveal the wound 
healing status and to detect AL after colorectal surgery. In this study, we demonstrated 
a correlation between LHI and anastomotic healing in a rat colectomy model with a 
novel mDLS device and further validated it in a surgical colitis model, exploring its 
diagnostic value. These data encourage further investigation of the device in detecting 
AL in colorectal surgery.
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Though recognizing the importance of tissue perfusion in anastomotic healing, few 
strategies exist to assist surgeons objectively in determining anastomotic perfusion 
once the laparotomy/laparoscopy is closed. Several early attempts from previous stud-
ies suggest that an elevation of indirect parameters (eg, pH, lactate, and pyruvate) might 
indicate the presence of AL [2,14,25]. Direct correlation between postoperative anas-
tomotic perfusion and its healing process has not yet been established. In this study, 
such a correlation was observed in both experiments regardless of the primary disease, 
which, in combination with the ROC analysis, provided direct evidence regarding the 
diagnostic value of the LHI measurements. In addition to the satisfactory diagnostic 
value for identifying mechanically weak anastomoses, poorer clinical manifestations, 
including anastomotic dehiscence and abscess formation, were found in the rats. Such 
differences were in line with the histological findings revealing worse inflammation and 
collagen deposition in the rats with insufficient anastomotic perfusion. Our data, in cor-
respondence with the previous literature, confirm the crucial role of tissue perfusion in 
the process of wound healing.
Different from postoperative measurements, many clinical trials have suggested a 
clinical value of the intraoperative perfusion measurement in detecting anastomotic 
ischemia [9,12,13,26]. However, the limitation of such methods is clearly illustrated by 
our data. The LHI data of the 3 rats with insufficient sutures demonstrate that bowel 
ischemia may not exist during operation under circumstances when AL is caused by 
certain intraoperative factors, let alone postoperative ones. Nevertheless, our data do 
not oppose any further application of intraoperative evaluation because rather than 
a standardized rat model without preoperative risk factors, substantial risk factors 
resulting from patient-related comorbidities (eg, uncontrolled diabetes, smoking, ath-
erosclerotic calcification) may cause bowel hypoxemia before the operation, which is 
probably detectable with the intraoperative perfusion measurement [27-29]. Moreover, 
our ongoing studies revealed that certain preoperative or intraoperative risk factors also 
influenced LHI changes during surgery (unpublished data). Further investigations with 
comprehensive analysis in this regard are being planned.
The applications of postoperative perfusion measurement are in 2 areas. One consists of 
objectively evaluating bowel perfusion during examination or reintervention in patients 
suspicious for AL. Such an application is greatly necessary because in many cases bowel 
ischemia is not detectable by the naked eyes during reoperation [25]. Moreover, our study 
also showed that mechanically insufficient anastomoses were not always accompanied 
by anastomotic abscess formation or dehiscence. Perfusion measurement may aid in 
the formulation of a better surgical plan based on a real-time bowel perfusion level and 
speculation of the mechanical strength of a suspicious anastomosis in circumstances when 
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clinical manifestations remain inconclusive. These measurements can be implemented in 
combination with a laparoscopic approach because of the very small size of the device. 
It can also be applied in combination with endoscopy for postoperative examination 
because mucosal and serosal blood flow measurements are linearly correlated [30].
Another avenue is postoperative real-time monitoring of anastomotic perfusion. The 
main strength of this mDLS device is its small size, which enables such monitoring, but it 
remains technically challenging. How to place it properly near the anastomosis and how 
to retract it are still major questions to be verified. Combining the perfusion sensor with 
an intra-abdominal drainage or with an intra-gastrointestinal tube might be a promising 
strategy, [31] and further investigation in this regard is still required with large animal 
models. Although difficult with the current technique, this remains a promising approach 
in the future. Doctors may implement real-time monitoring in patients with Bluetooth and 
data processing software, which will alert them when an early-stage AL occurs.
In addition to the technological development of the medical device, further investigation 
should also focus on LHI data mining. The DLS system has been developed for decades for 
various clinical indications [15,32]. The device in our study has been previously tested in 
human subjects at different clinical conditions for assessment of capillary skin flow, RBC-
endothelial interaction, and pulse wave hemodynamic characteristics [32]. We analyzed 
the data with a frequency between 1 and 5 kHz in the current study, which is considered 
to best represent tissue perfusion [16,17]. Substantial data can be further extracted to 
investigate the microcirculation with other characteristics. Integrating the data from 
different frequencies may reveal not only the hemodynamic characteristics but also the 
tissue oxygenation level, providing a comprehensive picture of the tissue environment. 
Investigations addressing these issues are currently under way in our research team.
In this rat model, we chose POD3 as the follow-up period, when ABP best represents 
the anastomotic healing process. In a shorter follow-up period, the mechanical strength 
of an anastomosis is still greatly influenced by the suture strength, whereas in the long 
term, many well-healed anastomoses usually burst outside the anastomotic area [33]. 
Both conditions attenuate the representativeness of the ABP, which may eventually 
influence the correlation analysis (LHI vs ABP) in this experimental study. The acute in-
flammatory response at the constructed anastomosis usually reaches its peak within 3 
days. When AL occurs, a large number of inflammatory cells infiltrate the anastomotic 
area, which results in abscess formation and collagen degradation, both weakening the 
anastomotic strength that can be detected by the ABP test [24]. Similar phenomena 
were also observed in our study.
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Given an ideal follow-up time, to determine the correlation pattern between anasto-
motic strength and anastomotic perfusion remained difficult with our study design, 
because there was very limited knowledge from the previous literature exploring this 
topic. Some previous data have shown that colonic oxygen tension was correlated with 
anastomotic breaking strength, [34] and bowel perfusion was in correspondence with 
severity of bowel injury in Inflammatory bowel disease (IBD) patients, [27] both of which 
seemed to fit a linear correlation. Hsieh et al [35] also developed an equation with a 
linear regression when they implemented a laser Doppler device to predict diabetic 
ulcer. However, we recognize that simply using a linear regression and the correspond-
ing equation to predict the anastomotic strength may include relatively high risks of 
bias. The R2 values in the results (ie, 0.52 and 0.63) further confirmed this and suggested 
the involvement of other factors that influenced the anastomotic strength. Therefore, 
we performed the ROC analysis to determine the diagnostic value of LHI and the cutoff 
point of a mechanically insufficient anastomosis. We believe that such an analysis is 
more reliable for future research and application of the LHI device.
In conclusion, our data suggest that postoperative blood flow evaluation with an mDLS 
device at the anastomotic site provides useful information regarding anastomotic heal-
ing and may facilitate detection of AL in colorectal surgery.
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SUPPLEMENTARy DATA
How is the LHI calculated?
The m-DLS signal is originated from the relative movement of the scattering particles. In 
the case of the blood flow the relative movement is caused by the velocity profile of the 
flowing blood in small vessels(see the picture below).
The mDLS technology takes advantage of the RBC velocity differences and produces a 
signals that resemble other well knows physiological signals such as PPG, Laser Doppler 
Velocimetry (LDV), and Invasive Blood Pressure (IBP).
mDLS differs from the LDV in that LDV measures the local velocity of blood flow, whereas 
the mDLS measures the red blood cells (RBC) velocity gradient which is directly related 
to the shear rate. According to basic low of laminar flow the shear rate increases when 
the velocity goes up, so the mDLS signal is a function of flow velocity. The measured 
signal is formed by the difference in Doppler shifts of all correlated and uncorrelated 
particles in the scattering volume. The signal is derived from the fluctuations of the 
intensity signal I(t). The measured parameter is the autocorrelation function ACF of I(t) 
which is defined by:
2)()()( ItItIACF  WW  
For the laminar blood flow the most important contribution to the correlation function 
measured by mDLS comes from all moving RBC pairs. These pairs are formed by the 
spatially related moving RBC’s, which are located in close vicinity to each other. The 
more distant particles give negligible weight into the g. Therefore, the mDLS is sensitive 
to the velocity gradient in laminar or turbulent flow.
In the case of Poiseuille laminar blood flow the blood moves back and forth with oscilla-
tory frequency ω in response to the oscillatory pressure gradient. The flow velocity u(r,t) 
is the function of radial location r in the vessel and time t. u(r,t) is described by:
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1 . In very simplified case if a vessel of radius R, axis symmetric 
velocity profiles v(r,t) can be described in cylindrical coordinates by the empirical rela-
tionship:
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where -1<(r/R)<1, f(t) is a periodic function of heart beat frequency, which is driven by 
systolic pressure wave and it is time phase-shifted with respect to the cardiac cycle, and 
ξ represents the degree of blunting. For example, in 30 micron arterioles, there is a range 
of ξ 2.4 – 4 at normal flow rates. If ξ=2, a parabolic velocity distribution is obtained. 
Blunting would occur even in larger arterioles at low flow rates. The standard deviation 
d(v) can be calculated by:
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The rms(dV) is proportional to the blood flow velocity. In terms of ACF decay time of 
autocorrelation function can be estimated by  )(
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. Actually, the decay time of the process is very short and it means that high frequency 
component of the signal is closely is associated with the arterial blood flow signal.
For small arterials (around 20 microns), the fluctuation of velocity from systolic to 
diastolic phases ranges from 1.5mm/s to 2.5 mm/s. This results in a very significant fluc-
tuation of standard deviation (Rms) during the systolic–diastolic cycle. Pulsatile signal, 
therefore, can be used for calculation of hemorheological parameters.
In (I. Fine et al, Journal of Biomedical Optics 17(8), 087002 (August 2012) it was shown 
the ACF , which is related to shear rate of blood, can be expressed in terms of power 
spectrum density so that as ³ ³  
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The value of I is driven by ζ(ω) and by the range of ω values. Whenever the ζ(ω) and range 
of (ω1 – ω2) are adjusted toward the low frequency components then LHI value will rep-
resent a contribution of the slow moving RBC’s. This kind of RBC’s can be found mainly in 
very small vessels or in the vessels with very strong hemodynamic resistances. When the 
selected frequencies range from the LHI integral goes toward the higher range of the 
frequencies, it means that LHI index represents high levels of shear rate and velocities.
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ABSTRACT
Aim
Postoperative ileus (POI), a transit cessation of bowel motility, is common after surgery. 
Previous knowledge from animal studies does indicate that the POI mechanism involves 
an inflammatory response, which is also activated during postoperative infectious com-
plications. This study aimed to determine whether the selected inflammatory biomarkers 
might facilitate an early detection of prolonged POI (PPOI) or infectious complications.
Methods
Forty-seven adult patients who underwent oncological colorectal surgery were in-
cluded. They filled out a perioperative diary to report their gastrointestinal symptoms. 
Blood samples were collected pre-operatively, and on day 1 and 3 after surgery. Levels 
of leucocytes, CRP, interleukin (IL)-6, TNF-α, and IL-1β were analyzed.
Results
Patients with PPOI had significantly longer stay in hospital than patients without 
(13.6±10.5 days versus 7.4±3.2 days, p<0.001); they also had higher levels of IL-6 ratios, 
leucocyte count, and CRP-levels after surgery, but not significant. Similar data were also 
found in the patients with infectious complications (incidence 48% in total, i.e. surgical 
site infection 26%, pneumonia 11%, anastomotic leakage 9%, urinary infection 9%), with 
higher levels of IL-6 ratios and CRP-levels after surgery (p<0.05 respectively). The ROC 
analysis found better diagnostic values of IL-6 ratio on both day 1 and 3 after surgery 
than that of CRP (POD 1; ROC 0.825, p<0.001).
Conclusion
Perioperative changes of the inflammatory cytokines cannot predict PPOI after colorec-
tal surgery. Instead, systematic changes of IL-6 level on postoperative day 1 and 3 may 
predict the infectious complications with a better diagnostic value compared with 
leukocyte count and CRP changes.
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INTRODUCTION
Surgical resection is still the cornerstone of colorectal cancer treatment. Nevertheless, 
colorectal surgery is associated with a high morbidity rate of 24-43% [1-3], which sig-
nificantly compromise a fast recovery after surgery and quality of life after discharge. 
Infectious complications including surgical site infection and anastomotic leakage are 
the major causes of postoperative morbidity and mortality [4]. Moreover, many patients 
also develop postoperative ileus (POI) characterized by a transient impairment of bowel 
function and reduced motility. In some of them, prolonged POI (PPOI) is diagnosed 
when POI does not resolve after 5 postoperative days or recurs after an apparent resolu-
tion. Such delayed recovery of bowel function leads to other serious outcomes such as 
longer hospitalization, hospital-acquired infections, pulmonary compromise and a large 
increase of medical cost as well [5].
Many studies on animal models have revealed that the mechanism of POI includes an 
inflammatory response caused by the intestinal manipulation and surgical trauma [6-8]. 
Therefore, inflammatory markers such as interleukin (IL)-1β, IL-6, TNF-α, and CRP have 
been suggested to be valuable for the early detection of POI. Previous studies reported 
that the level of IL-1β, IL-6, and TNF-α in PPOI patients were significantly higher at post-
operative day 5 in abdominal drain fluid than that in normal recoveries [9, 10]. However, 
due to the wide application of the ERAS (early recovery after surgery) program, perito-
neal drainage is omitted in many colorectal patients anymore. In such cases, measuring 
systematic levels of the inflammatory cytokines seems to be a promising alternative 
since it can be easily integrated into postoperative blood tests.
This approach is supported by animal studies, which have revealed that elevation of 
the inflammatory cytokines is also detectable in the blood in POI models in addition 
to a localized change [6, 7]. Nevertheless, clinical data to support this are still not yet 
available. Moreover, it is important to note that the classic pro-inflammatory response 
is also activated in infectious complications, and increasing levels of the inflammatory 
cytokines were also reported in these complications [11-16]. Therefore, we collected the 
perioperative blood samples of the patients who underwent colorectal surgery, trying 
to determine whether measuring the systemic inflammatory markers may aid to the 
early detection of PPOI or infectious complications.
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METHODS
Study population and design
Adult patients admitted to the Academic Colorectal Cancer Center Havenziekenhuis 
Rotterdam who underwent oncological colorectal surgery were included after informed 
consent. In total 50 patients were planned to be included in this prospective cohort 
during the period of November 2013 and November 2014. In accordance with the Dutch 
law on medical research in humans, this study was approved by the Medical Ethical 
Committee of the Erasmus University Medical Center, Rotterdam, the Netherlands (Per-
mit number: MEC-2013-246, NL43053.078.13) and patients gave their written consent 
after receiving oral and written information.
All patients were asked to fill out a questionnaire before surgery and every day after sur-
gery until postoperative day (POD) 7. The questions refer to their food and fluid intake, 
bowel movements and defecation, gastrointestinal symptoms and Visual Analogue Scale 
(VAS) pain score. Data collection included age, gender, body mass index (BMI), American 
Society of Anesthesiologists (ASA) score, medication use, smoking, operative procedure, 
postoperative complications including anastomotic leakage, fascia dehiscence, surgical 
site infection (SSI), urinary tract infection, pneumonia and postoperative course.
The primary goal of this study was to investigate whether the perioperative inflamma-
tory cytokine levels can predict PPOI. Secondarily, we also tried to associate the cytokine 
levels with the infectious complications.
Selection of variables and definitions
To ensure the objectiveness of our primary endpoint, PPOI was not diagnosed by the partici-
pating surgeons but via the retrospective review of the patient diary and medical record. The 
participating doctors diagnosed the other complications according to the criteria listed in 
Table 1, which presents the variables and definitions of complications and outcome [17-19].
Blood sample analysis
Peripheral blood was drawn from each patient before surgery (baseline), and on the first 
and third postoperative day in the morning, together with the routine blood tests. Leu-
cocytes and C-reactive protein (CRP) measurements were part of the standardized care 
and the outcomes were retrieved from the medical chart. Blood samples were centri-
fuged and plasma was stored at -80oC into two aliquots. Enzyme-linked immunosorbent 
assays (ELISAs) were performed according to manufacturer’s instructions to quantify 
the concentrations of systematic inflammatory markers IL-6 and TNF-α (PeproTech Inc., 
Rocky Hill, USA), and IL-1β (R&D Systems, Minneapolis, MN, USA) in blood plasma.
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ERAS (enhanced recovery after surgery) protocol
All patients were treated according to the ERAS protocol. Two hours before surgery 
patients pre-operatively received a carbon-hydrate loaded drink. In some cases of low 
anterior resection, an enema was given under prescription of the surgeon. In general, left 
sided colectomy and (low) anterior resections received bowel preparation with 2 liters of 
Macrogol 3350 (Klean prep 69 gr, Norgine Ltd, Harefield, United Kingdom). Immediately 
after surgery, nasogastric tubes were removed and patients are allowed to mobilize or 
drink fluid food. Normal diet was offered from the first postoperative day and on.
Table 1. The variables and definitions of complication and outcome
Complications/ outcome Definition
PPOI* Resolution of POI is defined as passage of feces with good toleration of solid food 
for at least 24 hours. PPOI is diagnosed if POI is not resolved after postoperative 
day 5; recurrent POI occurring after an apparent resolution of POI was also 
defined as PPOI [17, 19].
Anastomotic leakage Defect of the bowel wall integrity at the anastomotic site. A pelvic abscess close 
to the anastomosis is also considered as anastomotic leakage. The diagnosed 
leakage were Grade B or C according to classification of Rahbari et al. [18].
Surgical site infection (SSI) Erythema requiring initiation of antibiotic treatment or a wound requiring partial 
or complete opening for drainage of a purulent collection.
Pneumonia Presentation of clinical symptoms including cough, fever, dyspnoea or 
consolidation on chest radiography requiring antibiotic treatment with or without 
a positive sputum culture.
Urinary tract infection Presents of clinical symptoms e.g. fever, polyuria, and stranguria requiring 
antibiotic treatment.
Fascia defect Dehiscence of the abdominal wall with or without the need for reoperation
Reoperation During hospital stay, within 30 days postoperative or during readmission within 
30 days after initial discharge
Length of hospital stay Day of admission till the day a patient is ready for discharge, this means patient 
tolerate solid food, had passage of feces, and pain is adequately in control with 
oral analgesics
Readmission Admission within 30 days after discharge for more than 24 hours
Mortality Death occurring during hospital stay or within 30 days postoperative
* Prolonged postoperative ileus
Statistical analysis
The statistical analysis was carried out using the Statistical Package for the Social Sci-
ences (SPSS Inc., Chicago, USA, version 21.0 for Windows). Demographic data were 
presented in n (%), mean (SD) or median (95% confidence interval). Mann-Whitney U 
test, chi-square test, Pearson correlation test, and ROC analysis were employed accord-
ing to a proper indication. A 2-tailed p value < 0.05 was considered to indicate statistical 
significance.
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Table 2. Baseline and surgical characteristic comparison between the PPOI and no-PPOI patients.
no-PPOI (%) PPOI (%)
n=34 n=13
Patient characteristics
Age (yrs) 67.6 ± 10.4 71.2 ± 11.2
Gender
Male 21 (62) 6 (46)
Female 13 (39) 7 (54)
BMI (kg/m2) 27.2 ± 4.7 24.7 ± 4.2
ASA score
I 6 (18) 4 (31)
II 14 (41) 4 (31)
III 9 (26) 1 (8)
IV 0 0
Missing 5 (15) 4 (31)
Cardiac comorbidity 11 (32) 3 (23)
Diabetes Mellitus 6 (18) 1 (8)
Smoker 6 (18) 1 (8)
COPD 7 (21) 1 (8)
Use of statins 12 (36) 3 (23)
Use of antihypertensive 12 (36) 7 (54)
Neoadjuvant radiotherapy 2 (6) 0
Chemo-radiation 4 (12) 1 (8)
Abdominal surgery in history 12 (35) 3 (23)
Operation characteristics
Type of operation
Low anterior resection 10 (29) 2 (15)
Sigmoid resection 6 (18) 2 (15)
Hemicolectomy right 9 (26) 8 (62)
Hemicolectomy left 5 (15) 0
Colon transversum resection 1 (3) 1 (8)
APR 3 (9) 0
Approach
Laparotomy 13 (38) 5 (38)
Laparoscopy 20 (59) 7 (54)
Conversion 1 (3) 1 (8)
Stapled vs. hand sutured#
Sutured 19 (58) 9 (69)
Stapled 14 (42) 4 (31)
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RESULTS
Between October 2013 and November 2014, 54 patients were included, three patients 
were excluded because of protocol violations of the inclusion criteria, and four patients 
retracted the informed consent. In total 47 patients were included for analysis.
PPOI versus no-PPOI
In total 72% (34/47) of the patients recovered from POI within five postoperative days 
(POD5) and were assigned to the no-PPOI group; 28% (13/47) patients recovered on or 
after 6 days postoperatively (8/13) or had recurrence of POI (5/13) and were therefore 
defined as PPOI. Univariate analysis showed a similar baseline and operative character-
istics in the patients with or without PPOI (Table 2).
IL-6 levels were detectable in all samples in all three time-points in all patients. However, 
TNF-α and IL-1β were not detectable in the majority of samples. The detailed propor-
tions of detectable samples are listed in Supplementary Table 1 (S1).
The absolute median values of cytokines of positive samples are presented in Supple-
mentary Table 2 (S2). In the detected samples, we found several samples with sub-
stantially higher levels of cytokines compared with other samples, resulting in a large 
variation in results. We also found that cytokine levels of these patients remained high 
after surgery. Therefore a cytokine ratio was calculated with the following equation: ratio 
POD1 (or 3) = (cytokine level on POD1 (or 3))/(cytokine level before surgery) for further 
Table 2. Baseline and surgical characteristic comparison between the PPOI and no-PPOI patients. (con-
tinued)
no-PPOI (%) PPOI (%)
n=34 n=13
Anastomotic configuration*
Side-end 10 (29) 5 (42)
Side-side 14 (41) 7 (58)
End-end 6 (18) 0
Stoma 11 (32) 2 (13)
Profylactive drainage 4 (12) 1 (8)
Nasogastric tube** 10 (29) 6 (50)
Data are n (%), mean (SD). BMI=Body Mass Index, ASA= American Society of Anesthesiologists classifica-
tion.
# n=33 in no PPOI, n=13 in PPOI group
* n=30 in no PPOI group, n=12 in PPOI group
** n=12 in PPOI group
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analysis. Cytokine levels and ratios describe the ratio of cytokine levels at postoperative 
day 1 and 3 divided by the pre-operative cytokine level.
The PPOI group showed higher IL-6 ratios on POD3: 5.90 ± 9.11 than in the no-PPOI 
group: 2.44 ± 3.84 (Figure 1). Due to a low number of valid values, we found no differ-
ences in IL-1β ratio and TNF-α ratio between the two groups.
Figure 1A and 1B. IL-6 ratio in normal recoveries (no-PPOI) versus PPOI patients, every single dot repre-
sents a patient, the line indicates the median, and there are no significant differences. 
Both leucocytes and CRP were higher in the PPOI group, but there were no significantly 
differences between no-PPOI and PPOI group at any time point (Figure 2). Also a higher 
postoperative VAS score was seen in the PPOI group, though no statistical difference was 
observed.
In total 13.0% (6/46) were diagnosed with colorectal anastomotic leakage. In the PPOI 
group a significantly higher percentage of anastomotic leakage was seen, 38.5% (5/13) 
versus 3.0% (1/33) in the no-PPOI group, p = 0.005. The hospital stay duration was signifi-
cant longer in PPOI patients 13.6 ± 10.5 versus 7.4 ± 3.2 in the no-PPOI cases, p < 0.001 
(Figure 2D).
Infectious versus no infectious complication
There were no significant differences between the baseline and surgical characteristic 
comparison of patients with and without infectious complications (Supplementary Table 
S3). Different from the PPOI patients, patients with the infectious complications had 
significantly higher IL-6 ratios and CRP levels on POD1 and POD3 (p < 0.05, respectively, 
Figure 3A), while the leucocytes count, though also higher, was not significantly differ-
ent from patients without infectious complications, Figure 3C. Further detailed analysis 
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showed that signifi cantly higher levels of IL-6 ratios on POD1 and POD3 were found in 
SSI and colorectal anastomotic leakage (CAL) patients as is illustrated in Figure 3A, while 
the diff erences in CRP were not signifi cant (Figure 3B). No diff erences were observed in 
IL-1β and TNF-α ratios between the groups.
We performed the ROC analysis to determine the diagnostic value of CRP and IL-6 ratio 
in detection of infectious complications. Both on POD1 and POD3, IL-6 ratio had a larger 
area under curve (AUC) than that of CRP (Figure 4). Further analysis showed that the 
diagnostic value was achieved on POD1 with a cutting-off  point of 1.21 of IL-6 ratio, 
which yielded a sensitivity of 76% and a specifi city of 86%. Although the sensitivity was 
relatively low (43%), a cutting-off  point of 1.93 on POD1 reached a specifi city of 100%, 
meaning all patients with an IL-6 ratio higher than 1.93 on POD1 were diagnosed with 
infectious complications later on.
Figure 2. The Leucocyte count, CRP and VAS score in no-PPOI patients vs. PPOI. In 2A and 2B bars repre-
sent the mean and error bars the SD. There are no signifi cant diff erences. Figure 2C presents the VAS (visual 
analogue scale for pain) score, from postoperative day 1 up to postoperative day 6. Figure 2D presents 
patients with or without PPOI and the time in days of being ready for discharge. Patients with PPOI had a 
signifi cantly longer hospital stay p < 0.001.
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Figure 3. Comparison of IL-6, leucocyte count, and CRP between the patient group with infectious 
complication(s) (SSI, AL, pneumonia, UWI) and without infectious complication or with or without SSI (sur-
gical site infection) or with or without CAL (colorectal anastomotic leakage). A) shows that all IL6-ratio are 
signifi cant higher on both time points between all three groups; the infectious group POD1 p< 0.001 and 
POD3 p=0.001, SSI; POD1 p=0.001 and POD3 p=0.017, CAL; POD1 p= 0.027 and POD3 p=0.050. B) On POD1 
and POD3 the CRP levels were signifi cantly higher in the infectious complication groups (POD1 p=0.009, 
POD3 p=0.008). In the SSI groups CRP levels were signifi cantly higher in patients with SSI compared to 
patients without SSI on POD1, p < 0.001. Also in the groups with CAL had higher numbers of CRP though 
not signifi cant. C) Although the leucocyte count are higher in the infectious and CAL groups there were no 
signifi cant diff erences. Bars represent the mean, error bars the SD, p-values are indicated with an asterisk; * 
p-value ≤ 0.05, ** p-value ≤ 0.001.
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DISCUSSION
The importance of developing effective strategies to predict and eventually to treat the 
postoperative complications cannot be overemphasized. In this study, we investigated 
the association between the inflammatory cytokines and the postoperative complica-
tions. We found that systematic changes of IL-6 predicted the infectious complications 
but not prolonged postoperative ileus after colorectal surgery.
To develop the effective strategies, researchers depend on the translational knowledge 
from animal studies, which have been continuously contributing to the understanding 
of POI mechanism. Several experimental studies have reported the important role of 
IL-6 in the development of POI. Even little manipulation of the bowel induces activity 
of IL-6, which results in activation of nitric oxide and prostaglandins, and cause migra-
tion of leucocytes into the circular muscle of the bowel, and resulted in PPOI eventually 
[20-23]. However, with fruitful data obtained from animal studies, clinical attempts to 
predict POI by determining inflammatory mediator levels, the important mechanism in 
PPOI pathophysiology, remain limited. Zhu et al. found that peritoneal levels of IL-1, IL-6, 
and pro-calcitonin were higher in PPOI patients [24], indicating localized parameters 
are sensitive for PPOI prediction. Clinical data also found that IL-6 levels are higher in 
patients undergoing open surgery when compared with patients undergoing laparo-
scopic surgery [20], while open procedures had been demonstrated to delay recovery 
of POI [8].
In this study, we report a prospective cohort investigating the association between the 
inflammatory cytokines and the postoperative complications. We found that system-
atic changes of IL-6 predicted infectious complications but did not predict PPOI after 
colorectal surgery. In contrast to many previous animal studies, our results indicate that 
systematic cytokine levels yields poor predictive value in PPOI diagnosis. This can be 
partly explained by inevitable confounding factors (e.g. sex, age, type of surgery, preop-
erative risk factors etc.) in patient subjects which dilute the influence of POI on systematic 
inflammatory response [25], while those factors are usually controlled in animal studies. 
Figure 4. ROC analysis showed CRP and IL-6 ratio on POD1 (A), and POD3 (B), on both days the AUC was 
higher in for IL-6 ratio.
POD Biomarker AUC SE p 95% CI 
POD1 CRP 0.732 0.078 0.010 0.579 0.884
IL-6 0.825 0.067 0.000 0.693 0.956
POD3 CRP 0.731 0.077 0.008 0.580 0.882
IL-6 0.801 0.068 0.001 0.668 0.934
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Nevertheless, we believe that our included patients properly represent the common 
colorectal patient population. An ideal parameter should be able to identify the high-
risk patients. In addition, many animal models used in POI research have very different 
inflammatory response compared with human [26, 27]. For instance, different from the 
animal data, our study found that systematic TNF-α and IL-1β levels were extremely low. 
This was also reported by Ellebæk et al. [28], and our previous meta-analysis, in which we 
found that in peritoneal samples, IL-6 is already significantly higher in CAL patients on 
POD1, while elevation of TNF-α and IL-1β, both at much lower concentration, were not 
observed in the first 3 postoperative days [29].
As is shown in our results, cytokine levels are individually dependent. This has not yet 
been previously investigated in surgical patients. Previous studies also reported great 
variation in systematic IL-6 levels [30], therefore we chose ratio instead of absolute levels 
of cytokines to rule out the individual baseline variations, which resulted in a higher 
diagnostic value of the infectious complications than CRP in the ROC analysis.
Based on our results, it seems that only in severe complications but not PPOI, the 
overwhelming inflammatory response can be detected in serum in clinical settings. For 
those complications, leukocyte count and CRP are commonly used to assist an early 
diagnosis [31, 32], thus we also included them into our analysis. In accordance to the 
previous studies, our data also support the value of CRP in the diagnosis of infectious 
complications. Nevertheless, the ROC analysis further demonstrates that IL-6 yielded 
better diagnostic value than CRP in predicting the infectious complications. It is impor-
tant to note that the diagnostic value of IL-6 became evident very early on POD1. All 
patients had a ratio higher than 1.93 developed infectious complications, indicating the 
importance of IL-6 evaluation as a promising innovative biomarker for clinical practice.
Although many previous studies exclude patients with other complications from the 
PPOI group, we still included them to represent a common patient population. This is 
because it is possible to exclude those patients with complications (e.g. anastomotic 
leakage) from the POI or PPOI group in a retrospective database. But in a prospective 
cohort or clinical practice, a surgeon has to differentiate POI or PPOI from other severe 
complications that require more invasive interventions because many infectious compli-
cations first manifest abdominal symptoms before systematic manifestations. This may 
explain the significantly higher rate of the complications in the PPOI patients in our data.
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CONCLUSION
Postoperative ileus remains the most common complication after gastrointestinal 
surgery, without a satisfactory parameter for its early detection or prediction. In this 
study, we report a prospective cohort study investigating the association between 
inflammatory cytokines and postoperative complications. We found that serum IL-6 
changes can predict the infectious complications but not prolonged postoperative 
ileus after colorectal surgery. How to translate knowledge from rodent POI studies to 
clinical practice is evidently an urgent issue to be addressed. Further exploration of IL-6 
seems promising and may assist an early detection of the infectious complications after 
surgery.
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SUPPLEMENTARy DATA
Table S1. Percentage of positive samples in the no-PPOI and PPOI group.
no-PPOI PPOI
pre-OK (n=31) POD1 (n=34) POD3 (n=34) pre-OK (n=13) POD1 (n=13) POD3 (n=13)
Positive samples (%)
IL-6 100 100 100 100 100 100
IL-1β 25.8 29.4 32.4 15.4 7.7 15.4
TNF-α 12.9 20.6 35.3 7.7 30.8 46.2
Table S2. Absolute level of cytokine in plasma of the positive samples
no-PPOI PPOI
pre-OK (n=31) POD1 (n=34) POD3 (n=34) pre-OK (n=13) POD1 (n=13) POD3 (n=13)
IL-6 Median 377 418 498 100 126 219
IL-1β Median 13 14 13 12 15 14
TNF-α Median 163 40 30 67 78 103
no significantly differences
Table S3. Baseline and surgical characteristic comparison between patients with infectious complications 
and normal recovery.
No infectious complication Infectious complication
n=24 n=22
Patient characteristics
Age (years) 70.5 ± 10.3 68.8 ± 11.1
Gender
male 15 (63) 12 (55)
female 9 (37) 10 (45)
BMI (kg/m2) 26.1 ± 5.0 26.9 ± 4.2
ASA score
I 5 (21) 5 (23)
II 11 (46) 7 (32)
III 5 (21) 5 (23)
IV 0 0
missing 3 (13) 5 (23)
Cardiac comorbidity 10 (42) 4 (18)
Diabetes Mellitus 3 (13) 4 (18)
Smoker 3 (13) 4 (18)
COPD 3 (13) 5 (23)
Use of statins 7 (29) 8 (36)
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Table S3. Baseline and surgical characteristic comparison between patients with infectious complications 
and normal recovery. (continued)
No infectious complication Infectious complication
n=24 n=22
Use of antihypertensiva 9 (38) 10 (45)
Neoadjuvant radiotherapy 1 (4) 1 (5)
Chemoradiation 3 (13) 2 (9)
Abdominal surgery in history 9 (38) 6 (27)
Operation characteristics
Type of operation
low anterior resection 7 (29) 5 (23)
sigmoid resection 2 (8) 5 (23)
hemicolectomy right 9 (38) 8 (36)
hemicolectomy left 5 (21) 0
colon transversum resection 1 (4) 1 (5)
APR 0 3 (14)
Approach
laparotomy 7 (29) 10 (45)
laparoscopy 16 (67) 11 (50)
conversion 1 (4) 1 (5)
Stapled vs. hand sutured*
sutured 17 (71) 10 (48)
stapled 7 (29) 11 (52)
Anastomotic configuration**
side-end 6 (27) 8 (38)
side-side 13 (59) 8 (38)
end-end 3 (14) 3 (14)
Stoma 6 (25) 7 (32)
Profylactive drainage 1 (4) 4 (18)
Nasogastric tube* 8 (33) 8 (36)
Data are n (%), mean (SD). BMI=Body Mass Index, ASA= American Society of Aneshtesiologists classifica-
tion.
* n=21 in infectious group
** n=22 in no infectious group and n=21 in infectious group
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ABSTRACT
Background
This systematic review summarizes evidence regarding clinical endpoints, early detec-
tion, and differential diagnosis of postoperative ileus (POI).
Methods
Using MEDLINE, EMBASE, Cochrane, and Web-of-Science, we identified 2,084 articles. 
Risk of bias and level of evidence (LOE) of the included articles were determined, and 
relevant results were summarized.
Results
Eleven articles were included, most of which with substantial risks of bias. Bowel mo-
tility studies revealed that defecation together with solid food tolerance is the most 
representative clinical endpoint of POI (LOE: 2b); other clinical signs (e.g. bowel sounds, 
passage of flatus) did not correlate with a full recovery of bowel motility. Inflammatory 
parameters including interleukin (IL)-6, IL-1, and TNF-α might assist in an early detection 
of prolonged POI (LOE: 4). Clinical manifestations (e.g. nausea, vomiting, abdominal 
distension, bowel sounds, flatus) and X-ray examinations provided limited aid to the 
differential diagnosis of POI, while CT with Gastrografin had the best specificity and 
sensitivity (both 100%; LOE: 1c).
Conclusions
Postoperative defecation together with tolerance of solid food intake seems to be the 
best clinical endpoint of POI. CT has the best differential diagnostic value between POI 
and other complications. Prospective studies with a high LOE are in great need.
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INTRODUCTION
Postoperative ileus (POI) is a transient cessation of bowel motility after abdominal sur-
gery. It is generally considered as a self-limiting process, which recovers within 3–5 days 
after operation [1–3]. However, postoperative recovery of bowel function often extends 
beyond the expected duration and may cause other serious adverse outcomes such as 
hospital acquired infections, pulmonary complications, as well as an increase in medical 
costs [4–6].
Although various clinical manifestations, including the absence of bowel sounds, flatus, 
and defecation, or intolerance of an oral diet, have been used to indicate postoperative 
bowel function, substantial variations exist in the definition and clinical endpoints of 
POI among different studies [7]. To surmount that, Delaney et al. [8] published a clinical 
consensus update on the definition of POI in 2006, in which they defined POI as  ‘the time 
from surgical intervention until passage of flatus or stool and until initiation of adequate 
oral intake that is tolerated and maintains hydration during 24 h’. However, the applica-
tion of this consensus was not satisfactory. According to a recently published review, 
less than 20% (6/31) of new trials confirmed the definition provided by the consensus 
[7]. Choosing wrong clinical endpoints may substantially influence clinical practice and 
investigations. We noticed that most of the above-mentioned POI endpoints are lacking 
evidence support, and in many cases these endpoints failed to detect an earlier recovery 
of bowel function in laparoscopic surgery than in open surgery, while in contrast such 
difference has been constantly reported with bowel motility measurements [3, 9, 10]. 
It is thus questionable if these endpoints are able to represent a full resolution of POI.
Another important issue is that POI is usually diagnosed based on clinical symptoms 
and signs such as nausea, vomiting, abdominal distension, and lacking of bowel sounds, 
flatus, and defecation [11, 12]. However, these manifestations are also common in post-
operative small bowel obstruction, and may be seen in major surgical complications 
such as internal herniation, adhesions, anastomotic leakage, or intraperitoneal bleeding 
[13–18]. Many of these complications require immediate intervention; otherwise they 
may cause direct morbidity and mortality [19]. Uncomplicated POI, on the other hand, 
needs supportive care in most cases. Therefore, an early and accurate diagnosis of POI 
differentiating it from other complications becomes a crucial first step before further 
treatments. Unfortunately, evidence-based suggestions regarding how to establish an 
early and accurate diagnosis of POI are limited.
To give an overview of the current evidence regarding the clinical endpoints, early de-
tection, and differential diagnosis of POI, we conducted this systematic review. Relevant 
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studies were included and summarized, indicating their risk of bias and level of evidence 
(LOE), and evidence-based suggestions were also provided accordingly.
METHODS
Literature search strategy
The literature search for this systematic review was performed in August 2013 according 
to the PRISMA (Preferred Items for Reporting of Systematic Reviews and Meta-Analyses) 
guidelines in the databases including MEDLINE, EMBASE, Cochrane, and Web-of-Science 
libraries. There were no restrictions used during the search related to the publication 
year, publication language and type of study. The following search strategy was used in 
EMBASE and was modified accordingly for other databases:
(‘postoperative ileus’/de OR (ileus/de AND ‘postoperative complication’/de) OR ((post-
operative OR ‘post operative’ OR postsurg * OR ‘post surgical’ OR ‘post surgery’) NEAR/3 
(ileus OR paraly * OR motilit * OR obstruct * )):ab,ti) AND (diagnosis/exp OR (diagnos * 
OR detect * ):ab,ti) AND (‘sensitivity and specificity’/exp OR ‘prediction and forecasting’/
exp OR monitoring/exp OR (sensitive * OR specific * OR predict * OR monitor * OR efficac 
* OR evaluat * ):ab,ti) NOT ([animals]/lim NOT [humans]/lim).
Study Selection
The study selection criteria are shown in Figure 1. Two researchers (Z.W. and G.S.A.B.) 
screened the titles and abstracts of the identified articles independently for relevance 
to the subject. Only English articles targeting the clinical endpoints, early detection, 
and differential diagnosis of POI were included. For studies regarding risk factors of 
POI, a predictive analysis was required for inclusion. Reviews, Letters to the Editor, and 
Congress Abstracts were excluded. Afterwards, the references of these selected articles 
were screened for relevant articles.
Quality assessment and data extraction
The revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool [20] 
was used to assess the study quality by 2 independent authors. The tool assesses the 
risk of bias and applicability concerns by means of four key domains including patient 
selection, index test, reference standard, and flow and timing. After that, the LOE of 
each included article was also evaluated according to the Centre for Evidence-Based 
Medicine (2011).
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All the included articles were divided into three diff erent categories: clinical endpoints, 
early detection, and diff erential diagnosis. The following data were extracted from the 
included articles: fi rst author, year of publication, study design, number of patients, 
surgery type, POI defi nition/diagnosis, research subjective/ tool, and results/outcomes.
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 Study Selection 
 The study selection criteria are shown in  figure 1 . Two researchers (Z.W. and G.S.A.B.) screened the titles 
and abstracts of the identified articles independently for relevance to the subject. Only English articles 
targeting the clinical endpoints, early detection, and differential diagnosis of POI were included. For studies 
regarding risk factors of POI, a predictive analysis was required for inclusion. Reviews, Letters to the Editor, 
and Congress Abstracts were excluded. Afterwards, the references of these selected articles were screened 
for relevant articles.
 Quality Assessment and Data Extraction 
 The revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool  [20] was used to assess 
the study quality by 2 independent authors. The tool assesses the risk of bias and applicability concerns by means 
of four key domains including patient selection, index test, reference standard, and flow and timing. After that, 
the LOE of each included article was also evaluated according to the Centre for Evidence-Based Medicine (2011).
 All the included articles were divided into three different categories: clinical endpoints, early detection, 
and differential diagnosis. The following data were extracted from the included articles: first author, year of 
publication, study design, number of patients, surgery type, POI definition/diagnosis, research subjective/
tool, and results/outcomes.
 Results 
 Eleven articles were included in this systematic review. These articles were divided into 
the three categories clinical endpoints, early detection, and differential diagnosis, and some 
of them were analyzed in more than one category.
Records identified through database searching
(n = 2,084)
Records after duplicates removed
(n = 1,524)
Records screened
(n = 1,524)
Studies included in analysis
(n = 11)
Full-text articles assessed for eligibility
(n = 57)
Included references from
selected studies
(n = 2)
Records excluded
(n = 1,477)
Full-text articles excluded
(n = 48)
Irrelevant/Review/non-English full
text/full text not available
 Fig. 1. Study selection for relevant articles. 
Figure 1. Study selection for relevant articles
RESULTS
Eleven articles were included in this systematic review. These articles were divided into 
the three categories clinic l endpoints, early detection, diff erential diagnosis, and some 
of them were analyzed in more than one category.
The quality of each included study was evaluated according to the revised QUADAS-2 
tool [20] and is shown in Table 1. Most included studies have substantial risks of bias, but 
the applicability concerns of the patient selection and index test are comparably limited. 
Due to a very mall inclusio  number in each cat gory, the risk of bias an lysis across the 
studies was not applicable.
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Different terminologies of POI were found in the included studies (Table 2). In the early 
studies, the terminology of ‘postoperative paralytic ileus’ was often used [13, 14, 21]. In 
the 90s, the nomenclature ‘postoperative ileus’ (POI) started to be used in addition to 
‘paralytic ileus’ [2], and both of them have been found in recent studies. In this review, we 
chose to use postoperative ileus (POI). More than half of the included studies provided 
a definition of POI. Many of them defined it as the inhibition of gastrointestinal motility 
after surgery [16, 22, 23]. Other studies used clinical signs to characterize POI [2, 19, 24].
The diagnosis of POI was made according to clinical symptoms and signs in all included 
articles. Substantial differences, however, were found in diagnostic details such as tim-
ing and clinical endpoints (Table 2). Radiological examinations were mainly used for 
differential diagnosis [13, 14, 17, 19, 21–23, 25], and bowel motility examinations were 
only used for investigational purpose in the included studies [2, 16].
Clinical endpoints
Only two articles were included in the group of clinical endpoints (Table 3) [2, 16]. Van 
Bree et al. [16] performed a prospective cohort study (LOE: 2b), in which they compared 
clinical endpoints of POI and analyzed their correlations with colon transit time. The 
best correlation was found in the time to tolerance of solid food and passing stool (area 
under curve = 0.9). When the authors retrospectively analyzed their previous database, 
this new endpoint was also able to detect an earlier recovery of bowel function in 
laparoscopic than in open surgery, which was not found by using traditional indicators 
(passage of flatus, passage of feces, or tolerance of food intake) [16].
Table 1. Risk of bias evaluation based on Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2)
First author [ref.] Risk of Bias Applicability concerns
patient
selection 
index
test
reference
standard
flow and
timing
patient
selection 
index
test
reference
standard
Quan [17] - - - - - + -
Coletti [13] - - - - + + -
Zer [21] - - - - - + -
Quatromoni [14] - - - - - + -
Waldhausen [2] + + - ? + + -
Frager [25] + + - - + + -
Heinberg [19] + - - - + + -
Kronberg [24] - + - + - + -
Van Bree [16] + ? + - + + +
Zhu [22, 23] - + - + + + -
+ = Low risk; – = high risk.
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Van Bree et al. [16] also reported that bowel sounds were recorded in most paralytic ileus 
patients (6/7) during the first 3 days after surgery. Similar results were also reported by 
Waldhausen et al. [2], who found that the recovery of normal colon discrete and continu-
ous electric response activity took an average of 5.9 days after open surgery, which was 
much longer than the recovery of bowel sounds (2.4 days) but similar to passage of 
flatus and stool (5.1 days; LOE: 3b – ). However, this similarity was lacking correlation 
analysis, which substantially weakened its reliability.
Table 2. Terminology and clinical diagnosis of POI
First author
[ref.]
Year Patients: 
n
Terminology Diagnostic
tools
Clinical diagnostic criteria
Quan [17] 1961 60 Postoperative
intestinal ileus
Clinical signs 
+
X-ray
Nausea, vomiting, abdominal discomfort or 
severe pain and distention
Coletti [13] 1964 90 Paralytic ileus Clinical signs 
+
X-ray
Fever, vomiting, abdominal distention, 
peristaltic sounds, bowel movement
Zer [21] 1977 41 Paralytic ileus Clinical signs 
+
X-ray (with
Gastrografin)
Not specified
Quatromoni 
[14]
1980 41 Paralytic ileus Clinical signs 
+
X-ray
Abdominal distention, intestinal colic, bowel 
sounds, or absence of flatus or stool
Waldhausen [2] 1990 44 POI Clinical signs 
+
motility test
Nausea, bloating, and cramps, all of which 
resolved by postoperative day 7 or earlier
Frager [25] 1995 36 POI, paralytic
ileus
Clinical signs 
+
CT scan
Abdominal pain and distension,
nausea, vomiting, and diminished
bowel peristalsis within 10 days of
laparotomy
Heinberg [19] 2003 84 POI, paralytic
ileus
Clinical signs 
+
X-ray
Abdominal pain and distension,
nausea, vomiting, absent flatus, absent 
bowel sounds, fever, and leukocytosis
Kronberg [24] 2011 413 POI Clinical signs Absence of bowel function for ≥5 days or 
need for nasogastric tube
reinsertion after starting oral diet in the 
absence of mechanical obstruction
van Bree [16] 2013 84 POI, paralytic
ileus
Clinical signs 
+
motility test
Nausea, vomiting, bloating, delayed
passage of flatus and stool, and
inability to tolerate solid food
Zhu [22, 23] 2013 100 POI, 
prolonged
POI
Clinical signs 
+
radiography
Prolonged POI: ileus that persists >6 days 
following surgery with evident clinical 
symptoms and radiological imaging which 
must be diagnosed at
an early stage for immediate treatment
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Early detection of POI
Five studies [16, 19, 22–24] were included in this category, and the synopsis of the results 
is listed in Table 4.
Preoperative prediction
Although many studies on POI risk factors were found in our analysis, most of them were 
excluded because the predictive value of the risk factors was not evaluated. Only one 
study by Kronberg et al. [24] analyzed the predictive value of 3 independent risk factors 
including age ≥ 60 years, preoperative narcotic use, and previous abdominal operation. 
They found that 18.3% of patients with 2 or 3 risk factors developed prolonged POI, 
which was significantly higher than the rate of 2.7% in patients without risk factors. This 
study had a LOE of 2b, but the researchers excluded patients with other severe complica-
tions in their data analysis, and thus had a high risk of bias in patient selection. Another 
study from Heinberg et al. [19] retrospectively reviewed 84 patients who underwent 
gynecological surgery. They reported that a higher American Society of Anaesthesia 
(ASA) score was related to a radiographic diagnosis of POI.
Clinical symptoms and signs
Two studies focusing on clinical endpoints and the radiological differential diagnosis of 
POI also reported predictive values of clinical symptoms and signs in the early detection 
of POI [16, 19]. Van Bree et al. [16] reported that nasogastric tube reinsertion due to 
distension was required in all paralytic ileus patients (7/7) during the first 3 days, while 
only few of normal gastrointestinal transit patients (5/77) required it on day 3. Heinberg 
et al. [19] found that patients selected for plain films had longer time to resumption of 
clear liquids and regular diet; however, no single clinical manifestation had a significant 
correlation with the decision to obtain X-ray films.
Laboratory tests
Two recent studies by Zhu et al. [22, 23] evaluated the levels of C-reactive protein, 
pro-calcitonin, interleukin (IL)-1β, IL-6, and tumor necrosis factor alpha (TNF-α) for the 
prediction of prolonged POI. Due to a case-control design, both studies had a LOE of 4 
and a high risk in patient selection. They found that IL-1β, IL-6, and pro-calcitonin levels 
in peritoneal exudate on postoperative day 5 were significantly higher in 8 patients 
(8/100) who developed prolonged POI. The levels of C-reactive protein and TNF-α were 
irregular from day 1 to 5 but not significantly different between the case and control 
groups [22, 23].
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Differential diagnosis of POI
Six articles were included for a differential diagnosis of POI (Table 5) [13, 14, 17, 19, 21, 
25]. Except for the studies by Frager et al. [25] and Heinberg et al. [19], other studies 
regarding differential diagnosis all contained substantial risks of bias. Most of them had 
a case-control or case-series design, and thus only had a LOE of 4 [13, 14, 17, 21].
Clinical Manifestations
Quan and Stearns [17] reported that 2 patients (2/27) who were diagnosed with uncom-
plicated POI actually died of peritonitis or anastomotic leakage, which was confirmed 
by postmortem examinations. They also found that elevations of temperature, pulse, 
respiration rate, or white blood count did not give much additional information for the 
differentiation between POI and other complications [17]. Postoperative gastrointestinal 
symptoms such as nausea, vomiting, and abdominal distension were reported to pro-
vide limited information for differential diagnosis [13]. Even obstructive bowel sounds, 
a typical sign of mechanical obstruction, had little diagnostic value, as it only occurred 
in 39% (16/41) of patients with postoperative mechanical obstruction [14]. Among 
all clinical manifestations, only cramp like abdominal pain seemed to be an adequate 
symptom for mechanical obstruction according to the study by Coletti et al. [13] , in 
which they found no patients with paralytic ileus complaining of cramp-like pain, while 
most patients (34/45) with mechanical obstruction felt such pain.
Radiology
A series of studies showed that X-ray examinations were often inconclusive. It provided 
a low rate of diagnosis (42.9% in the study by Heinberg et al. [19] ), and the results were 
also not consistent with clinical impressions of POI, varying from 28.5% (4/14) [17] to 
44.4% (20/45) [13]. Such variation also existed between different radiologists. In the study 
by Quatromoni et al. [14], the plain film of 26 patients who were initially diagnosed with 
mechanical obstruction were submitted to a senior radiologist, who was blinded to clini-
cal signs or patient outcomes and was invited to retrospectively review the films again. 
Half of the patients were differently diagnosed with paralytic ileus, of which 2 patients 
had a definite mechanical obstruction, which was confirmed at reoperation. Different 
from the previous studies, Zer et al. [21] reported that the use of Gastrografin provided 
a reliable diagnosis in 68.3% of controversial cases (28/41) when clinical signs and X-ray 
were inconclusive. When distinguishing between mechanical small-bowel obstruction 
and POI, the highest accuracy was found with regard to CT. Frager et al. [25] compared 
the value of CT with that of X-ray and clinical findings to distinguish postoperatively 
between complete or partial small-bowel obstruction and paralytic ileus in 36 patients. 
The laparotomy findings (20 patients), clinical follow-up (13 patients), and contrast stud-
ies (3 patients) were used as the reference standard to evaluate the diagnostic value of 
83
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CT and X-ray, showing that CT was very sensitive (100%) and specific (100%). Due to a 
100% sensitivity and specificity, its LOE was determined as 1c.
DISCUSSION
POI is the most common complication after abdominal surgery. Substantial heterogene-
ity exists in the diagnosis of POI, and evidence-based recommendations regarding how 
to establish an early and accurate diagnosis of POI are still limited. This systematic review 
summarizes the limited evidence from previous studies, indicating their risk of bias and 
LOE, and it provides evidence-based recommendations regarding the early detection, 
clinical endpoints, and differential diagnosis of POI.
Various clinical endpoints of POI have been used not only in studies regarding POI 
diagnosis (our included studies) but also in studies targeting POI treatments [7]. The tra-
ditional endpoints of POI (e.g. occurrence of flatus or stool), though easy to determine, 
were often not able to present differences in bowel function detected by bowel motility 
measurements [3, 9, 10]. As is shown in this review, only van Bree et al. [16] performed 
a statistical analysis to evaluate the predictive value of those indicators and provided 
convincing evidence (LOE: 2b) in their study on bowel motility. Their methodology was 
the best one among our included studies. In their retrospective analysis, the proposed 
endpoint showed better sensitivity and predictive value than the traditional endpoints. 
These data support future applications of their proposed endpoint.
An inflammatory response caused by surgical procedures is considered as the main 
pathophysiology of POI [12, 26, 27]. Substantial experimental studies demonstrated 
that POI severity was correlated with levels of inflammatory cytokines such as TNF-α, 
IL-1, and IL-6, and the activation level of inflammatory cells (e.g. macrophages, mast 
cells) [27–34]. A pilot study from The et al. [35] revealed promising results in the pre-
vention of POI with mast cell stabilization treatment. These data imply the possibility 
of predicting POI by evaluating these immune mediators, but only Zhu et al. [22, 23] 
tested it in clinical practice. With a low LOE, their studies suggested a clinical value of 
IL-1, IL-6, and pro-calcitonin tests in detecting prolonged POI. Nevertheless, it is neces-
sary to notice that due to a case-control design, these studies contain a potential risk of 
overestimation of the test sensitivity. These inflammatory cytokines will also increase 
in other inflammatory or infectious complications such as anastomotic leakage and 
peritonitis [36], and an increased pro-calcitonin level was also found in patients with 
ischemic bowel obstruction [37]. An abnormal level of these cytokines may have more 
importance as a general alert for postoperative complications, warning surgeons to take 
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necessary interventions. To reach a higher reliability and LOE, further research searching 
a biomarker for POI or prolonged POI should include better statistical analysis methods 
(e.g. regression analysis) and avoid a case-control design. Using continuous variables as 
an endpoint (e.g. passage of feces and tolerance of a diet) may assist a better analysis.
Data from large-scale retrospective studies revealed many risk factors of POI including 
male sex, high ASA score, respiratory disease, and stoma construction [38, 39]. Unfortu-
nately, it remains unclear from the literature whether those identified risk factors entail a 
satisfactory predictive value that allows a prospective application for predicting POI, and 
more importantly, whether patients with these risk factors require different interven-
tions for the purpose of preventing POI. Based on our analysis, only Kronberg et al. [24] 
analyzed their data with regard to the former question and introduced a scoring system 
for the preoperative evaluation of POI. However, the applicability of a retrospective 
analysis might greatly vary in different centers, depending on patients’ characteristics. 
For instance, none of the three independent risk factors in this scoring system reached 
significance in the analyses from other databases [38–40]. Different centers, therefore, 
need to consider or even reevaluate the applicability of the predictive scoring systems 
from other databases. Of course, the scoring system of Kronberg et al. [24] seems more 
useful in excluding patients without risk factors of POI rather than selecting high-risk pa-
tients based on their results. Such new perspectives may also assist surgeons to develop 
individualized approaches for different patients.
The importance of the correct diagnosis of POI prior to further interventions cannot 
be overemphasized, since surgical management absolutely depends on its cause. After 
abdominal operation, bowel dismotility occurs in all patients with or without other com-
plications. Current understanding of POI has increased the tendency to attribute a failed 
recovery of bowel function to POI, or even uncomplicated POI, while many patients with 
POI manifestations may suffer from other severe complications [14–17]. Given that a 
delayed diagnosis of anastomotic leakage, small-bowel obstruction, and peritonitis may 
cause direct mortality and morbidity, we suggest that POI, especially prolonged POI, 
should be considered as a diagnosis by exclusion, and thus can only be made when 
necessary examinations and tests are done to exclude other complications. Our review 
shows that CT with Gastrografin provided the most reliable differential diagnosis be-
tween POI and mechanical obstruction (LOE: 1c) [25]. Our previous systematic review 
regarding the detection of anastomotic leakage also demonstrated it to be a reliable 
diagnostic tool [41], which may assist the differential diagnosis between POI and septic 
ileus, due to anastomotic leakage by radiological manifestations such as the existence 
of extraluminal contrast, perianastomotic air, and fluid collections in the CT scan as 
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adjuvants to the clinical manifestations and laboratory tests [42, 43]. These integrated 
results suggest that CT scan should be recommended when suspicion is aroused.
To find a good timing for postoperative CT, seeking clinical manifestations or biomarkers 
might be of assistance. Unfortunately, our review found that among the well-recognized 
bowel obstruction manifestations, only cramp-like pain remained to have differential 
diagnostic value with high specificity [13]; no biomarker has good specificity for a 
differential diagnosis of POI from other inflammatory complications [18]. Thus, the sur-
geons’ awareness remains one of the most important values to identify patients who are 
suspected to have postoperative complications with the currently available evidence.
In conclusion, currently available evidence regarding the clinical endpoints, early detec-
tion, and differential diagnosis of POI is limited with substantial risks of bias and low 
LOE. Based on the currently available evidence, postoperative defecation together with 
tolerance of solid food intake seems to be the best clinical endpoint of POI. CT has the 
best differential diagnostic value between POI and other complications. More prospec-
tive studies with high LOE are in great need.
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ABSTRACT
Rationale
Postoperative ileus (POI) is a transit cessation of bowel motility after surgery. Substantial 
evidences suggest that gum chewing accelerate the recovery of bowel motility after 
surgery. Perioperative nicotine administration reduces postoperative opioid use and 
prevents postoperative nausea and vomiting. Nicotine gum chewing combines stimu-
lation of the cephalic-vagal reflex by gum chewing, and activation of the cholinergic 
anti-inflammatory pathway by nicotine administration. We therefore hypothesized that 
nicotine gum chewing reduces POI and improves patient outcomes such as shortening 
the length of hospitalization as well as saving medical costs. As nicotine gum is com-
mercially available, inexpensive, and has been in use for many years without any severe 
side effects, it may have a wide clinical application in POI prevention.
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INTRODUCTION
Postoperative ileus (POI) is a common complication after abdominal surgery. It is a transit 
cessation of bowel mobility after surgery. Clinical manifestation of POI include nausea, 
vomiting, abdominal distension, and lack of flatus and defecation [1]. Delayed recovery 
of bowel function leads to other serious morbidity such as pulmonary complications, 
hospital-acquired infections, and longer hospitalization, and it also lead to higher medi-
cal cost [2]. The economic burden of POI in the USA health care system is estimated to 
surpass $1.5 billion per year [3].
Numerous risk factors such as previous surgery, general anesthesia and postoperative 
opioid consumption have been reported, contributing to prolonged bowel dismotility 
[4]. Targeting on them, multimodal fast-track perioperative care programs such as En-
hanced Recovery After Surgery (ERAS) including adequate pain relief, minimal invasive 
surgery, and early enteral nutrition, are now being implemented with promising results. 
Previous research revealed that surgical procedures trigger two different phases of POI: 
an early neurogenic phase and a late inflammatory phase. The latter one is considered to 
be a more clinically relevant cause of gastrointestinal dismotility [4], but efficient strate-
gies targeting it remains unavailable in clinical practice. In experimental studies anti-
inflammation therapy with stimulation of the vagus nerve showed promising results in 
preventing POI. Activation the vagus nerve increases bowel motility by controlling in-
flammatory cell recruitment via the cholinergic anti-inflammatory pathway [1,4,5]. With 
the promising experimental results, different strategies of vagus nerve stimulation (e.g. 
physiological, pharmacological, and electrical stimulation) are now being attempted in 
human patients.
THE HyPOTHESIS
Nicotine chewing gum may have double effect on stimulating the vagus nerve via 
physiological pathways by chewing, and via pharmacological pathways by the nicotine 
administration. Although no direct evidence is available to date, accumulative data from 
clinical and experimental studies are in favor of the hypothesis: nicotine gum chewing 
reduces the time of POI and improve patient’s outcomes via vagus nerve activation. We 
evaluated the current evidence supporting this hypothesis in the following parts.
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EVALUATION OF THE HyPOTHESIS
Part I. Influence of gum chewing in preventing POI
Gum chewing is a form of sham feeding, which mimics the cephalic phase of diges-
tion, stimulates the gastrointestinal motility via the vagal pathways [6]. In addition to 
the vagal pathway, ingesting contents of maxitols in sugar-free chewing gum may also 
accelerate the intestinal transit [7]. Since Asao et al. first demonstrated that gum chew-
ing stimulated bowel motility and aided early recovery from POI in surgical patients 
[8], many randomized clinical trials have reported similar results [2,9–12]. In general, 
consensus has been reached that gum chewing reduces the duration of POI in abdomi-
nal surgery in the recent decade [13]. The postoperative gum chewing is supported by 
many systemic reviews and meta-analysis [6,14–17], which reported that chewing gum 
could shorten both POI duration and postoperative hospitalization for approximately 
one day [18]. Importantly, gum chewing is not only beneficial in POI prevention after 
gastrointestinal surgery. It has shown satisfactory results in the prevention of POI in 
other types of intra-abdominal surgery (e.g. gynecological operations) as well [19,20].
Part II. Influence of perioperative administration of nicotine
Nicotine, a selective cholinergic agonist, is an essential regulator of the cholinergic 
anti-inflammatory pathway [21]. In animal models, nicotine has been shown to improve 
survival rates of sepsis by stimulating a7 nicotinic acetylcholine receptor (nAchR) [22]. 
Experimental studies have also shown the effect of specific a7 receptor agonist that 
ameliorates POI in rats [5], while other nAchR also play important roles mediating the 
cholinergic anti-inflammatory pathway [5,23].
Despite the nicotine replacement therapy (NRT), nicotine administration has also been 
investigated for other medical indications, and many of them provide us indirect evi-
dence of its possible effect on preventing POI. Perioperative administration of nicotine 
(e.g. nicotine patch) has been shown to reduce postoperative nausea and vomiting 
[24–26], which are common clinical manifestations of POI. Prevention of those symptoms 
may significantly accelerate the recovery of bowel function after surgery. Preoperative 
nicotine administration also reduces postoperative opioid consumption [27–30], while 
reducing opioid consumption is an important strategy of shortening POI [1,4,31]. This 
effect might be more evident to smoker patients because they may require more opioid 
compared to nonsmoker patients after surgery [32– 34]. Given that approximately 
25–40% of colorectal patients are smokers [35,36], respective recommendations of 
nicotine gum chewing (i.e. dosage, frequency) should be considered between smoker 
and non-smoker patients due to their different requirements in postoperative analgesia 
and varied responses to nicotine administration.
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It is important to notice that postoperative nausea and vomiting are strongly influenced 
by opioid administration in a dose dependent pattern [37]. Also, the a7 nicotinic recep-
tor seems to mediate the nicotine-induced analgesia [38], so its activation by nicotine 
administration may benefit the control of both postoperative pain and POI.
One main concern of perioperative nicotine use is its potential systemic influence or 
intoxication [39], especially in non-smoker patients. However, no obvious adverse 
events (e.g. cardiovascular events) were reported in the studies included in Part II, many 
of which only included non-smoker patients. There was no significant difference be-
tween the groups in postoperative heart rate, arterial blood pressure, respiratory rate, or 
oxygen saturation after temporal nicotine administration [28,29]. The effective nicotine 
dosage in those studies were lower than that in NRT, let alone the dosage in cigarette 
smoking [40]. However, localized side effects such as dislike the taste, irritation of the 
tongue, mouth, and throat, and occasional nausea caused by nicotine gum chewing 
should be expected [41]. But the incidence of these side effects is now much lower than 
it was with the earlier forms of the gum.
CONSEQUENCES OF THE HyPOTHESIS AND CONCLUSION
Substantial evidence suggests gum chewing accelerates the recovery of bowel motility 
after surgery. Nicotine gum chewing combines the stimulation of the cephalic-vagal 
reflex by gum chewing, and the activation of the cholinergic anti-inflammatory pathway 
by nicotine administration, it might be beneficial to the prevention of POI. As nicotine 
gum is commercially available, inexpensive, and has been in use for many years without 
any severe side effects, it may have a wide clinical application in POI prevention. Nico-
tine gum chewing may reduce POI via activating the vagal pathway and result in better 
patient outcomes such as shortening the length of hospitalization as well as saving 
medical costs.
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ABSTRACT
Purpose
Hyperbaric oxygen treatment (HBOT) has been found to improve the healing of poorly 
oxygenated tissues. This study aimed to investigate the influence of HBOT on the heal-
ing in ischemic colorectal anastomosis.
Methods
Forty Wistar rats were randomly divided into a treatment group that received HBOT for 
10 consecutive days (7 days before and 3 days after surgery), or in a control group, which 
did not receive the therapy. Colectomy with an ischemic anastomosis was performed in 
all rats. In each group, the rats were followed for 3 or 7 days after surgery to determine 
the influence of HBOT on anastomotic healing.
Results
Five rats from each group died during follow up. No anastomotic dehiscence was seen 
in the HBOT group, compared to 37.5% and 28.6% dehiscence in the control group on 
postoperative day (POD)-3 and 7 respectively. The HBOT group had a significantly higher 
bursting pressure (130.9 ± 17.0 mmHg) than the control group (88.4 ± 46.7 mmHg; p 
= 0.03) on POD3. On POD3 and POD7 the adhesion severity was significantly higher 
in the control groups than in the HBOT groups (p < 0.005). Kidney function (creatinine 
level) of the HBOT group was significantly better than of the control group on POD7 
(p = 0.001). Interestingly, a significantly higher number of CD206+ cells (marker for type 
2 macrophages) was observed in the HBOT group at the anastomotic area on POD3.
Conclusion
Hyperbaric oxygen enhanced the healing of ischemic anastomoses in rats and improved 
the postoperative kidney function.
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INTRODUCTION
Colorectal anastomotic leakage (CAL) is the most serious complication following 
colorectal surgery, causing substantial morbidity and mortality as high as 33% [1]. With 
continuous improvements in surgical techniques and perioperative care, the incidence 
of this complication still varies between 10-13% [2, 3], hardly decreasing in recent de-
cades despite developments in medical science and technology [4].
Regional ischemia has been considered as one of the main causes of anastomotic leak-
age [5-9]. Poor blood supply and perfusion of the rectal stump and ascending loop of 
bowel, or prolonged hypoxia are detrimental for wound healing and thus increase the 
risk of CAL [5, 10, 11]. Poor perfusion delays wound healing processes [12, 13]. The blood 
supply and perfusion of the preserved bowel, especially at the cutting edge, significantly 
affects the outcome of patients. Injury to the colon following an ischemic event is due to 
hypoxia and to reperfusion injury. Bowel ischemia results in hypoxia of the cells. Within 
one hour of ischemia, injury in the superficial part of the mucosa is already detectable. 
Prolonged severe ischemia causes necrosis of the mucosa layer, and lead to transmural 
infarction within 8 to 16 hours [14].
To prevent ischemia, one direct intervention is to provide oxygen. Oxygen is an essential 
component in tissue repair and wound healing. Oxygen stimulates collagen synthesis, 
matrix deposition, angiogenesis, epithelialization, and the eradication of bacteria [15-
17]. Perioperative use of oxygen has been reported to reduce CAL and improve patient’s 
outcome after colorectal surgery [18]. Clinical data have shown that perioperative 
hyperoxygenation reduced the occurrence of surgical site infections [19]. However, 
consensus in the interpretation of the data in this regard has not yet been reached and 
the mechanism of the oxygen therapy is still yet to be established.
The use of hyperbaric oxygen therapy (HBOT) is based on the same principle of hy-
peroxygenation and has been introduced in the treatment of surgical patients as well 
as in treatment of patients with chronic wounds [20, 21]. A positive influence of HBOT 
on anastomotic healing was first reported by Hamzaoglu et al. in 1998 [22]. Although 
this therapy is widely used in medical practice, its mechanism of action is still poorly 
understood. Previous study from Attard et al. has suggested that application of HBOT 
may reduce the production of inducible nitric oxide synthase protein (iNOS) expression 
[23], which is actively involved during the occurrence of CAL [24]. Many previous studies 
focused on localized changes such as collagen deposition and MMP (matrix metallopep-
tidase) activities [25].
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The accumulated data supports the hypothesis that HBOT may improve anastomotic 
wound healing via suppression of pro-inflammatory agents and stimulation of anti-
inflammatory agents [26]. This study was carried out to verify this hypothesis in an ex-
perimental rat model. HBOT was applied daily to all the rats 7 days prior to a partial 
colectomy with ischemic anastomosis, until 3 days after surgery. Macroscopic evaluation 
of anastomotic healing evaluation and immunohistochemistry were performed to in-
vestigate involvement of different inflammatory agents.
METHODS
Animals
Forty male Wistar-Albino conventional rats, 300-350 grams, were purchased from a 
licensed breeder (Harlan Laboratories, Boxmeer, The Netherlands). All rats were bred 
under specific pathogen-free conditions and kept under standard laboratory conditions 
in individually ventilated cages, and had ad libitum excess to water and regular rat chow. 
The experimental protocol was approved by the local Ethical Committee of Animal Ex-
perimentation of Erasmus University Rotterdam.
Experimental design
The animals were randomly divided into four different groups: control group, 3 days 
follow up; control group, 7 days follow up; HBOT group, 3 days follow up; HBOT group, 
7 days follow-up.
The HBOT groups received HBOT for 10 consecutive days from seven days prior to 
surgery until 3 days after surgery. Each HBO (hyperbaric oxygen) session consisted of 
100% oxygen under a pressure of 2.4 atm absolute for 90 minutes in the HBO Test Vessel 
P1460[27]. Animals were placed in a large transportation box (ten animals together) 
during the session. To exclude the possible bias due the HBOT procedure itself rather 
than the therapy itself, the control groups were also placed in a transportation box for 
the same time period in the same room, however, without undergoing HBOT.
On the day of operation, rats were anesthetized using 2% isoflurane/ O2; in addition, 
preoperatively, 0.05 mg/kg buprenorphine was administered as pain medication. After 
shaving and disinfecting the abdomen, the abdominal wall was opened through a 5-cm 
laparotomy. Subsequently, the ileocecolic arteries, the right colic artery, the middle colic 
artery, and the left colic artery were ligated (Silkam 4/0, B. Braun, Germany) to create 
an ischemic anastomosis (Figure 1). A partial colectomy was performed and proximal 
and distal ends of the colon were invertedly anastomosed with Dafilon 8/0 (B. Braun, 
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Germany). This model is earlier described, but in short, the colonic segment between 1.0 
cm aborally to the cecum and 0.5 cm above the caudal mesenteric artery was resected 
[28]. The end-to-end anastomosis in all groups was made with 12 continuous sutures. 
Finally, the abdomen was closed in two layers and the rats were resuscitated with 5 mL 
of normal saline solution subcutaneously to prevent dehydration. No antibiotics were 
used. The HBO groups received HBOT immediately after surgery, which continued on 
postoperative day (POD)1 and POD2, and on POD3 just before the re-operation. During 
follow-up the rats were weighted and observed daily and had ad libitum access to water 
and food.
Figure 1. Schematic overview of artery distribution in rat colon, anterior view. (1) ileocecocolic artery, (2) 
colic branch of ileocecocolic artery, (3) right colic artery, (4) cranial mesenteric artery, (5) middle colic artery, 
(6) left colic artery, (7) caudal mesenteric artery, (A) terminal ileum, (B) cecum, (C) proximal cutting edge, (D) 
colon, (E) distal cutting edge, (F) anus. Adapted from Wu et al. [28]
ASSESSMENT OF THE ANASTOMOSES
Clinical observation and physical examination
On POD 3 or POD7, rats were anesthetized again. Anastomotic healing was assessed 
by observational, physical, and histological examination. The abdomen was checked 
for signs of anastomotic dehiscence. Abscess formation was scored according to the 
following scoring system: 0 = no abscess; 0.5 = one very small abscess; 1 = several small 
abscesses; 2 = medium abscess; 3 = large or several medium abscesses; 4 = one very 
large or several large abscesses [29, 30]. Adhesion strength and amount were recorded 
using the Zühlke score [31]. After clinical observation, the anastomotic bursting pres-
sure test (ABP) was recorded in the same way as described previously [28]. In short, the 
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ABP was determined by insufflation of air in the closed segment of the colon, and the 
first leak of air was noted as the bursting pressure, the location was also noted.
Serum measurement
On POD3 or POD7 creatinine levels were measured in serum using the QuantiChrom 
assay kits (DIUR-500 and DICt-500, Gentaur Europe, Brussels, Belgium).
Histopathological evaluation
After the measurement of bursting pressure, a 1-cm-long colonic segment, 0.5 cm on each 
side of the anastomotic line, was resected and prepared for histopathological examina-
tion using standard procedures [28]. HE staining was performed and the anastomotic 
area of the slides was scored using the Ehrlich and Hunt numerical scale as modified by 
Phillips et al. [32]. The scoring system evaluated 4 parameters: inflammatory cell infiltra-
tion, fibroblast activity, development of new blood vessels, and collagen deposition. The 
parameters were graded from 0 to 4 as follows: 0 = no evidence, 1 = occasional evidence, 
2 = light scattering, 3 = abundant evidence, 4 = confluent cells or fibers. The samples were 
scored by three investigators (G.B, Z.W. K.L.), who were blinded for the clinical findings, 
group allocation, and the treatment. Immunohistochemical staining for iNOS (marker 
for macrophage type 1; M1, 1:400, Abcam plc, Cambridge, UK) and CD206 (marker for 
macrophage type 2; M2, 1:1600, Abcam) were also performed on anastomotic samples 
with the same method described previously [24]. After overnight incubation at 4°C, the 
slides were incubated with Envision secondary antibody (DAKO, Glostrup, Denmark). After 
30 minutes, Diaminobenzidine (DAKO, Glostrup, Denmark) was used for visualization of 
antigen-antibody reactivity. Slides were counterstained with hematoxylin.
To determine the positive target cell number on each slide, the same five fields were selected 
at the anastomotic site on each slide using a microscope with an imaging system (Olympus 
DP25, Tokyo, Japan), under 20 x 10 magnification (2560 x 1960 pixels). The cell numbers were 
counted with ImageJ (National Institutes of Health, Bethesda, MD). The average cell number 
of the selected fields was used for analysis. An M2/M1 index was calculated with the follow-
ing equitation. The natural logarithm was used to adjust the data to normal distribution.
M2⁄M1 index = ln (Number of CD206+ cells)/(Number of iNOS+ cells)
Statistical analysis
Statistical analysis was performed with SPSS 21.0 (IBM Inc., Chicago, USA). Data are pre-
sented as mean ± standard deviation (S.D.) or as median or as percentage. The Mann-Whit-
ney U test, t-test, and Pearson correlation test were used according to proper indications. 
We used the Levene’s test to test equality of variances. The one-way analysis of variance 
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was performed with the Kruskall-Wallis test for non-parametric parameters. All reported p 
values were two-sided; a p-value < 0.05 was considered to indicate statistical significance.
RESULTS
Overall and general observation
In both the control groups and HBOT groups 5 animals died, all deaths are unrelated 
to anastomotic leakage: 5 colon ischemia, 4 colon ischemic necrosis, 1 overdosed an-
aesthesia. Postoperative weight loss occurred in all rats without significant difference 
between the groups.
HBOT improves clinical parameters
Anastomotic dehiscence was strictly limited to the control groups. The POD3 group 
had 37.5% (3/8) leakage and the POD7 group 28.6% (2/7) versus a rate of 0% in both 
HBOT groups (p = 0.021). The number of abscesses between groups was not significantly 
higher in the control groups (p = 0.08) (Table 1). HBOT resulted in significantly less anas-
tomotic adhesions, which were significantly less severe as without oxygen therapy on 
both POD3 and POD7 evaluated with the Zühlke score(Figure 2).
Table 1. Comparison of anastomotic leakage and colon anastomoses abscess rate on POD 3 and POD 7 in 
the control and HBO groups.
POD 3 POD 7 p value
control HBO control HBO
Number of rats 10 10 10 10
Mortality (%) 20 (2/10) 20 (2/10) 30 (3/10) 30 (3/10) NS
Anastomotic dehiscence (%) 37.5 0 28.6 0 0.02
Colon anastomoses
        Abscess (mean number) 4 2 2 0 0.08
Dehiscence and abscess rate only include surviving animals
On POD3, the anastomotic bursting pressure (ABP) was significantly higher in the HBOT 
group than in the control group: 130.9 ± 17.0 mmHg vs. 88.4 ± 46.7 mmHg (p = 0.03) 
(Figure 3). The variance of ABP in POD3 in the HBOT group was also significantly lower 
(p = 0.004). ABP was not significantly different between the HBOT group and control 
group at POD7: 162.4 ± 39.7 mmHg vs. 141.1 ± 73.3 mmHg, (p = 0.51), but the variance 
of ABP was significantly lower in the HBO group (p = 0.009).
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The mean creatinine level in the HBOT group on POD3 was lower, though not signifi-
cantly, than in the control group; 13.4 ± 9.0 vs. 30.3 ± 28.6 mg/dl (p = 0.07). On POD7 the 
creatinine levels were significantly lower in the HBOT group than in the control group: 
9.0 ± 12.1 vs. 52.0 ± 25.2 mg/dl (Figure 4).
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Figure 2. Adhesion score (number of adhesions) and Zühlke score (strength of adhesions) around the 
anastomosis [31]. The adhesions on POD7 in the HBOT were significantly less firm; control 3.7 ± 1.1 versus 
HBOT 1.29 ± 0.8. *indicate significance (p = 0.001)
co
nt
ro
l
HB
OT
co
nt
ro
l
HB
OT
0
50
100
150
200
250
*
POD3 POD7
**
**
AB
P 
(m
m/
Hg
)
Figure 3. The anastomotic bursting pressure (ABP) in mmHg, was significantly higher on POD3 in the 
HBOT group 130.9 ± 17.0 mmHg vs. 88.4 ± 46.7 mmHg, p = 0.03. On POD7 we found a trend to an higher 
ABP in the HBOT group, but not significant (p =0.098), although the variance was significantly lower in the 
HBOT POD7 group. The variance of ABP between the groups was significantly different and is indicated with 
the p value on the dash line. *indicate p < 0.05, **indicate p < 0.01.
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Figure 5. Comparison of macrophage numbers at the anastomotic site on POD 3 and POD 7 of the HBOT 
groups and control groups. A and E are representative pictures of an overview of the abdomen at POD 3. A 
A picture of a rat from the HBOT group which has no necrosis or ischemia. E shows ischemia of the cecum. 
B Illustrates the CD206+ cell number (indication of M2 macrophages), the dot above the first bar indicate 
an outlier. C Illustrates the iNOS + cell number (indication of M1 macrophages), the dot above the second 
bar indicate an outlier. d Illustrates the M2/M1 index which is significantly in advantage of the HBOT POD3 
group; p = 0.02. The left side of the image represents an anastomosis of the HBOT POD 3 group, the left 
side of this image is the intraluminal side of the colon. The selected area in A1 is represented in A2. Of the 
same area the immunohistochemistry staining of CD206+ and iNOS+ is represented in A3 and A4, positive 
cells are colored with diaminobenzidine. The same is true for the representative histology slides for the 
control POD3 groups as shown in figure E1–E4. The arrows in A2 and E2 indicate the anastomotic line (20 
x 10 magnification)
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Figure 4. Creatinine levels measured as mg/dl were significantly higher in the control group than in the 
HBOT group on POD7; 9.0 ± 12.1 vs. 52.0 ± 25.2 mg/dl, p = 0.003 (*)
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Histology evaluation
The inflammatory cell infiltration, fibroblast activity, neoangiogenesis, and collagen 
deposition based on the HE staining were not evidently different between the groups 
(supplementary data 1). After 7 days more angiogenesis was observed in the HBOT 
group. Based on immunochemistry significantly more CD206+ cells (M2) were present 
in the HBOT group than in the control group on POD3; 50.0 ± 28.1 vs. 19.4 ± 16.2 cells, 
p = 0.016 (Figure 5). Also the M2/M1 index was significantly higher in the HBOT short-
term group; p = 0.02. The number of iNOS+ cells as a marker for type 1 macrophages 
(M1, pro-inflammatory marker) was higher in the short term control group although not 
significantly different (Figure 5). 
DISCUSSION
Colorectal anastomotic leakage is a dangerous short-term complication after colorectal 
surgery and may cause substantial immediate mortality if not treated as soon as pos-
sible. In this study, we evaluated the influence of HBOT on ischemic anastomotic wound 
healing and we found that HBOT improved the wound healing in ischemic colorectal 
anastomosis as shown with a higher ABP and less firm adhesions. We also observed 
improved postoperative recovery based on higher creatinine levels in the rats that 
received HBOT.
When comparing the data from this ischemic colorectal anastomosis model to the 
standard rat colectomy model [28] and to the other ischemic anastomosis models, the 
ligation of the arteries of the ascending stump resulted in catastrophic outcomes includ-
ing evident ischemia at the cecum after surgery and a mortality rate as high as 25%. This 
is comparable to the clinical situation in ischemic bowel patients [33]. To our knowledge, 
this model best mimics clinical outcomes also because most ischemic anastomosis 
models only cause a lower bursting pressure and localized changes after surgery. Our 
previous study showed that functional failure of the ascending stump perfusion results 
in CAL in patients [34]. Impaired tissue perfusion may result from patient-related factors 
such as smoking inflammatory bowel disease or diabetes [35-37]. Meanwhile, different 
technique-related factors such as the level of artery ligation and anastomosis configura-
tion may also influence anastomotic perfusion [34]. Our model inflicted a severe ischemic 
injury to the standard colorectal anastomosis, providing a satisfactory environment for 
evaluating the influence of HBOT.
Previous studies have reported the beneficial influence of HBOT on anastomotic heal-
ing such as increasing ABP [22, 38, 39] and reducing anastomotic adhesions. This was 
111
7
Chapter 7 | Hyperbaric oxygen therapy improves colorectal anastomotic healing
also observed in our study. Moreover, the reduction of intra-abdominal abscess forma-
tion indicates an anti-infection effect of HBOT playing an important role in its overall 
beneficial effect. Because tissue necrosis and ischemia-reperfusion injury caused by the 
anastomotic ischemia also impair the systematic condition, we expected such beneficial 
effect of HBOT might also be observed in addition to the localized changes. Though 
failed to reduce the mortality rate, the HBOT group resulted in better kidney function 
as a marker for general health on POD7, indicating a beneficial systematic effect. More 
importantly, the preconditioning effect remained after cessation of HBOT.
Perioperative oxygen therapy providing 100% oxygen under higher pressure has been 
demonstrated to be effective to prevent CAL, but the mechanism is not fully under-
stood. Moreover, it also influences the vascular response. The high concentration of 
oxygen causes vessel constriction, which has also been reported on HBO therapy cases 
[40, 41]. Though not fully understood, our preliminary observation found a different re-
sponse pattern in the HBOT groups after artery ligation (unpublished data), which may 
eventually influence the blood supply and oxygenation of the tissues after anastomosis 
construction.
Substantial amount of data demonstrate that the effect of HBOT is not limited to the 
direct oxygenation [12, 13]. Previous studies showed that HBO therapy increased the 
ABP even when anastomoses were constructed under contaminated conditions [42, 43]. 
HBOT has been demonstrated to increase expression of the anti-inflammatory genes as 
well as influencing the local production of inflammatory cytokines [43], many of which 
are productions of macrophages. In accordance with that, our data suggest that the 
influence of HBOT on the inflammatory response via alternatively activating the mac-
rophages. In addition to the increased ABP, the higher M2/M1 index also explains for a 
reduction of adhesion formation on anastomosis, probably because of earlier onset of 
regeneration as M2 macrophages enhance the regenerative responses as production of 
collagen [44, 45].
We investigated the mechanism of the HBOT on colorectal healing using perioperative 
treatment-format which according to the literature has demonstrated the most benefi-
cial effect using perioperative HBOT [39]. We are aware that it is difficult to select the 
patients who would have a greater risk of ischemic anastomosis and start the treatment 
preoperatively. However in some patients such disposition can be presumed preopera-
tively. Clinical data remain in query to investigate whether application of HBOT in high-
risk patients (e.g. smokers, patients with atherosclerosis, diabetic mellitus, cardiovascular 
disease, and low colon perfusion during operation due to low blood pressure, blood loss 
or multiple organ failure) may reduce CAL rate and improve clinical outcome. Whether 
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such application would benefit in a larger scale of patients (i.e. patients without clear 
risk of CAL) needs further investigation in the future.
CONCLUSION
Perioperative hyperbaric oxygen therapy prevents anastomotic leakage in ischemic 
colorectal anastomosis in the rat. The presence of anti-inflammatory macrophages is as-
sociated with the anastomotic healing. Application of HBOT as adjuvant therapy might 
be useful in the clinic when the patient is critically ill and giving the results of this study 
this needs testing in the near future.
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ABSTRACT 
The most dreaded complication of colorectal surgery is anastomotic leakage. Adipose 
tissue-derived stem cell sheets (ASC sheets) prepared from temperature-responsive 
culture surfaces can be easily transplanted onto tissues. These sheets are proposed to 
improve cell transplant efficiency and enhance wound healing. The aim of this study 
was to investigate whether application of ASC sheets could prevent leakage of sutured 
colorectal anastomoses. Insufficient suturing of colorectal anastomoses was performed 
in Wistar rats to create a colorectal anastomotic leakage model. Rats were randomized to 
ASC sheet application or control group. Leakage, abscess formation, adhesion formation, 
anastomotic bursting pressure (ABP), and histology were evaluated on postoperative 
day 3 or 7. ASC sheet application significantly reduced anastomotic leakage compared 
to controls, without increased adhesion formation. ASC sheet transplantation resulted in 
more CD3+ T-cells and CD163+ anti-inflammatory macrophages at the anastomotic site 
than the control group. ABP, vessel density and collagen deposition were not different 
between groups. Using cell sheet technology, we generated ASC sheets that prevented 
disruption of sutured colorectal anastomoses as shown by reduced leakage. Increased 
numbers of anti-inflammatory macrophages and T-cells might have contributed to this 
positive effect. 
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INTRODUCTION 
Gastrointestinal (GI) disease is the third most common cause of death, the leading cause 
of cancer death, and the most common cause of hospital admission (Source: British 
Society of Gastroenterology, clinical services 2007). In 2009, the US National Institutes 
of Health reported 20 million ambulatory surgical GI procedures, to resect tumors, to 
relieve obstruction, after trauma, or as part of bariatric surgery [1]. An important and 
life-threatening complication of GI surgery is anastomotic leakage. Despite years of 
research, the incidence of impaired wound healing and consequent leakage remains 
high, ranging from 3% in small bowel surgery to 25-27% in colorectal surgery with mor-
tality rates of up to 22% [2, 3]. Anastomotic leakage has a multifactorial etiology. Besides 
technical failures, restricted blood supply and uncontrolled inflammation are important 
reasons that contribute to impaired wound healing [4, 5].
Studies using human adipose tissue-derived mesenchymal stem cells (ASCs) have been 
successful in regenerating various tissues and promoting wound healing [6]. More im-
portantly, several reports indicate that ASCs help to ameliorate tissue inflammation and 
can accelerate new blood vessel formation. These capacities seem among others to be 
attributable to the ability of ASCs to secrete a myriad of growth factors and cytokines 
that can promote repair of injured tissue or improve the quality of tissues that are regen-
erated [7, 8]. The beneficial characteristics of ASCs could be exploited to promote the 
healing process in the intestinal wall after surgery, thus helping to prevent postopera-
tive complications. Recent studies using intraperitoneal ASC injections or ASC-coated 
bio-sutures showed no prevention from anastomotic leakage [9, 10]. Injection of ASCs 
as suspension or combined with biomaterials such as fibrin, collagen or gelatin is either 
associated with cell washout, insufficient cell retention or an inadequate distribution of 
transplanted cells. 
Currently, cell sheet technology is a promising technique for cell transplantation im-
proving cell retention. Cell sheets are typically prepared on special culture dishes that 
are coated with a temperature-responsive polymer. This polymer changes from being 
hydrophobic to hydrophilic when the temperature is lowered. In this way, intact cell 
sheets can be removed as one piece from the culture dishes without enzymatic treat-
ment, preventing destruction of cellular and cell-extracellular matrix interactions within 
the sheet [11, 12]. 
Despite the application of various tissue sealants and other biomaterials, no significant 
reduction in the incidence of anastomotic leakage has been accomplished over the last 
30 years [13]. Clearly, there is a need for new strategies therefore we propose a novel 
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approach in which ASCs are applied to the surgical wound area in cell sheets that are 
permeable to growth factors secreted by the ASCs and can be handled with ease by 
the surgeon. Therapeutic potential of ASC sheets was shown to improve cardiac tissue 
regeneration in the treatment of myocardial infarction [14], dilated cardiomyopathy 
[15], healing of hind limb ischemia [16] and chronic non-healing skin wounds [17]. Since 
cell sheet technology has been successfully used in improving healing of other soft tis-
sues (i.e., heart, skin) as we mentioned above, we explored whether ASC sheets could 
serve as an ideal approach for the local delivery of cells to enhance healing and prevent 
leakage after intestinal anastomosis. To our knowledge this is the first attempt of ASC 
sheet application on intestinal surgical wounds. 
The aim of this proof of principle study is to validate the efficacy of ASC sheets to prevent 
anastomotic disruption and leakage 3 and 7 days postoperatively in a colorectal leakage 
model in rats. 
MATERIALS AND METHODS
ASC sheet preparation
ASCs were isolated from subcutaneous abdominal adipose tissue (all women, mean 
age 40 ± 9 years old). ASCs were seeded at 400,000 cells/cm2 on 100% FBS pre-coated 
temperature responsive dishes (3.5 cm diameter, CellSeed, Tokyo, Japan). Every single 
sheet was made from one ASCs donor. ASCs were cultured in Dulbecco’s Modified Eagle 
Medium 1 g/l glucose (LG-DMEM, Gibco, Life technologies, Paisley, UK) supplement with 
10% fetal bovine serum (FBS, Lonza, Verviers, Belgium) with 50µg/ml gentamicin (Gibco) 
and 1.5μg/ml fungizone®(Gibco). After 48 hours, ASCs formed a coherent cell sheet. 
Thirty minutes before in vivo application, culture dishes were placed at room tempera-
ture to enable spontaneous detachment of the ASC sheets then culture medium was 
removed and refreshed with serum-free medium.
ASC sheet viability and histology in vitro
ASC sheet viability was evaluated by fluorescence microscopy on 0, 3, and 6 hours after 
detachment using a live/dead staining (Invitrogen, Life Technology, foster City, CA, USA). 
Briefly, ASC sheets were washed with Phosphate Buffered Saline (PBS, Gibco) after de-
tachment and incubated for 30 minutes in calcein AM dye 1 µl/ml and ethidium bromide 
dye 1.5 ml/ml at 37οC in a humid atmosphere with 5% CO2. The sheets were analyzed 
with fluorescence microscopy using Olympus IX71 inverted microscope, and images 
were captured with Cell F Imaging Software (Olympus: Hamburg, Germany, 2008). ASC 
sheets were fixed overnight in 4% buffered formaldehyde (Sigma, St Louis, Missouri and 
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Merck, Billerica, Massachusetts), set in in 2% agarose (Eurogentec, Liege, Belgium) and 
embedded in paraffin. Cross sections were stained with hematoxylin and eosin (H&E, 
Sigma).  
SPIO-labeling of ASC sheet for pilot experiment
In a pilot study, ASCs were labeled with the so-called superparamagnetic iron oxide 
particles (SPIO) using ferumoxides (Endorem, Guerbet S.A., Paris, France) complexed to 
protamine sulphate (LEO Pharma N.V., Wilrijk, Belgium) as previously described [18]. For 
removal of extracellular iron, cells were washed with PBS containing heparin 10 U/ml 
(LEO Pharma B.V., Breda, the Netherlands). SPIO labeling mix was made at a constant 
concentration of 100 µg/ml ferumoxides with 5 µg/ml protamine to ensure identical 
particle formation. SPIO-labeled ASC were combined with unlabeled ASCs in a 30:70 
ratio to form ASC sheets. Labeled ASC sheets were transplanted to 6 pilot rats after 
colorectal anastomosis to examine ASC sheet survival at POD3 (n=4) and 7 (n=2). Only 
for this pilot study, ASCs were labeled. In the following experiments, unlabeled ASCs 
were used to avoid any unwanted effects of labeling on ASC sheet function.
Animals
Male Wistar rats (weight 250–350g) were purchased from a licensed breeder (Harlan 
Laboratories, Boxmeer, The Netherlands). All rats were bred under specific pathogen-free 
conditions and randomly kept under standard laboratory conditions. Standard rat chow 
and water were supplied ad libitum. The research protocol was approved by the Ethical 
Committee of Animal Experimentation, Erasmus University Rotterdam (133-14-01). Sixty 
rats were randomly allocated to 4 experimental groups. The ASC sheet groups received 
local application of an ASC sheet around the colorectal anastomosis, anastomotic heal-
ing being evaluated on postoperative day 3 (n = 15) or 7 (n = 15). Rats in the control 
groups received no ASC sheet and anastomotic healing was evaluated at postoperative 
day 3 (n = 15) or 7 (n = 15). 
Surgical technique and application of ASC sheets
To evaluate the ability of ASC sheet to prevent leakage the colorectal anastomotic 
leakage rat model previously described by Wu et al. was used [19]. Briefly, the rats 
were anesthetized with isoflurane/oxygen inhalation, and 0.05 mg/kg buprenorphine 
intramuscularly. After aseptic preparation, a midline abdominal incision was made and 
the right, middle, and left colic arteries were ligated (Silkam 4/0; B Braun, Melsungen, 
Germany). The colonic segment was resected 1 cm aborally to the cecum and 0.5 cm 
above the caudal mesenteric artery. An insufficiently sutured end-to-end anastomosis 
was created by one-layer inverting suturing with 5 interrupted sutures (Dafilon 8/0, B 
Braun) (Fig. 1A). Rats were randomly divided into control or ASC sheet groups. To make 
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sure the same side of the sheet was always applied and to avoid variation because of 
different orientation of the sheets, the dish-side of cell sheet was always applied to the 
serosal surface of the colon in every rat. In the ASC sheet group, the dish-side of an 
ASC sheet was wrapped around the anastomosis line (Fig. 1B). The ASC sheet adhered 
spontaneously to the serosal surface of the colon and required no further suturing or 
glue. The control group received no other intervention except for the insufficiently su-
tured end-to-end colorectal anastomosis. Immediately after ASC sheet application, the 
abdomen was closed in two layers of running sutures (Safil 5/0, B. Braun). Immediately 
postoperatively, rats were rehydrated and warmed. The rats returned to a normal diet 
after recovery from surgery. 
Figure 1. Rat partial colectomy and ASC sheet application:(A) Schematic overview of the rat colon before 
and after partial colectomy*. Anatomy: (1) terminal ileum, (2) cecum, (3) rectum and anus, (4) anastomosis. 
(B) ASC sheet transplantation (from upper left to lower right); ASC sheets were grasped with forceps at two 
rims and applied on top of the colorectal anastomosis. Following application, the sheet was unfolded and 
wrapped around the anastmosis thereby ensuring to cover it completely. *The schematic overview was 
adapted with permission from Wu Z, et al. Reducing colorectal anastomotic leakage with tissue adhesive 
in experimental inflammatory bowel disease. Inflamm Bowel Dis. 2015; 21(5):1038-46. Copyright© 2016 
copyright Clearance center, Inc.
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Follow up 
Since both undifferentiated and differentiated ASCs have been used successfully for 
xenotransplantation in different other applications [20], no immunosuppressive drugs 
were used in this experiment. Wellness and weight of all rats were evaluated daily. On 
postoperative day (POD)3 or 7, rats were re-anesthetized and a re-laparotomy was 
performed. The abdomen was checked for signs of peritonitis, adhesions and abscesses 
(defined as ‘’elsewhere’’). At the anastomotic area, signs of stricture, disruption, adhe-
sion, and abscesses were checked. Two observers (PS and GB) performed all macroscopic 
observations and evaluations for each rat. 
Macroscopic observation 
Abscess severity was scored according to the previously described abscess score, in 
short: 0 = no abscess, 0.5 = one small abscess (< 1 mm), 1 = several small abscesses, 2 
= medium abscess (1-3 mm), 3 = one large (3-5 mm) or several medium abscesses, 4 = 
one very large (>5 mm) or several large abscesses [21]. Adhesions were recorded using 
the Zühlke score. In short: 0 = no adhesions, 1 = firm adhesions which can be separated 
with blunt dissection, 2 = strong adhesions which can only be separated with sharp dis-
section, 3 = very strong vascularized adhesions which can only be separated with sharp 
dissection and damage to surrounding tissue is hardly preventable. Anastomotic burst-
ing pressure (ABP) was determined after macroscopic observation by a third blinded 
researcher (AC). In short, ABP was determined by insufflation of air in a closed segment 
of the colon and pressure at time of the first air leak was noted as bursting pressure. 
The location of the burst was also noted. After the ABP measurement, the colorectal 
anastomosis was resected and prepared for histological examination.
Histological evaluation after transplantation
Histological and immunohistochemically assessment were conducted by two indepen-
dent blinded observers (PS and AC) in a fully randomized order to evaluate healing of the 
anastomosis. A segment of colon containing the colorectal anastomosis was harvested, 
washed with phosphate-buffered saline and opened longitudinally. After overnight 
fixation in 4% buffered formaldehyde, segments were embedded in paraffin. Paraffin-
embedded sections (6 µm) were deparaffinized and rehydrated. For morphological 
evaluation, sections were stained with H&E. Perl’s iron stain (Klinipath BVBA, Duiven, the 
Netherlands) was used for staining SPIO-labeled ASC sheets at POD3 and POD7 after 
transplantation in the pilot study. Picro Sirius red staining (Sigma, St Louis, Missouri) was 
used for collagen deposition. Immunohistochemistry was performed to assess vascular 
density (rat, CD34+), presence of T-cells (CD3+) and anti-inflammatory M2 macrophages 
(CD163+), ASC sheet survival (human mitochondria) and endothelial differentiation 
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(human CD31+) of ASCs at the colorectal anastomosis. Details of the methods used for 
staining are described in supporting information. 
Statistical analysis
Data are presented as mean ± standard deviation (SD) and analyzed with the Mann-
Whitney U test and Kruskal-Wallis one-way analysis of variance. To compare the 
incidence of anastomosis disruption between groups at each time point the two-tailed 
Chi-squared test was used. All reported P values are two-sided; a P value of < 0.05 indi-
cated statistical significance. All statistical analyses were done using SPSS 21.0 (IBM Inc., 
Armonk, NY, USA).
RESULTS
ASC sheet characteristics in vitro
ASCs cultured at 400,000 cells/cm2 in a temperature responsive culture dish for 48 hours 
formed cell sheets that could be spontaneously detached at room temperature (Fig. 2A). 
ASC sheets consisted of several cell layers (Fig. 2B). Viability of ASC sheets in medium at 
room temperature remained high until 6 hours after detachment (Fig. 2C). 
In vivo overall observations
During the first postoperative days, all rats lost weight and had a lower wellness score 
than before surgery. From POD4 onwards, all animals started to gain weight. The weight 
loss and wellness scores in the control and ASC sheet groups were not significantly 
different (supplementary data; Fig. S1). Three out of 60 rats (5%) died within 24 hours 
after surgery in both control (POD3) and ASC sheet groups (POD3 and POD7). Autopsy 
demonstrated that these deaths were caused by acute (e.g., bleeding and anesthesia-
related) complications; therefore, these animals were excluded from further analysis. 
Postoperative intra-abdominal evaluation
At re-laparotomy, the ASC sheet structure was visible around the anastomosis in all rats 
of the ASC sheet group at POD3 and POD7 (Fig 3A-B). Ten out of 14 rats in the control 
group had anastomotic disruption on POD3 (71%) versus 2 out of 14 (14%) in the ASC 
sheet group (P =0.002). No significant difference in the anastomotic disruption rate was 
observed at POD7 between the two groups. Significantly more rats in the control group 
had abscesses at POD7 around the anastomosis (10/15: 67%) compared to the group 
receiving an ASC sheet (4/14: 28%, P = 0.04). There were no differences in the occurrence 
of peritonitis, stricture formation, adhesions, and abscess formation elsewhere (Table 
1). The average abscess number around the anastomosis was significantly higher in the 
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control group than in the ASC sheet group on both POD3 (1.6 ± 0.5 versus 1.0 ± 0.7, 
P = 0.004) and POD7 (1.2 ± 1.2 versus 0.4 ± 0.6, P = 0.028), (Fig. 4A). The abscess score 
between the ASC sheet and control groups did not differ on POD3 but the abscess score 
of the ASC sheet group was significantly lower than the control group on POD7 (P = 
0.048, Fig. 4B). The number of intra-abdominal adhesions was significantly lower in the 
Figure 2. ASC sheet viability and morphology prior to implantation. (A) ASC sheet after detachment from 
the temperature responsive dish. (B) Cross section of ASC sheet stained with hematoxylin & eosin. (C) Live/
dead staining of ASC sheets at 0, 3 and 6 hours after detachment. Viable cells stained with calcein (green), 
non-viable cells stained with ethidium bromide (red). 
Figure 3. ASC sheet is visible around the anastomosis. (A) POD3 and 7 (B), white arrows point at anasto-
motic area and black arrows point at transplanted ASC sheets.
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Figure 4. Intra-abdominal macroscopic findings at colorectal anastomosis. (A) abscess number, (B) abscess 
score (0-4), (C) adhesion number, (D) adhesion score (0-4) and (E) anastomotic bursting pressure (ABP). ASC 
= adipose tissue-derived stem cells. POD3 = postoperative day 3. POD7 = postoperative day 7. Each bar 
represents average number +/- standard deviation from control (n= 14 in the control and ASC sheet group 
at POD3; n= 15 in the control group and n= 14 in the ASC sheet group at POD7). * P <0.05 between groups. 
# P <0.05 between different time points within the same group.
Table 1. Post operative macroscopic findings
POD3 POD7
Control (%) ASC sheet (%) p-value Control (%) ASC sheet (%) p-value
Peritonitis 1/14 (7.1) 0/14 (0) NS 0/15 (0) 0/14(0) NS
Anastomotic disruption 10/14 (71.4) 2/14(14.3) 0.002 3/15(20) 2/14(14.3) NS
Stricture 2/14 (14.3) 2/14(14.3) NS 2/15 (13) 2/14(14.3) NS
Abscess at anastomosis 14/14(100) 12/14(85.7) NS 10/15(66.7) 4/14(28.6) 0.04
Adhesion at anastomosis 14/14(100) 14/14(100) NS 15/15(100) 14/14(100) NS
Abscess elsewhere 11/14(78.5) 8/14(57.1) NS 6/15(40) 4/14(28.6) NS
Adhesion elsewhere 8/14(57.1) 3/14(21.42) NS 9/15(60) 7/14(50) NS
Values are presented as the number of rats and relative percentage. POD3= postoperative day 3, POD7= 
postoperative day 7. ASC = adipose tissue derived stem cell. NS; not significant by Chi-square test.
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ASC sheet group (P = 0.043) on POD3 (supplementary data, Fig. S2), but no significant 
differences in the number of adhesions (Fig. 4C) and adhesion scores (Fig. 4D) around 
the anastomosis were seen between the two groups on POD3 and POD7 . 
On POD7 the average bursting pressure was higher compared to POD3 in both groups 
but was not significantly different between groups (Fig. 4E). On POD3 bursting of all 
anastomoses in both the control and ASC sheet groups occurred at the anastomosis line. 
On POD7 bursting occurred predominantly at the anastomosis line in the control group 
(10 rats (66%), whereas in the ASC sheet group bursting mostly (8 rats: 57%) occurred 
proximally or distally to the anastomosis line. 
Histological evaluation 
To evaluate whether ASC sheets would still be present 3 and 7 days after transplantation, 
Perl’s iron stain was used for detection of SPIO-labeled ASC sheets. At both POD3 and 
POD7, SPIO-labeled ASCs were present at the colorectal anastomotic serosal side. (Fig. 
5A, B). Further evaluation of ASC sheet state was performed by using a human mito-
chondrial staining. At POD3 ASC sheets showed abundant positive staining for human 
mitochondria, while at POD7 positive cells were severely diminished (Fig. 6A,B). 
Figure 5. Tracking SPIO-labeled ASC sheet in a pilot experiment. SPIO-labeled ASC sheet stained with Perl’s 
iron stain (blue). The selected area with solid line (see also black arrows) indicates the anastomotic area, which 
is enlarged and illustrated below for representation of positively stained cells A-B. Blue iron stained SPIO-
labeled ASCs present in ASC sheet on serosal side of the colorectal anastomosis at (A) POD3 and (B) POD7. 
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To evaluate the effect of the ASC sheets on colorectal anastomosis vascularization, 
collagen deposition and infiltration of inflammatory cells, several specific immunohis-
tochemically stainings were performed. Local application of ASC sheets did not affect 
CD34 positive capillaries or collagen deposition at the colorectal anastomosis site. Al-
though the capillary density increased from POD3 to POD7 in both the control and ASC 
sheet groups (P < 0.01), there was no difference in the capillary density between groups 
at either time points (POD3, ASC sheet group 172.4 ± 44 vessels/cm2 versus control 
group 150.5 ± 42 vessels/cm2 and POD7, ASC sheet group 277.2 ± 95 vessels/cm2 versus 
control group 276.5 ± 83 vessels/cm2, Fig. 7A,E). No human ASC-derived CD31 positive 
endothelial cells were detectable within the ASC sheets before or after transplantation 
(data not shown). 
Similar findings regarding collagen deposition at the anastomotic site were found. 
Despite an increase of collagen deposition from POD3 to POD7 in both groups, groups 
were not significantly different from each other (POD3, ASC sheet group 2.2 ± 2.4% 
versus control group 0.7 ± 0.6%, and POD7, ASC sheet group 19.5 ± 0.6% versus control 
group 22.7 ± 10.5%, Fig. 7B,F). 
Figure 6. ASC sheet survival at anastomotic site. The selected area with solid line indicates the anasto-
motic area with ASC sheet, which is enlarged and illustrated below for representation of positive staining 
for human mitochondria A-B. (A) ASC sheet showed positive red staining of human mitochondria at POD3 
and (B) severely diminished positive staining at POD7 
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The number of T-cells and M2 macrophages was used to evaluate the inflammatory 
response at the anastomosis site. At POD3 a nonsignificant different number of CD3 
positive T-cells were found in the ASC sheet group (81.8 ± 36 cells/cm2) as compared to 
the control group (103.6 ± 45 cells/cm2). The number of CD3 positive cells increased in 
both groups from POD3 to POD7. At POD7 a significantly higher number of CD3 positive 
T-cells was detected in the ASC sheet group (508.6 ± 243 cells/cm2) than in the control 
group (204.6 ± 107 cells/cm2, P = 0.001, Fig. 7C, G). 
In the control group, the number of CD163 positive cells indicating M2 macrophages 
decreased significantly between POD3 (140.3 ± 67 cells/mm2) and POD7 (55.9 ± 37 cells/
mm2, P <0.001) whereas in the ASC sheet group, the number of CD163 positive cells did 
not differ between POD3 (159.6 ± 89 cells/mm2) and POD7 (122.8 ± 128 cells/mm2, Fig. 
7D, H). 
DISCUSSION  
Cell sheets are a recent development in regenerative medicine. They allow for the delivery 
of cultured cells and their deposited extracellular matrix and prevent cell loss associated 
with administering cells via injection or scaffold [22]. Previous studies demonstrated 
that ASC sheets show great promise in promoting the healing of several organ injuries. 
In this study, application of an ASC sheet to an insufficiently sutured rat colorectal anas-
tomosis resulted in reduced anastomotic disruption and abscess formation. ASC sheets 
facilitated an increase in the number of anti-inflammatory macrophages and T-cells at 
the anastomosis site, which might have contributed to this positive effect. 
Application of ASC sheets to colorectal anastomosis is feasible since ASC sheets are 
flexible and spontaneously adhere to the serosal surface rapidly. This might be due to 
adhesive proteins present at the dish-side of ASC sheet that remain after harvesting 
from a temperature responsive dish [23]. ASC sheet survival after in vivo transplantation 
has been shown in other in vivo models and varied form 3 days [24] up to 8 weeks [25]. In 
our in vivo model ASCs were still present in the sheets at POD3 and 7 and mitochondrial 
staining was present until day 3. These findings indicate that ASC sheet were present 
and contained living cells for at least 3 days after transplantation allowing them to exert 
their potential paracrine effects for several days. 
The recording of bursting pressure in colorectal anastomoses showed that on POD7, the 
average bursting pressure was not different between the groups. However, the bursting 
site in the ASC sheet group was mainly remote from the anastomotic line compared 
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Figure 7. Comparison of vascular density, collagen deposition, T-cell and anti-inflammatory macrophage 
amount at the anastomotic site on POD3 and POD7 between ASC sheet and control group. The compari-
sons were listed in A-D and illustrated in E-H. (A) Vascular density as assessed by average number of CD34+ 
vessels/mm2. (B) Collagen deposition determined by area percentage of Picrosirius red staining. (C) T-cell 
response determined by number of CD3+ cells/mm2. (D) Anti-inflammatory macrophage response as-
sessed by average CD163+ cells/mm2. POD3 = postoperative day 3. POD7 = postoperative day 7. ASC = 
adipose tissue-derived stem cells. Each bar represents average value +/- standard deviation from control 
(n=14 in the control and ASC sheet group at POD3; n=15 in the control group and n=14 in the ASC sheet 
group at POD7. * P <0.05 between groups, # P <0.05 between different time points within the same group. 
Representative examples of immunohistochemically staining of colorectal anastomosis for (E) CD34, (F) 
Picrosirius red, (G) CD3, and (H) CD163 of each group (200x).
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with the control group in which the burst occurred mainly at the anastomosis itself. 
These results suggest that when an intraluminal pressure is exerted to the colonic wall, 
anastomosis that is reinforced by ASC sheet is less susceptible to perforation. Alterna-
tive techniques that have been used previously in an attempt to prevent leakage of 
gastrointestinal anastomosis have been based on the sealing of the anastomosis with 
tissue adhesives or synthetic meshes [26, 27]. Although these techniques for leakage 
prevention have various levels of clinical efficacy, they are imperfect solutions that can 
give burdens for patients. The therapeutic potential of ASC sheets is generally thought 
to be attributable to ASCs paracrine ability, not the mechanical/physical strength of 
the ASC sheet to seal the wound [28-30]. Although ASC sheets are composed of only a 
thin layer of cells, it cannot be excluded that the reduction in dehiscence, and abscess 
formation in this study might be possible due to the mechanical ability of ASC sheets to 
seal the anastomosis and prevent leakage. However, merely external coating of colonic 
anastomoses has yet failed to show convincing results [31, 32]. Future experimental 
studies are warranted to determine and compare the mechanical role of external coat-
ing materials and ASC sheets for prevention of colon anastomotic leakage. 
To investigate whether the ASC sheets contributed to the healing of the anastomosis, 
capillary density and collagen deposition were evaluated, both being of great im-
portance for anastomotic healing. Although mesenchymal stem cells are believed to 
promote vascularization and stimulate collagen deposition, capillary density was not 
significantly different between the control and the ASC sheet groups in this model. 
Collagen deposition was also similar in the control and experimental groups on POD7. 
The lack of increased capillary density in the ASC sheet treated group conflicts with pre-
viously published data [16, 17] indicating that ASCs promoted angiogenesis in animal 
models characterized by low blood perfusion and ischemia such as hind limb ischemia 
[16], myocardial infarction, and skin wounds in diabetic rats [17]. However, no such ef-
fects were seen in a dilated cardiomyopathy model [15] or in gastric ulcer healing [33]. 
Possibly, the tissue to which the sheet was applied and whether or not this was ischemic 
might explain these differences. Transplanted human ASCs have been suggested to be 
able to differentiate into endothelial cells and thereby contributing to angiogenesis [34], 
however, this was not observed in the study presented here. The absence of increase 
in collagen deposition may indicate that although ASCs are able to produce collagen 
themselves [35] they do not promote collagen synthesis at the anastomosis site up to 
POD7. However, as suggested by Rabau et al [36] total collagen amount might be less 
important for anastomosis’ tensile strength than structure and arrangement of collagen 
matrix. 
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Inflammatory cells play a key role in the healing of intestinal anastomoses [37]. Macro-
phages and activated lymphocytes are the main inflammatory cells in wound healing 
and in the development of fibrosis. Macrophages fulfil multiple roles in inflammation: 
besides phagocytosis and encouraging inflammation, macrophages also have important 
anti-inflammatory properties. Macrophages that stimulate inflammation are called M1 
macrophages, whereas those that decrease inflammation and stimulate tissue repair are 
called M2 macrophages. Since the M2 subpopulation plays an important role in wound 
healing and ASCs have been shown to induce macrophage polarization towards the M2 
subtype [38], we focused on the presence of M2 macrophages at the anastomosis area. 
As shown before in fetal-membrane mesenchymal stem cell sheets [39], the number 
of M2 macrophages did not decline between POD3 and POD7 in the ASC sheet group 
when compared to the control group and might have stimulated the healing process at 
the anastomosis.
T-lymphocytes and more specific T-regulatory cells (T-regs), have the ability to release 
cytokines and growth factors that regulate other immune cells and positively affect 
wound healing [40]. On the other hand, in case of rejection of transplanted tissue, 
high numbers of cytotoxic T-cells are seen around the implanted tissue, together with 
abscesses and inflammation. In this study, the ASC sheet group had significantly more 
CD3+ T-cells within the anastomotic area than the control group at POD7, whereas 
the number of abscesses decreased instead of increased. Since the higher number of 
CD3+ T-cells at the anastomosis was accompanied with lower abscess number and 
anastomotic disruption, it is very unlikely that the increase of CD3+ T-cells is the results 
of rejection of the implanted ASC sheet. A more likely scenario is that the ASC sheets 
resulted in increased numbers of T-regs around the anastomosis thereby contributing 
to better healing of the wound. However, to our knowledge, a good staining for FoxP3, 
the classical marker for T-regs, is not available for rat at the moment.
Several studies suggest that human ASCs are immune-privileged and can survive in im-
munocompetent animals [41]. Both undifferentiated and differentiated ASCs have been 
used successfully for xenotransplantation [20]. Based on rat wellness score, and the posi-
tive effect of ASC sheets on colorectal anastomosis leakage we consider the presence of 
an (hyper)acute rejection in our study  unlikely. However, future better understanding of 
the functionality of allo- or xenogeneic-derived ASCs for therapy is warranted.
Unfortunately, it was not possible to fully blind the observers from the treatment group 
since the ASC sheet structure was obvious in macroscopic and microscopic evaluations. 
Moreover, we evaluated the effect of ASC sheets on colorectal anastomosis after POD3 
and POD7 since dehiscence is most likely to occur in this critical phase of colonic anas-
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tomotic healing[13]. We are aware of the fact that at this time point the wound healing 
process is not complete yet and further maturation and collagen remodeling will occur 
at later stages of anastomotic healing [42].
The present study suggests that application of human ASC sheets to experimental 
colorectal anastomosis is a promising technique to prevent short-term post-operative 
complications such as anastomotic disruption and abscess formation without increasing 
adhesion formation. To translate the potential of ASC sheets for future clinical applica-
tion, our results must be complemented with further short and long-term studies and 
defining the role of ASC sheets in the technique of colorectal anastomoses with regards 
to complications such as abdominal contamination and severe peritonitis. 
CONCLUSIONS
This study explored the proof of principle of a therapeutic potential of ASC sheet for 
preventing disruption of sutured colorectal anastomoses. ASC sheet application signifi-
cantly enhanced healing of colorectal anastomoses with decreased incidence of disrup-
tion and abscess formation. The increased numbers of anti-inflammatory macrophages 
and T-cells might have contributed to promotion of the healing process. This preclinical 
study indicates that ASC sheet application may have a therapeutic role in promoting 
colorectal healing and prevention of anastomosis-related complications. 
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SUPPORTING METHODS
ASCs isolation and culture 
Human ASCs were isolated from subcutaneous abdominal adipose tissue from eight 
healthy female donors (age 25-50 years) as leftover adipose tissue from breast recon-
struction surgery, with approval of the Medical Ethical Committee of the Erasmus Medi-
cal Center, Rotterdam (MEC-2014-092). ASCs were isolated as described previously.[8] 
Briefly, after digestion of the tissue, ASCs were plated in 40,000 cells/cm2 and grown in 
Dulbecco’s Modified Eagle Medium 1 g/l glucose (LG-DMEM, Gibco, Life technologies, 
Paisley, UK), containing 20% fetal bovine serum (FBS, Lonza, Verviers, Belgium), 50 µg/
ml gentamicin (Gibco), 1.5 μg/mL fungizone® (Gibco). Ascorbic acid-2-phosphate (25 
μg/ml, Sigma-Aldrich, St. Louis, MO, USA) and 1 ng/ml human recombinant fibroblast 
growth factor 2 (FGF2, AbDSerotec, Kidlington, UK)] were freshly added. After 24 hours, 
cultures were washed with Dulbecco’s phosphate-buffered saline (PBS, Gibco) with 
2% FBS to remove non-adherent cells and erythrocytes and refreshed with expansion 
medium (LG-DMEM with 10% FBS, 50 µg/ml gentamicin, 1.5 μg/mL fungizone® and 
freshly added ascorbic acid-2-phosphate and FGF2). Isolated ASCs were cultured at 37οC 
under humidified conditions in an atmosphere with 5% CO2. When cultures reached 90% 
confluence, ASCs were sub-cultured with 0.25% trypsin EDTA (Gibco) and reseeded at a 
density of 8,000 cells/cm2 for two passages and thereafter. ASCs at passages 2–5 were 
used for following experiments. 
Immunohistochemistry
All sections were treated with xylene and ethanol series to deparaffinize. Heat induced 
antigen retrieval was used by boiling sections at 95 °C for 20 minutes in citrate buffer or 
Tris-EDTA buffer solution. Vascular density was evaluated using antibodies against CD34 
(AF4117, dilution 1:200; R&D systems, Minneapolis, Minnesota). T-cells were identified 
by CD3 staining (Ab16669, dilution 1:100; ab16669; Abcam Cambridge, UK). M2 mac-
rophages were identified by CD163 staining (MCA3426A, dilution 1:100; AbDSerotec, 
Raleigh, NC, USA). Anti-human mitochondria antibody (Abcam AB92824, dilution 1:500, 
Cambridge, UK) was used to identify viable ASC sheet. Human endothelial cells were 
identified with a mouse anti human antibody against CD31 (M0823, dilution 1:100, Dako, 
Glostrup, Denmark). After blocking with normal goat serum each primary antibody was 
diluted in 1% bovine serum albumin in PBS and sections were incubated for 60 minutes 
at room temperature. The slides were then incubated with biotinylated goat-anti-rabbit 
link (BioGenex Laboratories, San Ramon, CA, USA) for 30 minutes followed by incubation 
with streptavidin-AP (Biogenex) for 30 minutes. Neu Fuchsin (Chroma, Kongen, Ger-
many), napthtol AS-MX phosphate (Sigma), sodium nitrate (Sigma), levamisole (Sigma) 
138
and dimethyformamid (Sigma) were used in the substrate. Hematoxylin was used as a 
counter stain. Isotype-matched antibodies were used as negative controls. 
The histological and immunohistochemical assessments were performed by two in-
dependent blinded observers (PS and AC). Seven images of each slide were taken for 
analysis including the anastomotic area and adjacent area in every layer. The number of 
positive cells for each photograph from high power field (200x magnification, Olympus 
BX50, Olympus, Hamburg, Germany) was counted with ImageJ (National Institutes of 
Health, Bethesda, MD). For CD3 and CD163, the values were expressed as average num-
ber of positive cells per mm2. For capillary density, values were expressed as average 
number of CD34 positive vessels per mm2. Quantification of collagen deposition within 
the anastomotic healing area was calculated as percentage of Picrosirius red positive 
staining area. Two sections were randomly selected from each slide and 3 images of the 
anastomotic area were evaluated using Image J software.
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SUPPLEMENTARy RESULTS
Supplementary Figure 1. (A) Postoperative weight changes and (B) wellness score (0-12). ASC= adipose 
tissue-derived stem cells. POD3 = 3 days post operation, POD7 = 7 days post operation.
Supplementary Figure 2.  Intra-abdominal macroscopic findings distant from colorectal anastomosis: (A) 
Abscess number, (B) abscess score (0-4), (C) adhesion number and (D) adhesion score (0-4). ASC = adipose 
tissue-derived stem cells. POD3 = postoperative day 3. POD7 = postoperative day 7. Each bar represents 
average number +/- standard deviation from control (n= 14 in the control and ASC sheet group at POD3; n= 
15 in the control group and n = 14 in the ASC sheet group at POD7), * P <0.05 between groups.
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ABSTRACT
Background
Although cyanoacrylate glue (CA) has been widely used in various kinds of medical ap-
plications, its application in gastrointestinal anastomosis remains limited, and outcomes 
of experimental studies have not been satisfactory. This systematic review summarizes 
research regarding CA application in intestinal and colorectal anastomosis, and corre-
lates methodological aspects to experimental outcomes.
Methods
A systematic literature search was performed using Medline, Embase, Cochrane and 
Web-of-Science libraries. Articles were selected when CA was applied to intestinal or 
colorectal anastomoses. Included articles were categorized according to CA molecular 
structure; the method details in each study were extracted and analyzed.
Results
Twenty-two articles were included. More than half of the inclusions reported positive 
outcomes (7 articles) or neutral outcomes (8 articles). Analysis of the methods revealed 
that methodological details such as CA dosage, time of polymerization are not con-
sistently reported. Porcine studies, inverted anastomosis, and n-butyl-cyanoacrylate 
studies showed more positive outcomes; everted anastomosis, and oversized sutures 
may negatively influence the outcomes.
Conclusions
Due to the positive outcome from the porcine studies, application of CA in GI anastomo-
sis still seems promising. To achieve a better consistency, more methodological details 
need to be provided in future studies. Optimizing the dosage of CA, choice of animal 
model, inverted anastomosis construction, and other method details may improve 
intestinal and colorectal anastomoses with CA application in future studies.
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INTRODUCTION
Cyanoacrylate (CA) was invented more than 60 years ago for industrial applications [1, 
2]. Famous for its strong adhesiveness, various commercial names such as “crazy glue” 
or “instant glue” are well known in daily life. Moreover, the strong adhesiveness of CA 
also made it an ideal candidate for replacement of conventional sutures in medical use, 
such as wound closure. In addition to a strong bond, a fully and evenly sealed anasto-
mosis can be created with CA, avoiding excessive tissue approximation that can induce 
disturbances in the microcirculation [3, 4]. In 1998, the Food and Drug Administration 
(FDA) approved Dermabond (2-octyl-cyanoacrylate) for topical skin wound closure [5], 
which was the first FDA approved CA for medical use. Ever since then, more and more 
medical-use CA have appeared on the market for different indications [6, 7].
Except for skin wounds, the gastrointestinal anastomosis is another important type 
of wound closure. However, the use of CA in this field is still limited, and no clearly 
documented clinical attempts have been made so far. Though substantial experimental 
efforts have been made, the results of animal studies have not yet been encouraging. 
Some experimental studies reported anastomoses could be well constructed with CA 
[8, 9]; while others reported a mortality rate as high as 30-40% [10, 11]. Besides large 
variations in results, inconsistencies with regard to the methodology were also noticed 
in those experiments. As it has been demonstrated that the anastomotic technique 
used in clinical gastrointestinal surgery influences the outcomes, we hypothesized that 
the inconsistent results of experimental studies are partly due to differences in their 
methods. Thus, the purpose of this systematic review is to summarize the experimental 
studies regarding CA application in intestinal and colorectal anastomosis, correlating 
the methodological details to the experimental outcomes.
METHODS
Search methods
This systematic review was performed according to the PRISMA (Preferred Items for 
Reporting of Systematic Reviews and Meta-Analyses) guidelines [12]. The systematic 
literature search was performed on the 5th of November 2012. The systematic search of 
literature was performed using the databases of Medline, Embase, Cochrane and Web-
of-Science libraries. The same search strategy was used in all the databases. The search 
strategy encompasses the following:
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(cyanoacrylate/de OR ‘cyanoacrylate derivative’/de OR ‘cyanoacrylic acid octyl es-
ter’/de OR enbucrilate/de OR bucrilate/de OR ‘poly (ethyl 2 cyanoacrylate)’/de OR 
(cyanoacryl* OR ‘cyano acrylate’ OR ‘cyanoacrylic acid’ OR ‘octylcyano acrylate’ OR 
enbucrilate* OR bucrilate* OR enbucrylate* OR bucrylate* OR butylcyanoacryl* 
OR fimomed OR histacryl OR histoacryl OR sicomet OR isobutylcyanoacrylat* OR 
ocrilate OR ocrylate OR octylcyanoacrylat* OR dermabond OR omnex OR glubran 
OR surgiseal OR floraseal OR ‘derma flex qs’ OR gluseal OR octyseal OR worm-
glu OR periacryl OR indermil OR liquiand OR xion):ab,ti ) AND (‘gastrointestinal 
surgery’/exp OR ((‘gastrointestinal tract’/exp OR ‘digestive system’/exp) AND 
(surgery/exp OR (surg* OR operat* OR preoperat* OR postoperat* OR perioperat* 
OR intraoperat*):ab,ti)) OR (((gastr* OR digestiv* OR intestin* OR anal OR anus OR 
anorect* OR rect* OR bariatr* OR pancrea* OR stomach* OR antireflux* OR colon* 
OR colorect* OR bowel* OR duoden* OR esophag* OR oesophag*) NEAR/3 (surg* 
OR operat* OR postoperat* OR preoperat* OR perioperat* OR intraoperat* OR 
anastom* OR suture* OR adhesi* OR glue* OR sealant* OR hemosta* OR coat* 
OR lesion* OR wound* OR dehisc* OR disattach* OR attach*)) OR vagotom* OR 
colectom* OR gastrostom* OR stoma* OR appendectom*):ab,ti)
Study selection
Two independent researchers (Z.W. and G.B.) screened all the articles (the title and the 
abstract) in a standardized manner. Articles were included only if the CA glue was ap-
plied in an intestinal or colorectal anastomosis. The search was restricted to publications 
in English. Presentations, reviews and letters to editor were not included. All references 
from the selected articles were screened for further possible inclusions.
Data extraction
For all selected studies, a standard data extraction form was filled in, and the following 
data were extracted: year of publication, first author, subject (animal species), number 
of animals, glue (chemical name), glue (commercial name), usage (CA sutureless anas-
tomosis / sealant), dosage, curing time, anastomotic material (additional material to 
create the anastomosis other than CA), suture material (chemical component), suture 
size, suturing technique, GI level, and outcome (positive / negative, judged according to 
conclusions of the articles).
RESULTS
A total number of 962 articles were found, from which 22 studies were included for final 
data analysis (Figure 1). Among these, seven articles had positive outcomes; eight had 
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neutral outcomes; the others had negative outcomes. As is listed in Table 1, CA with dif-
ferent molecular structures produced by different manufacturers were used and tested. 
The included articles were divided according to the chemical structure of the CA used, 
and their chemical names (commercial names if applicable) were listed. Further subdi-
visions were made according to the use of CA with regard to anastomosis (sutureless 
anastomosis or sealant).
Table 1. Cyanoacrylate adhesives used in the included studies
Chemical structure Abbreviation Trade name Manufacturer
Metho-cyanoacrylate MCA 910 Easterman Ethicon
(Somerville, New Jersey, USA)
Etho-cyanoacrylate ECA Pattex Henkel
(Dusseldorf, Germany)
N-butyl-cyanoacrylate NBCA Histoacryl (blue) B. Braun
(Melsungen, Germany)
NBCA Glubran 2 GEM Italia
(Via reggio, Italy)
2-octyl-cyanoacrylate OCA Dermabond Ethicon
(Norderstedt, USA)
OCA Gluseal GluStitch, Inc
(Delta, BC, Canada)
Metho-cyanoacrylate (MCA)
Four studies were included that report the use of MCA [2, 10, 11, 13]. A sutureless anasto-
mosis was created in all of them, and none of these studies had positive outcomes (Table 2).
In 1962, O’Neill et al. used MCA (Eastman 910) to create a sutureless anastomosis in 
canines’ small intestine or colon. In this model, a clamp was used to construct an everted 
anastomosis [11]. They found that most of the intestinal anastomoses (11 / 12) were 
satisfactory and no death occurred, but 28.6% (4 / 14) of canines died when CA anasto-
moses were created in the colon [11]. A similar clamp was also used by Weilbaecher et 
al., who performed the intestinal anastomosis with a greater number of canines. Mortal-
ity rate as high as 34% (34/101), and no advantage of MCA were found when compared 
with conventional suture methods [10]. A high mortality rate of 22% (8 / 35) was also 
found when Gennaro et al. used an intraluminal gelatin stent to create a colonic MCA 
anastomosis in a rat model [2]. Different from those experiments, Linn et al. reported 
a canine study [13], in which no anastomosis-related mortality occurred. Anastomoses 
with MCA had less inflammation than the conventional group, but stricture occurred 
in 40% of the anastomoses when a new invagination technique to construct the MCA 
anastomoses was used [13].
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Etho-cyanoacrylate (ECA)
Only one study used ECA to create the CA sutureless anastomosis [3], and no study used 
MCA as an anastomotic sealant (Table 2).
In 2009, Elemen et al. used ECA (Pattex) to construct end-to-end, side-to-side, or side-to-
end intestinal anastomoses in a rat model. No deaths occurred during follow up, and no 
differences in bursting pressure were found between the CA anastomosis and sutured 
anastomosis, while higher hydroxyproline levels (a parameter of anastomotic wound 
healing) and shorter operating time were found in the CA groups [3].
N-butyl-cyanoacrylate (NBCA)
Nine studies regarding NBCA were included [8, 9, 14-20] (Table 2). Among these, three 
studies focused on the sutureless anastomosis [8, 16, 17], three studies looked into NBCA 
sealant [9, 18, 20], and the other three tested both applications [14, 15, 19]. In the NBCA 
studies, all four large animal studies had positive results [8, 9, 14, 15], while of the other 
five rat studies, only one had positive outcomes [20].
Records identified through database searching
(n = 1431)
Records after duplicates removed
(n = 962)
Records screened
(n = 962)
Records excluded
(n = 927)
Full text articles assessed for
eligibility
(n = 35)
Full text articles excluded
(n = 16)
Review / non-English full text
Studies included in analysis
(n = 22)
Included references from
selected studies (n = 3)
Figure 1. Study selection for relevant articles
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Matsumoto et al. reported a comparison between CA in different molecular structures 
(N-butyl-, Amyl-, Heptyl-cyanoacrylate) in a canine model of intestinal anastomosis. 
Only NBCA showed good wound healing without stenosis after four or twelve weeks 
[21]. Another comparison between NBCA (Glubran 2) and OCA (Dermabond) was per-
formed in a porcine model [8]. The CA sutureless anastomoses were constructed in the 
colorectum with a modified stapling device, in which all the staples were taken out in 
advance. All the NBCA anastomoses were satisfactory, while two leakages occurred in 
the OCA group; NBCA was also superior to OCA regarding to the adhesion and stenosis 
severity [8]. Tebala et al. also tested NBCA with different suturing techniques in a porcine 
model [15]. They performed 11 different types of anastomosis. Good wound healing was 
observed in macroscopic, histological and angiographic examinations; foreign body 
reaction was even less in the sutureless anastomosis group than the sealant group [15]. 
Tebala et al. also created an insufficient anastomosis in a pig model by removing 1/5 of 
the sutures or staples from a normal anastomosis [9]. NBCA was then used to seal the 
defect. Anastomotic healing was sufficient, and no ileus occurred during the follow up 
[9].
Positive results of CA use were reported in a rat study by Ensari et al. [20]. In this study, 
the authors constructed an ischemic-reperfused intestinal anastomosis and used NBCA 
(Glubran 2) to reinforce it. Higher bursting pressures were found after the CA reinforce-
ment with or without the initial ischemic intervention, while more adhesions were 
found in the CA groups [20]. Weiss et al. tested another NBCA (Histoacryl) and created 
gastrojejunal anastomoses in a rat model, comparing it with resorbable sutures. In this 
study, anastomotic healing regarding leakage rate, stricture, peritonitis, and mortality 
were similar between both groups. The only significant difference was a shorter oper-
ating time in the NBCA group [16]. Bae et al. tested the same glue in a rat model, in 
which they created NBCA (Histoacryl) reinforced anastomoses and the NBCA sutureless 
anastomoses in the rat colon. No leakage occurred in any of these groups, but more 
strictures, lower bursting pressure and more severe inflammation was found in the CA 
reinforced group and the CA sutureless group [19]. Similarly, a lower bursting pressure 
was also reported by Ozmen et al. in a CA sutureless colonic anastomosis with two 
holding sutures [17]. NBCA has also been tested in high-risk animal models. Kayaoglu 
et al. used 0.2 mL NBCA (Glubran 2) as sealant to reinforce the anastomosis in a fecally 
contaminated environment. Similar macroscopic wound healing and bursting pressure 
were found on day 3 and day 7 in both the CA group and the suture group; however, 
more inflammation and necrosis were found in the CA group [18].
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Iso-butyl-cyanoacrylate (isoBCA)
Four studies regarding isoBCA were included [22-25], of which no study had positive 
results. Dating back to 1980, Kirkegaard et al. used isoBCA to create the sutureless 
anastomosis with a gelatin stent [25]. They found more stenosis and inflammation in 
the CA group, however these complications were significantly reduced when the CA 
anastomosis was covered with an omental tag [25].
High mortality was reported by all the other isoBCA studies. Stirling et al. used isoBCA 
to create the sutureless everted anastomosis, which resulted in a mortality rate of 27.0% 
(10/37) of canines [22]. In 1968, Hale et al. first used a rat model to compare the influence 
of isoBCA as sutureless anastomosis or as suture reinforcement. Twelve of 16 canines 
(75%) died in the sutureless anastomosis group, while conventional anastomoses or 
CA reinforced anastomoses were mostly satisfactory [23]. In 1971, Uroskie et al. used a 
canine model and performed two intestinal anastomoses in each animal, in which the 
distal anastomosis was sealed with isoBCA. Sixty percent (9/15) of the animals died dur-
ing the follow-up due to anastomosis-related complications, mostly due to AL in the CA 
reinforced anastomoses [24].
2-octyl-cyanoacrylate (OCA)
Three studies on OCA were included [26-28]. None reported additional advantages in 
anastomotic healing when OCA was applied.
Kanellos et al. resected a segment of 1.0 cm in the rat transverse colon, and randomly 
chose OCA (Dermabond) or sutures to create the sutureless anastomosis. Similar leak-
age rates, bursting pressures and histological results were found between the CA and 
suture groups [26]. In 2009 Irkorucu et al. also used OCA (Gluseal) to seal or construct 
rat colonic anastomoses after inducing wound ischemia. Similar bursting pressure and 
hydroxyproline concentrations were found between groups, while more adhesions were 
found in the CA reinforced and the sutureless groups than the conventionally sutured 
groups [28]. However, in an ischemic anastomosis model by Nursal et al., the mechanical 
strength of the OCA (Dermabond) anastomosis was significantly lower on day 7 than 
the conventionally sutured groups; furthermore, a higher inflammatory response and 
necrosis were found in the OCA group [27].
Other
Galvao et al. used CA to assist a cuff apparatus to create an invaginated anastomosis on 
rat intestine. The chemical structure of the used CA was not described in this study, but 
satisfactory anastomoses were still found in both macroscopic and histological evalua-
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tions, the CA anastomosis also cost much less time. However, after one and three days, 
tissue lesions due to CA toxicity were observed [29].
Method details
As is shown in Table 2, methodological details of each included study were listed. These de-
tails mainly focused on the material and technique used for the anastomosis construction.
CA dosage and curing time
Of all 22 included studies, only four studies specified the amount of CA used in each 
anastomosis. One study used 1.0 mL CA to create the sutureless anastomosis in a pig 
model [8], obtaining positive outcomes. 0.5 mL and 0.2 mL CA were also used in three 
rat models for creating sutureless anastomoses or as an anastomotic sealant [18, 20, 27]. 
In these rat studies, only one reported positive conclusions [20]. Only eight studies listed 
the curing time after CA application, which varied from 10 seconds to 4 minutes [2, 10, 
11, 16, 22, 24, 29].
Animal species
Three different animal species were used in the included studies. Most studies used 
animal was the rat (14 studies), and four of them had positive outcomes [3, 20, 25, 29]. 
Six canine studies were included. All of them were performed in the 1960’s and 1970’s, 
while only one had positive conclusions [14]. Only three porcine studies were included, 
all showing positive conclusions [8, 9, 15].
Anastomotic construction
Fourteen studies described or had figures demonstrating the anastomotic pattern such as 
inverted (serosa to serosa), everted (mucosa to mucosa) or invaginated (mucosa to serosa) 
anastomosis. Six studies employed an inverted anastomosis [8, 9, 15, 16, 18, 24], among 
which three had positive outcomes [8, 9, 15]. Five studies used an everted anastomosis [2, 
10, 11, 19, 22]; none of these had positive results. Three studies constructed an invaginated 
anastomosis [13, 14, 29], and two of them showed positive outcomes [14, 29].
Sutureless anastomosis constructed with CA was tested in 18 studies, of which five 
reported positive outcomes [3, 8, 14, 15, 29]. Different materials such as clamps, stents, 
modified staplers or holding sutures were used to approximate the two cutting edges, as 
is shown in Table 2. Within those materials, none of the studies that used an anastomotic 
clamp (3 studies [10, 11, 22]) showed positive outcomes. In the other studies which used 
holding sutures or a modified stapler to create CA anastomosis, mostly the canine and 
porcine studies (3/4) had positive results [8, 14, 15]. In the contrast, only one rat study 
(1/8) with holding sutures had positive results [3].
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Nine studies tested CA as a sealant after construction of a primary anastomosis; among 
these, four reported positive results (two porcine studies [9, 15], one rat study [20]). 
Most of these studies used different suture materials (silk, polypropylene or glycolic 
acid) and varying suture techniques for the construction of the primary anastomosis. 
Except for materials, different suture sizes were tested as well. Two porcine studies used 
3/0 sutures, both of these having positive outcomes [9, 15]. Five studies used 5/0 or 6/0 
sutures, mostly in rat models [18, 19, 23, 24, 28], and none of them conclude positively. 
One rat study used 7/0 sutures, and it had positive outcomes [20].
DISCUSSION
Substantial efforts have been made to test the feasibility, effect and safety of the use of 
CA in intestinal and colorectal anastomosis. Using CA as suture-replacement, early ex-
periments in the 1960s and the 1970s failed to create a successful sutureless anastomosis 
[10, 30], some recent results, though promising, still vary from one to another. Previous 
opinions mainly put the blames on the chemical characteristics of CA [2, 7]. Indeed, intra-
abdominal (actually intra-peritoneal) application of CA is distinct from its topical use 
such as skin wound closure, because intra-abdominally applied CA can only be absorbed, 
metabolized, and degraded by the body instead of falling off by itself. However, this 
still does not explain everything, as most current available CA contain longer molecular 
chain, which are less toxic than short length CA [7]. Creating anastomoses with artificial 
materials not only requires a good mechanical strength, but should also induce a good 
physiological wound healing which eventually supports the bowel continuity and bio-
mechanical strength by itself. All these influences indicate the importance to investigate 
methodological details in CA application, such as selection of CA molecular structure, 
dosage, animal model, and anastomotic technique. With this aim, this review summarizes 
the studies regarding application of CA in intestinal and colorectal anastomosis, linking 
the method details to the outcomes. We found that these studies contained great in-
consistencies in the methods. Furthermore, some important factors and details in the 
methods might influence outcomes, which are discussed respectively below.
CA molecular structure
CA was tested as a potential suture replacement because of its strong adhesiveness, which 
makes it possible to seal a technically flawed anastomosis, and even to create a sutureless 
anastomosis. Our previous ex-vivo study showed that adhesiveness is similar among differ-
ent types of CA, but is much stronger than that adhesive strength in other categories of 
tissue adhesives (unpublished data). When choosing CA for specific surgical applications, it 
is therefore more important to take other factors into account, such as tissue toxicity [31, 32].
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In general, shorter chain CA monomers (i.e. methyl-cyanoacrylate) create significant 
amounts of heat during polymerization, and are known to degrade into toxic end-prod-
ucts, resulting in severe tissue reaction and inflammation, while longer chain-length 
CA is associated with more hydrophobic and bacteriostatic properties and less tissue 
toxicity [2, 7]. However, in intestinal and colorectal anastomoses, data from the studies 
that compared different CA seem to prefer in NBCA to other shorter or longer monomers 
[21, 27, 33]. Our results in this review also agree with this, as most CA studies with MCA, 
isoBCA or OCA had negative outcomes, and more than half of the NBCA studies reported 
positive ones [8, 9, 14, 15, 20]. Nevertheless, one must note that, with the current limited 
data, it is still too early to conclude which CA is the best for intestinal and colorectal 
anastomoses. The biological properties of CA are influenced not only by its molecule 
structure, but also by the additional components added into the adhesives. Develop-
ments in biochemistry may bring further improvements in CA molecule structure for 
specific use as intestinal and colorectal anastomotic.
CA dosage
As well as the molecular structure, an important role in the tissue reaction of CA is also 
played by CA dosage. Unfortunately most studies did not provide details on this. One can 
imagine that an overdose of CA, comparable to a very high number of sutures or staples 
around the anastomosis, may lead to more side effects rather than a further increase in 
anastomotic strength. As CA is known to react exothermically during polymerization, CA 
overdose may cause direct tissue damage during polymerization, and increase adhesion 
formation, lengthening the long-term degradation time.
The currently available information is not enough to allow an analysis of the optimal 
amount of CA for intestinal and colorectal anastomosis in different animal models. 
According to the study of Paral et al., 1.0 mL of CA should be enough to construct a 
sutureless anastomosis in the porcine model [8]. Compared with the dosage for porcine 
anastomosis, 0.5 mL and 0.2 mL CA might be too much for rat anastomosis, as the rat 
colon is more than ten times smaller. Some clues on optimal CA dosage can be found 
from data in vascular surgery, where only 0.4 μl CA was enough to create vessel anas-
tomosis in rats [34]. While the manufacturers’ original applicator can be directly used in 
porcine or other big animal models, a small syringe with a blunt needle is recommended 
in rodent models to ensure accurate CA application.
Animal model
Not only due to the poor outcomes from the previous literatures, but also because of 
ethical concerns, canine models might not be suitable for future CA studies. This review 
shows that all previous studies using porcine models had positive results, implying that 
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this might be the best large animal model for future CA studies regarding to intestinal 
and colorectal anastomosis. This is also supported by the previous systematic review, 
which also found the porcine model to be superior to those with other animal species, 
as the pig’s GI tract is much more similar to a human’s than a rodents’ [35]; this enables 
human-size surgical tools and human-dose CA to be used directly on porcine. However, 
the high costs of large animal models result in most animal studies on CA being per-
formed on rat models. As stated earlier, most of the previous rat studies in this field were 
not a success. This is most probably due to the small size of the rat. Almost all techniques, 
and also the material size and dosage will thus need to be specifically adjusted for rats.
Anastomotic technique
Construction of a successful anastomosis is not simply connecting two endings together 
and reaching a mechanical strength as high as possible. A good and safe physiological 
wound healing without complications (i.e. anastomotic leakage, adhesion, stenosis) 
is more important from a clinical perspective [36]. For anastomosis of the digestive 
tract, the inverted-suture technique has been demonstrated to lead to a sufficient 
biomechanical strength as well as a better wound healing than the everted pattern; 
invaginated anastomosis is hardly used in clinic due to higher risks to develop stenosis 
and other complications [36-39]. Outcomes from CA research also confirm this, as all the 
studies using everted anastomosis had negative results, while more than half of those 
using inverted anastomosis had positive outcomes [8, 9, 15]. Comparing data from the 
included studies, we recommend that an inverted-suturing technique should also be 
used in future CA studies.
Overall, the use of CA in intestinal and colorectal anastomosis has two functions: to con-
struct a sutureless anastomosis, or to reinforce a primary anastomosis as an anastomotic 
sealant. For sutureless anastomosis, various materials have been used to approximate the 
two bowel endings before CA application. Among these materials, the modified circular 
stapler (in which the staples are removed prior to use) in large animal models might be a 
good option because the CA can easily be applied on the inverted anastomosis [33]. As 
a small stapler for rodents is lacking, the use of holding sutures was described in most of 
the rat studies. However, it does not yet seem to be satisfactory according to our results. 
One possible reason is that the holding sutures are not able to guarantee the inverted 
connection, thus creating an everted anastomosis that may complicate wound healing 
if CA is polymerized between the two wound edges. Also, instructions for topical usage 
of CA in skin wound closure indicate that the application of CA between the wound 
edges should be prohibited [7]. To ensure an inverted anastomosis, a special stent might 
be a good replacement for holding sutures, but more work on this is still required.
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For the use of CA as a sealant, the suture material and its size are also important factors 
for a good anastomosis. Our data shows that 3/0 sutures, often used in human intestinal 
and colorectal anastomosis, are suitable for large animal models; 5/0 sutures may be 
inappropriate for the rat intestinal and colorectal anastomosis, as no study reported 
positive outcomes with these. This may due to the large size of the 5/0 sutures (diameter 
of absorbable 5/0 suture: 0.15-0.199 mm [40]) relative to that of the rat colon (thick-
ness of adult male rats: around 0.6 mm [41]). The 3/0 sutures (0.30-0.349 mm [40]) are 
much smaller and lighter compared to the human colon (thickness: 2.6 mm [42]) or 
porcine colon. For rat intestinal and colorectal anastomosis, smaller size sutures such as 
7/0 (0.07-0.099 mm [40]) or 8/0 (0.05-0.069 mm [40]) seemed to be proper while more 
evidence is still required.
CONCLUSION
In view of the positive outcomes of the large animal experiments, the application of 
CA in intestinal and colorectal anastomosis seems promising. However, the great incon-
sistency and lack of detailed information in the previous literature made comparison 
of methodology difficult. To achieve a better consistency, studies should provide more 
details in the methods. If the dosage of CA, the choice of animal model, inverted anas-
tomosis construction, and other method details also are improved, future studies will 
achieve better intestinal and colorectal anastomoses with CA.
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ABSTRACT
Background
Colorectal anastomoses created in a contaminated environment result in a high leakage 
rate. This study investigated whether using anastomotic sealants (TissuCol®, Histoacryl® 
Flex, and Duraseal®) prevents leakage in a rat peritonitis model.
Methods
Sixty-seven Wistar rats were divided into control and experimental groups (TissuCol-, 
Histoacryl-, and Duraseal-group). Peritonitis was induced one day before surgery with 
the caecal ligation puncture model. On day 0, colonic anastomosis was constructed 
with sutures and then sealed with no adhesive (control group) or one select adhesive 
(experimental groups). Bursting pressure, abscess formation and adhesion severity were 
evaluated on day 3 or day 14. Hematoxylin and eosin staining and immunohistochemi-
cal staining for CD4, CD8, CD206 and iNOS were performed.
Results
On day 3 bursting pressures of the TissuCol-group (120.1±25.3 mmHg), Histoacryl-group 
(117.3±20.2 mmHg), and Duraseal-group (123.6±35.4 mmHg) were significantly higher 
than the control-group (24.4±31.7 mmHg, p<0.001). Abscesses around the anastomosis 
were found in the control-group (6/7) and Duraseal-group (2/9), but not in the TissuCol-
group or Histoacryl-group. A higher number of CD206+ cells (M2-macrophages), a lower 
number of iNOS+ cells (M1-macrophages), a higher M2/M1 index, and a higher CD4+/
CD8+ index were seen at the anastomotic site in all experimental groups compared with 
the control group on day 3. On day 14 abscesses were only found in the control group. 
Adhesion severity in the Duraseal-group was significantly lower than that in the control 
group (p=0.001).
Conclusions
Anastomotic sealing using TissuCol®, Histoacryl® Flex, or Duraseal® seems to be an 
effective and safe option to prevent leakage in contaminated colorectal surgery. The 
presence of large numbers of anti-inflammatory macrophages seems to be involved in 
preventing the leakage.
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INTRODUCTION
Under certain conditions such as abdominal trauma or perforation in diverticulitis and 
colorectal carcinoma, emergency surgery is initiated in order to repair bowel defects 
in a contaminated environment. Instead of a Hartmann’s procedure for perforated di-
verticulitis, primary anastomosis has become a well-accepted intervention in selected 
patients [1-4], resulting in similar or even better clinical outcomes regarding postop-
erative mortality and complication rates than Hartmann’s procedure [1, 5, 6]. However, 
performing primary anastomosis in a contaminated environment is challenging and still 
causes substantial leakage [7-9], especially in urgent situations. Patients with perforated 
diverticulitis who underwent primary anastomosis alone suffered a leakage rate of 
19.3% [10], which is much higher than the leakage rate of approximately 9% following a 
low anterior resection for rectal cancer [11].
Intra-abdominal sepsis induces nitric oxide production at the anastomotic site, which 
activates substantial inflammatory responses and subsequently impairs the collagen 
synthesis thereby delaying anastomotic healing [12, 13]. Macrophages are one of the 
main factors in the inflammatory response, and based on their behavior this response 
is either pro-inflammatory (M1) impairing wound healing or anti-inflammatory (M2) 
promoting wound healing; other immune cells such as T lymphocytes, though not fully 
understood, were also reported to be involved in the response [14]. Interestingly, the 
deleterious influence of inflammation is localized on the anastomosis and does not 
affect new collagen synthesis in the uninjured colon, where the biological barrier is 
intact [12]. This suggests that using a tissue adhesive or sealant as an artificial barrier 
to obstruct contact between intra-abdominal pathogens and anastomosis may reduce 
the deleterious effects of inflammation, thus preventing anastomotic leakage. Among 
different tissue adhesive compounds, fibrin glue and cyanoacrylate glue have been sub-
stantially investigated in both experimental and clinical studies with promising results 
[15-17]. Other sealants, such as polyethylene glycol glue, also had satisfactory results 
as an adhesion barrier system [18]. These tissue adhesives have been tested in different 
environments [17, 19, 20], however knowledge regarding their influence on anasto-
motic healing in a contaminated environment is still limited. We therefore conducted an 
experiment under conditions of peritonitis induced by the rat caecal ligation puncture 
(CLP) model that has been used in previous studies [21, 22]. Colonic anastomoses were 
constructed and sealed with select tissue adhesives. This study aimed to investigate 
the influence of the select tissue adhesives on anastomotic healing, and to determine 
whether they are safe and effective solutions to prevent anastomotic leakage under 
contaminated conditions.
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METHODS
Animals
Male Wistar rats, weighing 250-350 grams, were purchased from a licensed breeder (Har-
lan Laboratories, Boxmeer, the Netherlands). All rats were bred under specific pathogen-
free conditions, and kept under standard laboratory conditions. Standard rat chow and 
water were supplied ad libitum. The research protocols of all experiments were approved 
by the Ethical Committee on Animal Experimentation of Erasmus University Rotterdam.
Peritonitis model
To induce peritonitis, the rat caecal ligation puncture (CLP) model was used [21, 22]. 
In brief, rats were anaesthetized with isoflurane/oxygen inhalation, and the abdomen 
was opened through a midline incision. Then, the caecum was ligated distally to the 
ileocecal valve with a non-absorbable nylon suture (Ethilon 4-0, Ethicon, Somerville, 
USA), maintaining the continuity of the bowel. The distal caecum was punctured once 
with an 18-gauge needle, and was gently compressed until feces were extruded. The 
abdomen was closed with two layers of running sutures (Safil 5-0, B Braun, Melsungen, 
Germany). Wellness of all rats was evaluated during the follow-up, and animal with se-
verely compromised wellness (i.e. ceased food intake, circulatory or respiratory difficulty, 
severe weight loss, severely abnormal locomotion) would be euthanized and examined 
prematurely for humane endpoint.
Surgical technique and follow up
Twenty-four hours later, the rat was anesthetized again. The abdomen was reopened, 
and a culture swab was taken to confirm peritonitis. After that, 6 mg/kg of gentamicin 
(Centrafarm, Etten-Leur, The Netherlands) was injected intramuscularly. The ligated 
caecum was resected, the abdominal cavity was rinsed with at least 20mL phosphate 
buffered saline (PBS, 37°C), and colorectal anastomosis was performed afterwards. A 
colon segment of 1 cm in length was resected approximately 3 cm proximally to the 
peritoneal reflection. An end-to-end one-layer continuous anastomosis was constructed 
in an inverted fashion with Dafilon 8-0 (B. Braun, Melsungen, Germany). One researcher 
(ZW) performed all anastomoses under microscopic vision enhancement. Following 
that, one tissue adhesive was selected and applied at two parts: at the descending colon 
around the anastomosis as a sealant (distal segment), and 1 cm in length at the begin-
ning of the ascending colon (proximal segment). The tissue adhesives were prepared 
according to the instruction manuals. Because all tissue adhesive were designed for 
human patient with much larger amount of adhesive than the amount we applied on 
rats, one tissue adhesive was randomly chosen on the operation day and reused within 
the manual-instructed time period until reaching the planned group size. If necessary, 
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a blunt needle was used to guide an accurate adhesive application around the anasto-
mosis. The average amount of applied tissue adhesive is listed in Table 1. According to 
the applied tissue adhesive, rats were divided into the control group, TissuCol-group, 
Histoacryl-group, and Duraseal-group. To ensure full polymerization of tissue adhesives 
after application, we allowed the adhesives to set for five minutes before closing the 
abdomen with a running suture (Safil 5-0, B Braun, Melsungen, Germany).
On postoperative day (POD) 3 or POD14, rats were anesthetized again and re-laparotomy 
with a U-shape incision was performed. The abdomen was examined for manifestations 
of abscess formation, anastomotic dehiscence, and adhesions. Adhesion severity was 
recorded using the Zühlke score [23]. Bursting pressure was determined afterwards, and 
the bursting location was noted. The samples from the distal and proximal segments 
were harvested for histological examination, then the rat was euthanized.
Table 1. Chemical components and postoperative mortality
Chemical components Manufacturer Amount per 
anastomosis 
(mL)
Number of 
animals
Postoperative 
deaths
Control - - - 17 3
TissuCol® Fibrin glue, with aprotinin Baxter (Deerfield, 
USA)
0.1 16 0
Histoacryl® 
Flex
n-butyl-2-cyanoacrylate B. Braun, (Melsungen, 
Germany)
0.02 17 3
Duraseal® Polyethylene glycol Covidien, (Mansfield, 
USA)
0.1 17 1
Total - - 67 7
Note: Overall mortality 7 / 67 = 10.4%.
Histology and immunohistochemistry
All the harvested segments were fixed overnight in 4% buffered formaldehyde and em-
bedded in paraffin. The distal samples were cut longitudinally and the proximal samples 
were cut transversely, both in a depth of 5 micrometers. Hematoxylin and eosin (HE) 
staining was performed in all samples.
Three parameters including inflammatory cell infiltration, fibroblast activity, and collagen 
deposition at the anastomotic site were evaluated for all the HE stained distal samples. 
For each parameter a ranking was made for all the slides with the following strategy: first, 
one researcher (ZW) and one pathologist (KL) performed a blind evaluation of each slide 
under a microscope using the Ehrlich and Hunt numerical scale as modified by Phillips 
et al. [24]. After scoring, a ranking was made within the slides having the same score by 
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cross-comparing the slides. Then the slides on the margin of each score were compared 
and adjusted again (e.g. compare highest ranked ones with score 1 with lowest ranked 
ones with score 2). Finally all the ranked slides were consecutively rearranged (sorted from 
the lowest to highest rank) and minor modifications were made if necessary.
Immunohistochemical staining for CD4 (T helper cells), CD8 (T suppressor cells), CD20 (B 
lymphocytes), iNOS (M1-macrophages), and CD206 (M2-macrophages) was performed 
on distal samples. The slides were first deparaffinized and boiled in Tris/EDTA pH 9.0 
for 15 min. Endogenous peroxidase activity was blocked with 1.5% H2O2 in PBS for 10 
min. Slides were blocked for 30 min with a 5% non-fat dry milk in PBS solution. The pri-
mary antibody of CD4 (1:100, Emelca Bioscience, Breda, Netherlands), CD8 (1:200, AbD 
Serotec, Kidlington, UK), CD20 (1:100, Emelca Bioscience, Breda, Netherlands), CD206 
(1:400, Abcam plc, Cambridge, UK), or iNOS (1:1600, Abcam plc, Cambridge, UK) was 
applied respectively, and the slides were incubated overnight at 4°C. On the second day 
the slides were washed with PBS, and subsequently incubated with Envision secondary 
rabbit-anti-mouse or rabbit-anti-rabbit antibody (DAKO, Glostrup, Denmark) for 30 min. 
Diaminobenzidine (DAKO, Glostrup, Denmark) was used for visualization of antigen-
antibody reactivity. Finally all slides were counterstained with hematoxylin, dehydrated 
and mounted.
A blinded investigator using a microscope under 40x10 magnification counted the posi-
tive cell amount of each staining. For the anastomotic site, three fields were selected: 
one on each cutting edge, the other one on the interface. For the serosa-glue site, three 
fields were also chosen at the interface of the tissue adhesive and adjacent tissue; in the 
control group, three fields were chosen at the interface of adhesion and adjacent tissue. 
The number of positive cells for each staining was counted, and the average of the three 
fields was used for analysis. An M2/M1 index was calculated with the equitation blew. A 
natural logarithm was used to adjust the data from exponential distribution into linear 
distribution. A similar equitation was also used for the CD4/CD8 index.
M2⁄M1 index = ln (Number of CD206+ cells)/(Number of iNOS+ cells)
Statistical analysis
Statistical analysis was performed with SPSS 21.0 (IBM software, USA). Data were pre-
sented as mean (S.D.) or percentage. The one-way analysis of variance was performed 
with the Kruskal Wallis Test or Chi-square Test, and a p-value < 0.05 was considered 
to indicate statistical significance. In multiple comparisons, α was corrected with the 
number of comparisons with the following formula: α’ = α / N (α = 0.05, N = number 
of comparisons). When a significant difference was reached in the Kruskal Wallis Tests, 
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multiple comparisons were made between the control group and each corresponding 
tissue adhesive the Mann-Whitney U Tests or Chi-square Tests in this study, so N = 3 was 
chosen for correction. Only a p’-value < 0.017 (0.05/3) was considered to indicate statisti-
cal significance in the multiple comparisons. All reported p-values were two-sided.
RESULTS
A total number of 67 rats were used in the experiment and seven rats (10.4%) died during 
follow-up. Six deaths occurred on the day of the operation due to septicemia, but no anas-
tomotic related complications were observed during autopsy. One rat had bloody stools 
after its operation and died on POD3, with its autopsy showing abscess formation on the 
anastomosis. There was no statistical difference in mortality rate between groups (Table 1).
After induction of fecal peritonitis with CLP model, all rats manifested septic symptoms 
such as compromised activities, nasal/ocular exudates, fluffy hair, diarrhea and weight 
loss, but no rat was prematurely euthanized for humane endpoint. On the operation day, 
weight loss were seen in all rats with an average of 10 to 12 grams in each group; no sig-
nificant difference was found between groups. Abdominal fecal peritonitis were observed 
in all rats, manifesting as existence of ascites with fecal content. Abdominal culture tests of 
the ascites further confirmed bacterial contamination with Gram-positive (e.g. Enterococ-
cus, Staphylococcus) and Gram-negative (e.g. Escherichia coli, Proteus) flora.
Intra-abdominal observations
On POD3, anastomotic dehiscence occurred in 28.6% (2/7) of rats in the control group, 
but not in other groups. Abscesses on the anastomosis was found in 85.7% (6/7) of rats 
in the control group, 22.2% (2/9) of rats in the Duraseal-group, but not in the TissuCol-
group or Histoacryl-group, and it was significantly different between groups (p < 0.0001). 
On POD14, abscess formation on the anastomosis were found in one rat from the control 
group whereas none was found in the other groups.
The bursting pressure in the control group was 24.4 ± 31.7 mmHg. This was significantly 
lower than that in the TissuCol-group (120.1 ± 25.3 mmHg, p = 0.001), Histoacryl-group 
(117.3 ± 20.2 mmHg, p = 0.001), and Duraseal-group (123.6 ± 35.4 mmHg, p = 0.001, 
Figure 1). In the control group, 85.7% of the segments burst at the anastomotic line 
during the test, while the rates in the other groups differed between 28.6% (Histoacryl-
group) and 50% (TissuCol-group). On POD14, most anastomotic segments did not burst 
at the site of the anastomosis in the ABP tests.
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Anastomotic adhesion formation was found in all rats. On POD3, the number of adhesions 
was significantly different between groups (p = 0.012). An average adhesion number of 
3.7 was found in the control group, which was significantly higher than the TissuCol-
group (average: 1.8; p = 0.004) and Histoacryl-group (average: 1.9; p = 0.015), but not 
significantly higher than the Duraseal-group (average: 2.8). Most rats were scored 2 in 
the Zühlke score (blunt dissection possible but partly sharp dissection possible; begin-
ning of vascularization), and no difference was found between groups. In contrast, on 
POD14, the number of adhesions was similar between groups (average varied between 
1.4 and 1.7), while their severity significantly differed (p = 0.004). The lowest adhesion 
score was found in the Duraseal-group (average of 1.3; firm adhesion, easy to separate 
by blunt dissection; no vascularization). It was significantly lower than the control group 
(p = 0.001), which had an average severity of 3.1 (lysis possible but sharp dissection only, 
clear vascularization).
HISTOLOGy AND IMMUNOHISTOCHEMISTRy
Anastomotic site
All the distal-segment slides showed an acute inflammatory response at the anastomotic 
site on POD3. The inflammatory cell infiltration was highest in the control group, which 
was significantly higher than that in the Histoacryl-group (p = 0.009). Lower fibroblast 
activity and collagen deposition was seen in the control group compared with the 
experimental groups, but their differences were not statistically significant (Figure 2). A 
lower number of CD206+ cells (M2) and a higher number of iNOS+ cells (M1) were seen 
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POD14, an abscess formation on the anastomosis was found
in one rat from the control group whereas none was found in
the other groups.
The bursting pressure in the control group was 24.4±
31.7 mmHg. This was significantly lower than that in the
TissuCol group (120.1±25.3 mmHg, p=0.001), Histoacryl
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group (p=0.001), which had an average severity of 3.1 (lysis
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Histology and immunohistochemistry
Anastomotic site
All the distal-segment slides showed an acute inflammatory
response at the anastomotic site on POD3. The inflammatory
cell infiltration was highest in the control group, which was
Table 1 Chemical components and postoperative mortality
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Postoperative
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Control – – – 17 3
TissuCol® Fibrin glue, with aprotinin Baxter, (Deerfield, USA) 0.1 16 0
Histoacryl® Flex n-butyl-2-cyanoacrylate B. Braun, (Melsungen, Germany) 0.02 17 3
Duraseal® Polyethylene glycol Covidien, (Mansfield, USA) 0.1 17 1
Total – – 67 7
Overall mortality 7/67=10.4 %
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Fig. 1 Comparison of anastomotic bursting pressures (ABP) on postop-
erative days (POD) 3 and 14. Values are mean (S.E.M.). On POD3,
overall comparison, p=0.001, Kruskal-Wallis test. On POD14, overall
comparison, p=0.039, Kruskal-Wallis test. The p values of Mann-
Whitney pairwise comparisons are illustrated in the figure when relevant
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Figure 1. Comparison of anastomotic bursting pressures (ABP) on postoperative day (POD) 3 and 14. Val-
ues are mean (S.E.M.). The On POD3, overall comparison, p = 0.001, Kruskal-Wallis Test. On POD14, overall 
comparison, p = 0.039, Kruskal-Wallis Test. The p values of Mann-Whitney pairwise comparisons are illus-
trated in the figure wh n relevant.
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in the control group, and the M2/M1 index for the control group was also statistically 
significantly lower than all the tissue adhesive groups respectively (p = 0.002; Figure 3). 
A significant correlation was found between the ABP value and the M2/M1 index (R = 
0.682; p < 0.0001). Similar changes were also seen in the CD4+ cells (T helper cells), CD8+ 
cells (T suppressor cells), and CD4+/CD8+ index (Figure 4), although only the difference 
between the control group and the TissuCol-group regarding CD8+ cells was statistically 
significant.
On POD14 most slides demonstrated sufficient wound healing on the anastomosis, 
showing as re-continuity of mucosal and muscle layers, less inflammatory cell infiltra-
tion and higher collagen deposition. There was no significant difference in fibroblast 
activity and collagen deposition between the control group and the adhesive groups. 
A higher number of iNOS+ cells (M1) and a lower M2/M1 index was seen in the control 
group compared with the tissue adhesive groups (Figure 3).
Serosa-glue interface
On POD3, similar numbers of iNOS+ cells and CD206+ cells were seen at the serosa-
glue interface. The M2/M1 index, though higher in the tissue adhesive groups, was not 
significantly different between groups. On POD14, a significant higher M2/M1 index was 
observed in the Histoacryl-group compared with the control group at the serosa-glue 
interface (Figure 5).
Proximal samples
In proximal samples, except for a minimal number of inflammatory cells, evidence of an 
inflammatory response was not seen in the control group. Similar to the distal samples, 
a moderate reaction was seen at the serosa-glue interface in the TissuCol-group, 
Histoacryl-group and Duraseal-group on POD3, which manifested as macrophage infil-
tration around the tissue adhesive, without interrupting the continuity of the mucosal, 
sub-mucosal and muscle layers of the colon. On POD14, the foreign body reaction in 
the TissuCol-group was observed to have significantly reduced, and the glue was not 
observed (neither macroscopically nor microscopically) in 75% (6/8) of the rats. The 
reaction in the Histoacryl-group and Duraseal-group was still moderate.
DISCUSSION
Performing anastomosis in a contaminated environment results in a high leakage rate 
of colorectal anastomosis and poor clinical outcomes, threatening patient’s safety. To 
investigate whether using tissue-adhesive sealants prevents leakage in a contaminated 
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significantly higher than that in the Histoacryl group (p=
0.009). Lower fibroblast activity and collagen deposition were
seen in the control group compared with the experimental
groups, but their differences were not statistically significant
(Fig. 2). A lower number of CD206+ cells (M2) and a higher
number of iNOS+ cells (M1) were seen in the control group,
and the M2/M1 index for the control group was also statisti-
cally significantly lower than all the tissue adhesive groups
respectively (p=0.002, Fig. 3). A significant correlation was
found between the ABP value and the M2/M1 index (R=
0.682, p<0.0001). Similar changes were also seen in the
CD4+ cells (T helper cells), CD8+ cells (T suppressor cells),
and CD4+/CD8+ index (Fig. 4), although only the difference
between the control group and the TissuCol group regarding
CD8+ cells was statistically significant.
On POD14, most slides demonstrated sufficient wound
healing on the anastomosis, showing as re-continuity of muco-
sal and muscle layers, less inflammatory cell infiltration, and
higher collagen deposition. There was no significant difference
in fibroblast activity and collagen deposition between the con-
trol group and the adhesive groups. A higher number of iNOS+
cells (M1) and a lower M2/M1 index were seen in the control
group compared with the tissue adhesive groups (Fig. 3).
Serosa-glue interface
On POD3, similar numbers of iNOS+ cells and CD206+ cells
were seen at the serosa-glue interface. TheM2/M1 index, though
higher in the tissue adhesive groups, was not significantly dif-
ferent between groups. On POD14, a significant higher M2/M1
index was observed in the Histoacryl group compared with the
control group at the serosa-glue interface (Fig. 5).
Proximal samples
In proximal samples, except for a minimal number of inflam-
matory cells, evidence of an inflammatory response was not
seen in the control group. Similar to the distal samples, a
moderate reaction was seen at the serosa-glue interface in
the TissuCol group, Histoacryl group, and Duraseal group
on POD3, which manifested as macrophage infiltration
around the tissue adhesive, without interrupting the continuity
of the mucosal, submucosal, and muscle layers of the colon.
On POD14, the foreign body reaction in the TissuCol group
was observed to have significantly reduced, and the glue was
not observed (neither macroscopically nor microscopically) in
75% (6/8) of the rats. The reaction in the Histoacryl group and
Duraseal group was still moderate.
Discussion
Performing anastomosis in a contaminated environment re-
sults in a high leakage rate of colorectal anastomosis and poor
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Fig. 2 Comparison of histological parameters on postoperative days
(POD) 3 and 14. Values are mean ranking (S.E.M.). On POD3, overall
comparison of inflammatory cell infiltration ranking (a) yielded a p=
0.003 with the Kruskal-Wallis test. Lower fibroblast activity and collagen
deposition were seen in the control group compared with the experimen-
tal groups (b, c). Overall comparisons resulted a p>0.05 in the other
parameters, Kruskal-Wallis test. The p values of Mann-Whitney pairwise
comparisons are illustrated in the figure when relevant
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Figure 2. Comparison of histological param-
eters on postoperative day (POD) 3 and 14. Val-
ues are mean ranking (S.E.M.). On POD3, overall 
comparison of inflammatory cell infiltration 
ranking (2.A) yielded a p = 0.003 with the Krus-
kal-Wallis Test. Overall comparisons resulted a 
p > 0.05 in the other parameters, Kruskal-Wallis 
Test. The p values of Mann-Whitney pairwise 
comparisons are illustrated in the figure when 
relevant.
clinical outcomes, threatening patient’s safety. To investigate
whether using tissue-adhesive sealants prevents leakage in a
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Fig. 3 Comparison of macrophage subtype (i.e., M2 and M1) amount at
anastomotic site on postoperative days (POD) 3 and 14. Values are mean
of cell count (S.E.M.). On POD3, overall comparison of M2 (a), p=
0.003; M1 (b), p=0.011; and M2/M1 (c), p=0.002, Kruskal-Wallis test.
On POD14, overall comparison of M2 (a), p>0.05; M1 (b), p=0.016;
and M2/M1 (c), p=0.010, Kruskal-Wallis test. The p values of Mann-
Whitney pairwise comparisons are illustrated in the figure when relevant
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Fig. 4 Comparison of T lymphocyte amount at anastomotic site on
postoperative days (POD) 3 and 14. Values are mean of cell count
(S.E.M.). On POD3, overall comparison of CD4+ (a), p=0.042; CD8+
(b), p=0.027; CD4+/CD8+ (c), p>0.05, Kruskal-Wallis test. Overall
comparisons on POD14 all resulted a p>0.05, Kruskal-Wallis test. The
p values of Mann-Whitney pairwise comparisons are illustrated in the
figure
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Figure 3. Comparison of macrophage subtype (i.e. 
M2 and M1) amount at anastomotic site on postopera-
tive day (POD) 3 d 14. Values re mean of ce l count 
(S.E.M.). On POD3, overall comparis n of M2 (3.A), p 
= 0.003; M1 (3.B), p = 0.011; M2/M1, (3.C) p = 0.002, 
Kruskal-Wallis Test. On POD14, overall comparison of 
M2 (3.A), p > 0.05; M1 (3.B), p = 0.016; M2/M1, (3.C) p = 
0.010, Kruskal-Wallis Test. The p values of Mann-Whit-
ney pairwise comparisons are illustrated in the figure 
when relevant.
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clinical outcomes, threatening patient’s safety. To investigate
whether using tissue-adhesive sealants prevents leakage in a
Co
ntr
ol
Tis
su
co
l
His
toa
cry
l
Du
ras
ea
l
Co
ntr
ol
Tis
su
co
l
His
toa
cry
l
Du
ras
ea
l
0
50
100
150    0.002
CD206+ cell counting
C
el
lc
ou
nt
POD 14
POD 3
Co
ntr
ol
Tis
su
co
l
His
toa
cry
l
Du
ras
ea
l
Co
ntr
ol
Tis
su
co
l
His
toa
cry
l
Du
ras
ea
l
0
50
100
150
   0.017
0.006
0.0050.005
iNOS+ cell counting
C
el
lc
ou
nt
Co
ntr
ol
Tis
su
co
l
His
toa
cry
l
Du
ras
ea
l
Co
ntr
ol
Tis
su
co
l
His
toa
cry
l
Du
ras
ea
l
-2
-1
0
1
2
3    0.004
0.003
   0.009
0.0030.003
Ln (CD206+/iNOS+)
A
B
C
Fig. 3 Comparison of macrophage subtype (i.e., M2 and M1) amount at
anastomotic site on postoperative days (POD) 3 and 14. Values are mean
of cell count (S.E.M.). On POD3, overall comparison of M2 (a), p=
0.003; M1 (b), p=0.011; and M2/M1 (c), p=0.002, Kruskal-Wallis test.
On POD14, overall comparison of M2 (a), p>0.05; M1 (b), p=0.016;
and M2/M1 (c), p=0.010, Kruskal-Wallis test. The p values of Mann-
Whitney pairwise comparisons are illustrated in the figure when relevant
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Fig. 4 Comparison of T lymphocyte amount at anastomotic site on
postoperative days (POD) 3 and 14. Values are mean of cell count
(S.E.M.). On POD3, overall comparison of CD4+ (a), p=0.042; CD8+
(b), p=0.027; CD4+/CD8+ (c), p>0.05, Kruskal-Wallis test. Overall
comparisons on POD14 all resulted a p>0.05, Kruskal-Wallis test. The
p values of Mann-Whitney pairwise comparisons are illustrated in the
figure
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Figure 4. Comparison of T lymphocyte amount 
at anastomotic site on postoperative day (POD) 
3 and 14. Values are mean of cell count (S.E.M.). 
On POD3, overall comparison of CD4+ (4.A), p 
= 0.042; CD8+ (4.B), p = 0.027; CD4+/CD8+, p > 
0.05 (4.C), Kruskal-Wallis Test. Overall compari-
sons on POD14 all resulted a p > 0.05, Kruskal-
Wallis Test. The p values of Mann-Whitney pair-
wise comparisons are illustrated in the figure.
contaminated environment, we constructed colorectal anasto-
moses under fecal contamination using the rat CLPmodel. All
three chosen tissue adhesives increased the biomechanical
strength of anastomosis in the short term, without increasing
the risk on adhesion formation in the long term. The increased
presence of anti-inflammatory macrophages (M2) and the
decrease of the presence of pro-inflammatory (M1) macro-
phages is associated with increased biomechanical strength
and most likely contributed to the positive effect of the tissue
adhesives. These results support the further application of
these tissue adhesives in a contaminated environment.
In this study, bacterial peritonitis induced with the CLP
model caused high mortality, intra-abdominal abscess for-
mation, anastomotic dehiscence, and low bursting pres-
sures in the control group rats on POD3. These results are
in line with previous studies [22, 25, 26]. In comparison,
we found that under sterile conditions, colonic anastomot-
ic bursting pressure approximated an average of 80–
90 mmHg (unpublished data). Lipopolysaccharide (LPS)
from intra-abdominal bacteria triggers the classical activa-
tion of macrophages (M1), secreting nitric oxide and pro-
inflammatory cytokines (i.e., tumor necrosis factor
(TNF)-α, interleukin (IL)-12), subsequently enhancing
cell-mediated immunity [27]. Although the exact mecha-
nisms of nitric oxide in anastomotic healing is not yet
determined, previous studies found that sepsis-induced
nitric oxide production subsequently impaired collagen
synthesis and thus delayed colonic anastomotic healing
in the early phases [12, 13]. Accumulation of nitric oxide
also causes apoptosis of neutrophils [28], manifesting as
abscess formation. These histological changes were also
observed in the control group, and more importantly a
correlation between the M2/M1 index and the bursting
pressure was also found on POD3. These data demonstrate
that bacterial peritonitis impaired anastomotic healing in
the short term in our CLP model and that macrophages
play a role in this process.
We also observed that tissue adhesives reduced abscess
formation and increased the bursting pressure in the short
term. These positive influences on wound healing are
unlikely to be completely determined by the sealant adhe-
siveness. We previously evaluated the adhesiveness of 12
commercially available tissue adhesives in an ex vivo rat
colon model [29]. According to that study, only cyanoac-
rylate (including Histoacryl® Flex) had a strong adhesive-
ness that may instantly increase anastomotic strength. In
contrast, all tested fibrin and PEG glues (including
TissuCol® and Duraseal®) had very limited adhesiveness,
which might hardly give additional strength to the anasto-
mosis [29, 30]. However, as is shown in our results, both
TissuCol® and Duraseal® significantly increased the
bursting pressure on POD3, indicating involvement of
other mechanisms.
Activation of macrophages is critical in the acute phase
of wound healing. In the early phase, the wound strength
mainly comes from the sutures and type III collagen
produced by fibroblasts [31]. The fibrogenesis by
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Fig. 5 Comparison of macrophage subtype (i.e., M2 and M1) amount at
serosa-adhesive site on postoperative days (POD) 3 and 14. Values are
mean of cell count (S.E.M.). Despite overall comparison of M2/M1 on
POD14 (c) yielding a p=0.036, all the other overall comparisons on
POD3 or 14 resulted a p>0.05 (a, b), Kruskal-Wallis test. The p values
of Mann-Whitney pairwise comparisons are illustrated in the figure
Int J Colorectal Dis
Figure 5. Comparison of macrophage subtype (i.e. 
M2 and M1) amount at serosa-adhesive site on post-
operative day (POD) 3 and 14. Values are mean of cell 
count (S.E.M.). Despite overall comparison of M2/M1 
on POD14 (5.C) yielded a p = 0.036, all the other over-
all comparisons on POD3 or 14 resulted a p > 0.05, 
Kruskal-Wallis Test. The p values of Mann-Whitney 
pairwise comparisons are illustrated in the figure.
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environment, we constructed colorectal anastomoses under fecal contamination us-
ing the rat CLP model. All three chosen tissue adhesives increased the biomechanical 
strength of anastomosis in the short term, without increasing the risk on adhesion 
formation in the long term. The increased presence of anti-inflammatory macrophages 
(M2) and the decrease of the presence of pro-inflammatory (M1) macrophages is associ-
ated with increased biomechanical strength and most likely contributed to the positive 
effect of the tissue adhesives. These results support the further application of these 
tissue adhesives in a contaminated environment.
In this study, bacterial peritonitis induced with the CLP model caused high mortality, 
intra-abdominal abscess formation, anastomotic dehiscence, and low bursting pres-
sures in the control group rats on POD3. These results are in line with previous studies 
[22, 25, 26]. In comparison, we found that under sterile conditions colonic anastomotic 
bursting pressure approximated an average of 80-90 mmHg (unpublished data). Li-
popolysaccharide (LPS) from intra-abdominal bacteria triggers the classical activation 
of macrophages (M1), secreting nitric oxide, proinflammatory cytokines (i.e. tumor 
necrosis factor (TNF)-α, interleukin (IL)-12), subsequently enhancing cell-mediated im-
munity [27]. Although the exact mechanisms of nitric oxide in anastomotic healing is 
not yet determined, previous studies found that sepsis-induced nitric oxide production 
subsequently impaired collagen synthesis and thus delayed colonic anastomotic heal-
ing in the early phases [12, 13]. Accumulation of nitric oxide also causes apoptosis of 
neutrophils [28], manifesting as abscess formation. These histological changes were also 
observed in the control group, and more importantly correlation between the M2/M1 
index and the bursting pressure was also found on POD3. These data demonstrate that 
bacterial peritonitis impaired anastomotic healing in the short term in our CLP model 
and that macrophages play a role in this process.
We also observed that tissue adhesives reduced abscess formation and increased the 
bursting pressure in the short term. These positive influences on wound healing are 
unlikely to be completely determined by the sealant adhesiveness. We previously evalu-
ated the adhesiveness of twelve commercially available tissue adhesives in an ex-vivo 
rat colon model [29]. According to that study, only cyanoacrylate (including Histoacryl® 
Flex) had a strong adhesiveness that may instantly increase anastomotic strength. In 
contrast, all tested fibrin and PEG glues (including TissuCol® and Duraseal®) had very 
limited adhesiveness, which might hardly give additional strength to the anastomosis 
[29, 30]. However, as is shown in our results, both TissuCol® and Duraseal® significantly 
increased the bursting pressure on POD3, indicating involvement of other mechanisms.
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Activation of macrophages is critical in the acute phase of wound healing. In the early 
phase, the wound strength mainly comes from the sutures and type III collagen produced 
by fibroblasts [31]. The fibrogenesis by fibroblasts is enhanced by alternatively activated 
macrophages (M2), while the classical activation of macrophages (M1) has negative 
influence on collagen deposition [27, 32]. In addition to the actual cell count, the M2/M1 
index is also a representative parameter for macrophage function in tissue reaction [33, 
34]. Our data showed a lower number of M1, a higher number of M2, and a higher M2/
M1 index in the tissue adhesive groups in the short term. The data suggest an alteration 
in the macrophage activation. We hypothesized that the tissue adhesive might isolate 
the contact between the anastomosis and intra-abdominal bacteria, and thus prevented 
the endotoxin-induced proinflammatory responses. This was further supported by the 
results of the Duraseal-group. In that group, a similar amount of iNOS+ cells as in the 
control group was found at the serosa-glue site (macroscopically presenting as abscess 
formation), but the anastomotic site was protected from this deleterious environment 
by the adhesive sealant, and far fewer iNOS+ cells were seen around the anastomosis, 
probably contributing to the high bursting pressure on POD3.
T lymphocytes also play an important role in the wound healing process. Previous 
studies reported that accumulation of CD8+ cells had a negative influence on collagen 
deposition and thus impairing early phase wound healing [35], which was also seen 
in our data accordingly. After exposure to LPS, type I interferon (IFN-α, β) produced by 
antigen-presenting cells activates CD8+ cells (T suppressor lymphocytes) [36], which 
trigger the apoptosis process of the infected somatic cells via the caspase cascade. The 
involvement of CD4+ cells (T helper cells) in wound healing is complicated. T helper 1 
cells are involved in cellular immunity, and enhance iNOS production in macrophages 
[37]. T helper 2 lymphocytes and mast cells, however, produce IL-4 and other cytokines, 
which stimulates fibroblasts to produce extracellular matrix proteins, fibronectin, and 
collagen [38]. Although we did not further differentiate between the subpopulations 
of T helper cells, in a previous study on thermal injury, a decrease in CD4+/CD8+ ratio 
could only be found in infected wounds but not in the wounds without infection [14, 39]. 
A similar phenomenon was only seen in our control group which had a contaminated 
anastomotic wound. These data are in line with the observation in macrophage activa-
tion, and they further elucidate that applying the tissue adhesives prevents localized 
infection on the anastomosis and thus activates an alternative inflammatory response.
Previous studies found that the protective effect of tissue adhesive on the anasto-
mosis was temporary, mainly in the short term [20, 40, 41]. De Hingh et al. reported 
that biomechanical strength of anastomoses is most vulnerable on POD3, and then 
gradually recovers in the CLP model [26]. Other studies showed that the strength at 
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the anastomosis was higher than the intact colon in the long term, when the bursting 
location was not at the anastomotic site [25, 42]. Similar changes in bursting pressure 
and inflammatory cells were also seen in our data. Such phenomena are consistent with 
clinical observations, as most clinical anastomotic leakages occur within the first seven 
postoperative days, especially after contaminated procedures [25, 43]. In this regard 
tissue adhesives are required to provide effective protection during the first critical days 
after surgery prior to a long-lasting protection. Our results showed application of select 
tissue adhesives assists wound healing during the crucial period.
Increasing the anastomotic strength in the short term, it is also important that the 
applied tissue adhesives do not cause other adverse events in the long term. Among 
those events, adhesion formation and foreign body reaction are the most concerning 
ones for intra-abdominal application of biomaterials [19, 20]. Our data showed that the 
tissue adhesives used did not increase adhesion formation. The foreign body reaction 
after adhesive application were moderate in all tissue adhesive groups, which were also 
shown in the M2/M1 index in the long term.
Among the select tissue adhesives, fibrin glue has been known as inert [41, 44, 45], and 
polyethylene glycol glue has been used as an adhesion barrier [18]. A moderate foreign 
body reaction and adhesion formation after application of the cyanoacrylate glue, how-
ever, was not expected because it was reported to increase inflammatory reactions, ne-
crosis and adhesion formation in normal or high-risk conditions [46-48]. The inconsistency 
between previous cyanoacrylate studies and our data can be explained by several reasons. 
First, our amount of cyanoacrylate, 0.02 mL, was much smaller than that in the previous 
studies [20, 46], and thus fewer adverse events could be expected. In addition, most cya-
noacrylate studies with positive results used n-butyl-cyanoacrylate, which causes a less 
inflammatory response and tissue toxicity than other cyanoacrylate molecules [20]. There-
fore Histoacryl® Flex was also used in this study which is made of n-butyl-cyanoacrylate. 
These differences, though small, might significantly influence outcomes.
In conclusion, the application of the select tissue adhesives (i.e. TissuCol®, Histoacryl® 
Flex, and Duraseal®) increased anastomotic strength in the short term without increas-
ing the long-term risk for adhesion formation. The alternative activation of macrophages 
and T cells most likely mediated these positive effects. Our results support the further 
application of anastomotic sealants in contaminated colorectal surgery.
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ABSTRACT
Background
Anastomotic leakage after gastrointestinal surgery remains a challenging clinical prob-
lem. This study aimed to investigate the effectiveness of TissuCol (fibrin glue), Histoacryl 
Flex (n-butyl-2-cyanoacrylate), and Duraseal (polyethylene glycol) on colorectal anasto-
motic healing during experimental colitis.
Methods
We first performed colectomy 7 days after 10 mg trinitrobenzene sulfonic acid (TNBS)-
induced colitis to validate a rat TNBS-colitis- colectomy model. Subsequently, this 
TNBS-colitis-colectomy model was used in 73Wistar rats that were stratified into a colitis 
group (CG, no adhesive), a TissuCol group (TG), a Histoacryl group (HG), and a Duraseal 
group (DG). Anastomotic sealant was applied with one adhesive after constructing an 
end-to-end hand-sewn anastomosis. Clinical manifestations, anastomotic bursting pres-
sure, and immunohistochemistry of macrophage type-one (M1) and type-two (M2) was 
performed on postoperative day (POD)3 or POD7.
Results
TNBS-caused mucosal and submucosal colon damage and compromised anastomotic 
healing (i.e. abscess formation and low anastomotic bursting pressure). On POD3, higher 
severity of abscesses was seen in CG. Average anastomotic bursting pressure was 53.2 ± 
35.5 mmHg in CG, which was significantly lower than HG (134.4 ± 27.5 mmHg) and DG 
(95.1 ± 54.3 mmHg) but not TG (83.4 ± 46.7 mmHg). Furthermore, a significantly higher 
M2/M1 index was found in HG. On POD7, abscesses were only seen in CG (6/9) but not in 
other groups; HG had the lowest severity of adhesion.
Conclusions
We describe the first surgical IBD model by performing colectomy in rats with TNBS-
induced colitis, which causes intra-abdominal abscess formation and compromises 
anastomotic healing. Anastomotic sealing with Histoacryl Flex prevents these complica-
tions in this model. Alternative activation of macrophages seems to be involved in its 
influence on anastomotic healing.
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INTRODUCTION
Inflammatory Bowel Disease (IBD) is a chronic relapsing disorder, and significantly im-
pairs patient’s quality of life. Although oral and parenteral therapies are the mainstays 
in the management of IBD, surgical treatment is still required in case of unsuccessful 
medical management or occurrence of severe complications. Approximately 20-30% of 
patients with chronic ulcerative colitis (UC) ultimately require surgical treatment, and 
30% of them need a total colectomy within five years after diagnosis [1-3].
Despite a residual chance for relapse, these patients still suffer substantial risk of short- 
and long-term surgical complications after operation. After surgical intervention such as 
ileal-pouch-anal anastomosis, an overall complication rate approximating 30% to 40% 
in IBD patients has been reported. The patients have even higher rates of complications, 
especially the infectious ones (68%) when receiving high doses steroids [3, 4]. A major 
course of the infectious complications (e.g. pelvic sepsis) is leakage at the sutured or 
stapled anastomotic site [3, 5]. Therefore, preventing anastomotic leakage is a major 
objective in the request for preventing postoperative complications. Unfortunately, 
however, effective strategies are still lacking to date.
Using tissue adhesives as an artificial barrier at the anastomotic site seems to be a 
promising avenue for combating anastomotic leakage rates [6]. Previously, we evalu-
ated the mechanical strength and biological reaction of tissue adhesive in rat models 
and showed that several tissue adhesives (i.e. TissuCol®, Histoacryl® Flex, and Duraseal®) 
effectively prevented leakage in contaminated conditions [7, 8]. However, the potential 
applicability of these results in the setting of inflammatory bowel disease is obscure at 
best and further investigation in this regard is urgently needed before human testing 
can commence.
In the microbiologically contaminated environment of the inflamed intestine, preven-
tion of colorectal anastomotic leakage critically depends on skewing the ratio between 
pro-inflammatory macrophages (M1) and regulatory macrophages (M2) [7]. In addition, 
macrophages also play an important role in IBD pathology per se, but their exact role 
remains controversial. Though not fully understood, it has been reported that nitric ox-
ide (NO) production through inducible nitric oxide synthase (iNOS) by M1 macrophages, 
perpetuates chronic inflammation [9]. Conversely, accumulation of M2 macrophages has 
been reported to reduce the severity of IBD [10]. In view of their principal and antago-
nistic roles in anastomotic healing, further investigation as to strategies to increase the 
M2 component and to decrease the M1 component of the macrophage compartment 
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is of evident importance to devise rational clinical strategies for furthering anastomotic 
healing in IBD patients.
Although many IBD models have been established and contributed greatly to mecha-
nistic insight in IBD as well as to potential treatment [11-15], a model focused on the 
surgical treatment of this disease is conspicuously lacking. To this end in this study we 
developed a novel surgical IBD model by combining the rat colectomy model with the 
trinitrobenzene sulfonic acid (TNBS) induced colitis model to study these questions 
[16, 17]. Colonic anastomoses were constructed in rats with colitis and sealed with one 
selected tissue adhesive. Clinical manifestations, anastomotic healing, and the ratio of 
M2- and M1-macrophages using immunohistochemistry were evaluated after surgery 
to determine the effect of the adhesives. The results show that tissue adhesives and 
especially Histoacryl® Flex improves outcome, which open the way for human trials test-
ing this adhesive in the surgical treatment of IBD patients 
METHODS
Animals
Male Wistar rats, weighing 300-350 grams, were purchased from a licensed breeder 
(Harlan Laboratories, Boxmeer, the Netherlands). The rats were bred under specific 
pathogen-free conditions and kept in individually ventilated cages. The study was per-
formed according to a research protocol approved by the Ethical Committee on Animal 
Experimentation of Erasmus University Rotterdam.
Establishing a novel rat TNBS-colitis-colectomy (TCC) model
We developed the TCC model by combining the TNBS colitis model with our previously 
validated rat colectomy model [16, 18].
The rats were fasted for one day before TNBS-colitis induction to ensure a generally 
empty colon. On the day of colitis induction, the rats were anaesthetized with isoflurane/
oxygen inhalation, and a plastic cannula (7.5 cm in length) was inserted trans-anally into 
the rat colon. TNBS solution (10 mg diluted in 25% ethanol, 0.25 ml; TNBS group, 5 rats) 
or 25% ethanol (0.25 ml; control group, 10 rats) was injected respectively. The rats were 
put in a head-down position for 5 minutes and then returned to the cages with free 
access to food and water.
Seven days later, a partial colectomy was performed in all rats according to our previ-
ously published method and conditions (Figure 1) [18], resecting the major part of the 
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colon distal to the caecum. Subsequently, an end-to-end one-layer continuous anas-
tomosis was constructed in an inverted fashion with Dafilon 8-0 (B. Braun, Melsungen, 
Germany). One trained researcher (ZW) performed all anastomoses under microscope. 
After closing the abdominal wall, 5 mL saline was subcutaneously injected to prevent 
dehydration. TNBS-caused colon damage was evaluated during surgery; functional, 
macroscopic and histological changes regarding anastomotic healing were evaluated 
on postoperative day (POD)-3.
Figure 1. Schematic overview of the rat colon and the methodology employed for the trinitrobenzene 
sulfonic acid (TNBS)-colitis-colectomy model, anterior view. (A) Rat colon before colectomy. (B) Rat colon 
after colectomy. Anatomy: a. caecum, b. terminal ileum, c. rectum and anus, d. colitis lesion (intra-luminal). 
Procedure: (1) Seven days before the colectomy, a TNBS solution (10 mg diluted in 25% ethanol, 0.25 ml) is 
injected trans-anally with a plastic cannula and this causes colon damage (d); (2) During colectomy, a major 
part of the colon (i.e. selected with dashed line and indicated with grey colour) is resected ; (3) After colon 
resection, an end-to-end one-layer continuous anastomosis (red arrow) was constructed in an inverted 
fashion.
Evaluating tissue adhesives in the rat TCC model
Evaluation of tissue adhesives in the rat TCC model was performed according to proce-
dures essentially similar as those described above for development and validation of 
this model. Seventy-three rats with TNBS-colitis were used in this experiment.
Following anastomosis construction, one selected tissue adhesive was applied around 
the anastomosis as a sealant. The tissue adhesive was prepared according to the instruc-
tion manual. According to the applied tissue adhesive, rats were divided into the colitis 
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group (no adhesive applied), TissuCol group, Histoacryl group, and Duraseal group. 
A blunt needle was used to guide adhesive application when necessary. A standard 
amount tissue adhesive was applied as in our previously published study and listed in 
Table 1[7]. After application, a five-minute curing time was allowed to ensure full polym-
erization of the adhesive. The colitis group, which serves as the non-adhesive negative 
control, was alternatingly operated between the tissue adhesive groups in order to rule 
out any systematic bias. TNBS-induced colon damage was also evaluated during surgery; 
functional, macroscopic and histological changes regarding anastomotic healing were 
evaluated on POD3 and POD7.
Table 1. Chemical components and dosage of the selected tissue adhesives employed in the study.
Commercial 
name
Chemical 
components Manufacturer
Adhesive dosage per 
anastomosis (mL)
TissuCol® Fibrin glue, with aprotinin Baxter, (Deerfield, USA) 0.1
Histoacryl® Flex n-butyl-2-cyanoacrylate B. Braun, (Melsungen, Germany) 0.02
Duraseal® Polyethylene glycol Covidien, (Mansfield, USA) 0.1
Evaluation of colon damage
During the colectomy, the rat colon was carefully examined for signs of adhesions to ad-
jacent organs and other pathological changes. Immediately after resection the resected 
colon was opened longitudinally and flushed with PBS solution. One blinded researcher 
(SV) weighted and measured the length of the resected colon, and a colon weight ratio 
was calculated (i.e. colon weight/length ratio, g/cm). Subsequently, the colon sample 
was scored according to the system described by Monozzi et al. (see Supplemental 
Digital Content, Table S1.a) [16]. H&E staining of the colon damage specimens was per-
formed. The slides were scored according to the histological scoring system which was 
used by Monozzi et al. (see Supplemental Digital Content, Table S1.b) [16].
Evaluation of intra-abdominal manifestations and histology
On POD3 or POD7, rats were anesthetized and the abdomen was examined for mani-
festations including intra-abdominal abscess formation, anastomotic dehiscence and 
adhesion. Abscess severity was scored according to the previously described abscess 
score, which was further adapted for its use in this rat model [19, 20] (see Supplemental 
Digital Content, Table S2). Adhesion severity was recorded according to the Zühlke score 
[21]. Anastomotic bursting pressure (ABP) was determined after macroscopic observa-
tion with the previously described method [7, 18].
H&E stained slides of the anastomotic area of the slides were scored using the Ehrlich 
and Hunt numerical scale as modified by Phillips et al. [21]. One pathologist (KL) and 
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one researcher evaluated all the slides in a fully randomized order. Immunohistochemi-
cal staining for CD206 as a marker for M2 macrophages and iNOS as a marker for M1 
macrophages was performed on anastomotic samples employing the same method 
described in our previous study [7]. The primary antibody against CD206 (1:400, Ab-
cam plc, Cambridge, UK) or iNOS (1:1600, Abcam plc, Cambridge, UK) was applied. 
To determine the positive cell count on each slide, eight fields were selected on each 
slide using a microscope with an imaging system (Olympus DP25, Japan), under 20x10 
magnification (2560x1960 pixels). Five fields were selected at the anastomotic site and 
three fields were selected at the serosa-adhesive site, the interface of the tissue adhe-
sive and adjacent tissue (see Supplemental Digital Content, Figure S1.). In the groups 
without tissue adhesive application, the latter three fields were chosen at interface of 
serosa and adjacent tissue (anastomotic adhesion). Following the randomization of the 
slide number with a computer program, the number of positive cells for each field was 
counted with ImageJ (National Institutes of Health, USA). The average number of the 
five fields (i.e. macrophage at anastomotic site) and the three fields (i.e. macrophage 
at serosa-adhesive site) was used for analysis respectively. An M2/M1 index, using the 
natural logarithm to adjust the data to normal distribution, was calculated according to 
the following equitation.
M2⁄M1 index = ln (Number of CD206+ cells)/(Number of iNOS+ cells)
Statistical analysis
Data of the validation experiment were first analysed separately to validate the TCC 
model, but were thereafter pooled with the other data for final analysis to improve 
statistical power. Statistical analysis was performed employing SPSS 21.0 (IBM software, 
USA). Data were presented as mean ± standard deviation (S.D.) unless stated otherwise. 
To detect differences in the variance between groups, Levene’s test was used. The one-
way analysis of variance was performed with the Kruskal-Wallis Test (for non-parametric 
parameters) or one-way ANOVA (for normal distributed parameters), and a p-value < 
0.05 was considered to indicate statistical significance. For post-hoc comparisons, the 
Fisher’s least significant difference (LSD) test was used for normal distributed parameter. 
In pairwise comparisons, the Mann-Whitney U test was used. Comparisons were made 
between the colitis control group and each of the tissue adhesive groups, not between 
the tissue adhesive groups. All reported p values are two-sided.
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RESULTS
Validation of the TNBS-colitis colectomy (TCC) model
We set out to establish a model that would allow us to investigate the effects of dif-
ferent tissue adhesives in an IBD-relevant context. To this end we decided to combine 
TNBS colitis with colectomy in experimental rodents. For validating this approach a total 
number of 15 rats were employed, 10 rats allotted to a control group, whereas 5 other 
ones were subjected to TNBS treatment. Seven days after TNBS administration, colon 
hyperemia and ulceration were clearly evident in the TNBS group, resulting in an aver-
age gross colon damage score of 2.6 ± 1.1, which was significantly higher than the score 
of 0.4 ± 0.5 in the control group (p = 0.002). The resected colon weight ratio was 0.13 ± 
0.04 g/cm in the TNBS group, which was higher but not significantly different from the 
control group (0.11 ± 0.01 g/cm).
On POD3, one rat from the TNBS group had anastomotic dehiscence. An average burst-
ing pressure of 47.0 ± 34.3 mmHg was observed in the TNBS group, which was lower 
than that in the control group (84.0 ± 34.9 mmHg, p = 0.129). We concluded that our 
novel TCC model would allow us to test the influence of tissue adhesives in an IBD-
relevant setting.
TNBS-Colitis damage evaluation
A total number of 73 rats were used for evaluating the influence of tissue adhesives on 
anastomotic healing. Of these experimental animals, 9.6% (7/73) died within 24 hours 
after surgery, with no difference being evident between groups in this respect. Autopsy 
showed that all deaths were due to acute complications (e.g. bleeding, anaesthesia) 
other than anastomotic leakage and thus these animals were excluded from further 
analysis.
Comparisons of the colitis rats from the validation experiment with the ones from the 
tissue adhesive experiment resulted in satisfactory similarity with regard to the colon 
damage and anastomotic healing (see Supplemental Digital Content, Figure S2), allow-
ing the data to be pooled together (named colitis group) for further analysis.
Seven days after TNBS-colitis induction, colon damage such as hyperaemia, ulceration 
and adhesion formation was seen in all colitis rats (Figure 2). The average gross colon 
damage score of each group varied between 2.0 to 3.0, with no significant difference 
between groups; the resected colon weight/length ratio was not different between the 
groups as well (see Supplemental Digital Content, Figure S2), suggesting that applica-
tion of tissue adhesives is not associated with any systematic experimental bias per se.
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Compared to the normal rats (i.e. the control group), the resected colon weight/length 
ratio, and macroscopic damage score of the colitis rats was significantly higher (p < 
0.001 respectively; Figure 2.). Inflammatory cell infiltration, mucosal and sub-mucosal 
damage, and poor regeneration were seen in colitis rats during histological evaluation, 
resulting in an average histological damage score of 5.9 ± 2.6, which was significantly 
higher than an average of 3.0 ± 1.9 in the normal rats (p = 0.002; Figure 2).
Figure 2. Comparison of the colonic damage between control rats and rats with trinitrobenzene sulfonic 
acid (TNBS)-induced colitis. In the control rats, 0.25 ml of 25% ethanol was trans-anally injected, n = 10; in 
the colitis rats, 0.25 ml of 10 mg TNBS diluted in 25% ethanol, n = 78 in A and B, n = 15 in C. (A) Resected 
colon weight ratio (i.e. wet weight over segment length). (B) Gross colonic damage score. (C) Histology 
score of colon damage. Values are mean (± S.E.M.). The p values of Mann-Whitney analysis of statistical 
significance between the groups are provided as well. (D) Compared to the normal rat colon (on the right), 
a colitic colon (on the left) manifests wall thickening, ulceration, and necrosis (black arrow) as is illustrated 
with the intra-luminal view of the rat colon sample. (E) Histological manifestation of TNBS colitis. The top 
part of the figure represents the extra-colon side, and the bottom side image represents the intra-colon 
side. The selected area is enlarged and illustrated in F. Normal structure of colon mucosa and sub-mucosa is 
destructed, and substantial inflammatory infiltration and adhesion (red arrow) is seen instead.
Postoperative intra-abdominal evaluation
On POD3, 73.7% of colitis rats (28/38) displayed intra-abdominal abscess formation but 
no significant difference between the groups was noted. Most abscesses were formed 
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near the anastomotic site, and higher severity of abscess formation was seen in the 
colitis group, but this did not reach statistical significance in the overall comparison 
between the groups. Significantly different adhesion severity was observed (p = 0.021; 
Figure 3). Though not significant, higher severity of adhesion formation was seen in the 
colitis group and the TissuCol group.
Figure 3. Comparison of abscess and adhesion severity on postoperative day (POD)-3 and POD7 between 
the various experimental groups employed in this study. (A) Overall comparison of abscess severity yielded 
a p > 0.05 on POD3 but a p < 0.001 on POD7 as determined using the Kruskal-Wallis test. On POD7, abscess 
formation was only observed in the colitis group, which yielded significantly higher abscess severity com-
pared to the other groups on POD7. (B) Overall comparison of adhesion formation resulted in p = 0.021 on 
POD3 and p = 0.040 on POD7 when analyzed with the Kruskal-Wallis test. The Histoacryl group had signifi-
cantly lower anastomotic adhesion severity than the colitis group. The figure also provides the p values of 
Mann-Whitney pairwise comparisons between the colitis group and other groups when relevant. Values 
are mean (± S.E.M.), n = 16 in the colitis group on POD3, n = 7-10 in the other groups.
An average bursting pressure of 53.2 ± 35.5 mmHg was seen in the colitis group on 
POD3, which was significantly lower than the control group (84.0 ± 34.9 mmHg, p = 
0.027) and the Histoacryl group (134.4 ± 27.5 mmHg, p < 0.001), and lower than the 
Duraseal group with marginal significance (95.1 ± 54.3 mmHg, p = 0.049) but not the 
TissuCol group (83.4 ± 46.7 mmHg, p = 0.12; Figure 4).
On POD7, intra-abdominal abscess formation was found in 66.7% rats of the colitis 
group (6/9) but not in any other group (p = 0.002; Figure 3). Most rats had anastomotic 
adhesions that were strong or firm adhesions based on the Zühlke score. The highest 
adhesion score was found in the colitis group (3.4 ± 0.5), which was significantly higher 
than that observed in the Histoacryl group (2.7 ± 0.5; p = 0.033) but not different from 
the other two groups (Figure 3).
189
11
Chapter 11 | Reducing CAL with tissue adhesives in IBD
On POD7, the highest bursting pressure was observed in Histoacryl group (213.3 ± 
20.1 mmHg), but it was not significantly higher than the control, Duraseal, or TissuCol 
group (160.6 ± 90.2 mmHg, 195.0 ± 43.4 mmHg, 203.8 ± 23.1 mmHg; p > 0.05). The 
intra-experimental group variation of the ABP in the colitis group was significant larger 
from the TissuCol group (p = 0.031) and Histoacryl group (p = 0.032).
Histological evaluation
H&E scores were similar between groups with no significant difference, and acute inflam-
mation was seen on H&E stained slides on POD3 in all groups (see Supplemental Digital 
Content, Figure S3). The number of CD206+ cells (indicating M2-macrophages) at the 
anastomotic site was similar between groups on POD3, while a higher number of iNOS+ 
cells (indicating M1 macrophages) were seen in the colitis group. The M2/M1 index was 
significantly different between groups on POD3 (p = 0.016), and a higher M2/M1 index 
was found in the control group and Histoacryl group (Figure 5). At serosa-adhesive 
interface, a significantly higher number CD206+ cells was found in the Histoacryl group; 
similar numbers of iNOS+ cells were seen in all the colitis rats on POD3, which were all 
higher than the control group. The M2/M1 index was similar between the colitis rats, 
which were all lower in average than the control group.
Figure 4. Comparison of anastomotic bursting pressure (ABP) on postoperative day (POD)-3 and POD7 be-
tween the various experimental groups employed in this study. Values are bars and whiskers (min to max, 
middle line at median); n = 15 in the colitis group on POD3; n = 7-10 in the other groups. On POD3, overall 
comparison, p = 0.002, Kruskal-Wallis Test. The control group and the Histoacryl group yielded significantly 
higher ABP compared to the colitis group. The p values of Mann-Whitney pairwise analysis are provided as 
well. On POD7, an overall comparison yielded a p > 0.05 as determined with the Kruskal-Wallis test. The Tis-
suCol group and Histoacryl group showed significantly less variation in ABP when compared to the colitis 
group. The p values, as determined with Levene’s test, are provided and were indicated with a dashed line.
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Histology with H&E staining revealed less inflammatory cell infiltration, more fibroblasts 
and more collagen deposition at the anastomotic site on POD7 than those on POD3 (see 
Supplemental Digital Content, Figure S3). The number of iNOS+ cells was significantly 
reduced compared to that on POD3, without difference between groups. A higher M2/
M1 index as compared to the earlier time points was also found in each experimental 
group, but no difference between the groups was detected. Pooling the M2/M1 index 
data of POD7 with those of POD3, a significant correlation was found between the ABP 
value and the M2/M1 index (R square = 0.105; p = 0.004). At serosa-adhesive interface, 
similar numbers of CD206+ cells and iNOS+ cells, and similar M2/M1 indexes were ob-
served between the groups (Figure 5).
DISCUSSION
Surgical treatment is required in many IBD patients, and with limited preventive strate-
gies, substantial severe short-term postoperative complications still occur. In this study, 
we developed a novel experimental surgical IBD model (i.e. the TNBS-colitis-colectomy 
model: TCC model) and investigated the influence of three tissue adhesives on anas-
tomotic healing in this model. Among the selected adhesives, especially Histoacryl® 
Flex significantly increased the biomechanical strength of anastomosis, and reduced 
accumulation of pro-inflammatory macrophages at the anastomotic site.
← Figure 5. Comparison of macrophage amount at the anastomotic site and the serosal-adhesive site on 
postoperative day (POD)-3 and POD7 between the various experimental groups employed in this study. 
The comparisons were listed in A and B, and illustrated in C-H. Values are the means (S.E.M) of cell counts, 
n = 16 in the colitis group on POD3, n = 7-10 in the other groups. (A) Comparison of macrophage amount 
at the anastomotic site. (B) Comparison of macrophage amount at the adhesive site. A.1 and B.1 illustrates 
comparison of regulatory M2-macrophage (indicated as CD206+) amount; A.2 and B.2 illustrates com-
parison of inflammatory M1-macrophages (indicated as inducible nitric oxide synthase positive, iNOS+) 
amount; A.3 and B.3 illustrates comparison of M2/M1 index, i.e. ln(CD206+/iNOS+). * indicates p < 0.05 in 
the overall comparison using the Kruskal-Wallis Test. The p values of Mann-Whitney pairwise comparisons 
between the colitis group and other groups were also provided when relevant. (C) Histological observation 
of an H&E stained anastomosis from the control group. The right side of the image represents the extra-
luminal side, and the left side represents the intra-luminal side of the colon. The selected area indicates the 
anastomotic area which were also chosen in one rat from each group respectively on POD3. The chosen 
anastomoses are listed in the Column 1 in D-H. (D-H) Immunohistochemistry staining of CD206 and iNOS 
at the anastomotic site and the adhesive site. In each row, column 1 illustrates the H&E stained anastomotic 
area of the selected sample. The selected area with solid line indicates the anastomotic area which is en-
larged and illustrated in column 2 and 3 for representation of the CD206+ and iNOS+ cells respectively. The 
selected area with dashed line indicates the adhesive area which is enlarged and illustrated in column 4 
and 5 for representation of the CD206+ and iNOS+ cells respectively. # indicates area where the adhesive is 
present (i.e. in the TissuCol group) or existed but dissolved during staining (i.e. in the Histoacryl group and 
Duraseal group).
192
The rodent TNBS-colitis model has been widely used for IBD research and has appropri-
ate visual, histological and also gene-expressional changes resembling those observed 
in human ulcerative colitis [16, 22-24]. Our gross observations and histological results 
are in line with the previous data with consistent colon damage in the colitis rats. 
Although we did not perform subtotal colectomy or ileal pouch-anal anastomosis in 
the rat model, performing partial colectomy on basis of the colitis model also allows 
us to resect most part of the diseased segment [17], which is also the clinical purpose 
of surgical intervention in IBD patients. Our data demonstrate that the presence of 
colitis compromises surgical outcomes with main features including lower ABP, higher 
intra-abdominal abscess and adhesion severity, which are in agreement with clinical 
findings in IBD patients. Accumulation of M1 macrophages at the anastomotic site is 
likely to play a role in the impaired anastomotic healing process in the colitis group. We 
base this statement on two observations: first, compromised ABP and higher number of 
M1-macrophage was observed in the colitis group as compared with the control group; 
second, the significant increase of ABP in the Histoacryl group was accompanied with 
a lower number of M1 macrophages and a higher M2/M1 index at anastomotic site. It 
is well known that IBD has a chronic and recurrent course with mucosal damage and 
over-recruitment of inflammatory cells. The M1 macrophages at anastomotic site in our 
TCC model may have been accumulated due to both colitis and anastomotic healing. 
Unfortunately, our results do not allow us to determine the origin of M1-macrophage at 
the anastomotic site in the TCC model and further investigation in this respect is needed.
The mechanism as to how tissue adhesive may act in preventing anastomotic leakage 
is not yet fully understood. We observed lower severity of abscess formation on POD3 
and full clearance of intra-abdominal abscesses in the tissue adhesive groups on POD7. 
These data indicate tissue adhesives may act in this model through prevention of intra-
abdominal abscess formation and correspond to earlier data from our laboratory, albeit 
that this previous study was not performed in an IBD-relevant context [7]. The most ob-
vious cause of the prevention of such abscesses is a sealing effect blocking intra-luminal 
content from leaking into the abdominal cavity. Among our selected tissue adhesives, 
compositions of Duraseal, a synthetic hydrogel (i.e. polyethelene glycol and trilysine), 
provided us the possibility to evaluate the effect of a pure watertight anastomotic seal-
ant. It has no component influencing the wound healing process [6]. These data further 
suggest that the sealing effect observed in our study may not entirely depend on the 
mechanical strength of tissue adhesives.
The pathogenic differences of IBD from other disease are important factors influencing 
the effectiveness of tissue adhesives. It has been reported that fibrin glue used as a non-
surgical treatment of anal fistula failed to reach satisfactory outcomes in IBD patients 
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[25]. In line with this, our data also suggest that in the context of colitis these mechani-
cally weak sealants with or without wound-healing components are less effective when 
compared with the cyanoacrylate. This is mainly based on two observations in our study. 
First, although the average was higher, ABP of 40 mmHg or lower on POD3 was still 
observed in both the TissuCol and Duraseal groups, while ABP in the Histoacryl group 
were all higher than 90 mmHg. Moreover, the M2/M1 index of the TissuCol and Duraseal 
groups on POD3 still demonstrated an inflammatory rather than an anti-inflammatory 
status as observed in the control and Histoacryl group. The M2/M1 index at the serosa-
adhesive site also indicates an acute foreign body reaction, especially in the Duraseal 
group. These data may also partly explain the unsatisfactory clinical results of fibrin glue 
application.
In addition to a watertight sealing effect, the strength of Histoacryl® Flex is much higher 
than the other selected adhesives, providing sufficient additional mechanical strength to 
a primary anastomosis regardless of its original configuration (i.e. sufficient, insufficient 
or even sutureless anastomosis) [17, 26, 27]. Such reinforcement may further provide a 
firm contact between the cutting edges, creating an ideal environment for anastomotic 
healing. Moreover, more M2 macrophages were observed at serosa-adhesive interface 
in the Histoacryl group, which are known to foster regenerative responses through con-
nective tissue inducing characteristics including the stimulation of collagen production 
[28, 29]. It is not an easy task to further verify whether strong adhesiveness of Histoacryl® 
Flex is the main mechanism of preventing leakage, because modification of the adhe-
siveness of cyanoacrylate may also change its biological properties. However, from a 
practical point of view, our data, together with the evidence from other animal studies, 
have revealed the effectiveness and safety of n-butyl-cyanoacrylate as an anastomotic 
sealant [30]. It seems to be a promising adjuvant in a surgeon’s toolbox.
We recognize that one main limitation of the TCC model is that it only partially mimics 
human IBD pathology. In addition, most of the diseased colon segment was resected 
in during colectomy, which may limit the severity of the inflammatory response in 
long-term after surgery. We therefore chose POD7 (14 days after colitis induction) but 
not any longer as our second follow-up time. This limitation probably explains the high 
ABP values in all the groups on POD7. Nevertheless, significant variations were still 
observed in the colitis group. Different from increasing the bursting pressure on POD3, 
the selected tissue adhesive seemed to prevent the failure of wound healing on POD7. 
It is known that application of cyanoacrylate provides an immediate reinforcement 
with much reduced ABP variation [17]. The increase of ABP was accompanied with a 
decrease in M1 macrophages in all groups. Combining the short- and long-term data 
revealed a significant correlation between the M2/M1 index and ABP, which is in line that 
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timely switching of the macrophages from the M1 to the M2 phenotype is important to 
enhance anastomotic healing.
The use of anastomotic sealant is only one strategy to prevent postoperative compli-
cations and results may further improve when combined with other interventions. 
Especially pharmacological treatments are of great importance in current IBD medical 
regime, also in a post-operative setting. We think that the model introduced in the 
present study might aid efforts to understand the influence of pharmacological therapy 
(e.g. anti-TNF-α, anti-IL-6) on postoperative complications in IBD patients and help un-
derstanding the factors governing impaired wound healing process. Investigations 
addressing this possibility are currently underway in our laboratory.
CONCLUSION
In conclusion, we describe here a novel surgical IBD model by performing colectomy 
in rats with TNBS-induced colitis, which causes substantial intra-abdominal abscess 
formation, compromises anastomotic healing. We also demonstrate that application of 
the selected tissue adhesives, especially Histoacryl® Flex, has a favourable effect to the 
colorectal anastomotic healing and prevents postoperative complications in the this 
model. Timely switching of the macrophages from M1 to M2 phenotype seems to be 
associated with less complications during the early phases of anastomotic healing.
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ABSTRACT
Background
Previous experimental studies on the use of cyanoacrylate glue (CA) for prevention 
of anastomotic leakage (AL) have shown promising results. The aim of this study is to 
investigate the effect of CA in prevention of AL in a high risk porcine model.
Methods
Twenty-four pigs were divided into four groups with ischemic anastomosis and; 1) 
sufficient complete suture technique (ISCH), 2) sufficient suture, and CA reinforcement 
(CA-ISCH), 3) insufficient suture technique (ISCH-AI), 4) insufficient suture, and CA (CA-
ISCH-AI). In CA-groups, N-butyl-2-cyanoacrylate was applied between the colon ends. 
Anastomotic bursting pressure (ABP), abscess, and adhesion formation were evaluated 
on postoperative day 7. Tissue samples were obtained for histology.
Results
The AL-rate was 4/6 in the ISCH-AI group compared to none in the other three groups. 
The mean ABP was 167±54mmHg in the ISCH-group versus 213±43mmHg in the CA-
ISCH-group (p=NS) and 145±102mmHg in the ISCH-AI-group versus 187±19mmHg in 
the CA-ISCH-AI-group (p=NS). The adhesion score was greater in the ISCH-group than in 
the CA-ISCH-group (4.2±1.3 vs 1.7±0.82; p=0.019). Stricture of the anastomosis occurred 
only in non-CA-groups (3/12, 25%).
Conclusion
Anastomotic reinforcement with cyanoacrylate is effective and safe to prevent leakage 
in a high risk, colo-colonic anastomosis in a porcine model.
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INTRODUCTION
Anastomotic leakage (AL), with an incidence between 3-19%, is a severe complication 
after colorectal surgery and is associated with high morbidity and mortality rates [1, 
2]. Despite proper patient selection and operative technique, AL cannot be completely 
avoided.
Staple line or anastomotic reinforcement techniques have been developed in attempts 
to decrease leakage in the first week postoperatively. A recent review published by Bet-
zold et al. described three main categories of products that reinforce the anastomosis 
including permanent, semi-absorbable, and bio-absorbable materials [3]. Of the bio-
absorbable materials, only fibrin glue and the polyglycolic acid/ trimethylene carbonate 
reinforcement of staple lines (Gore-Tex Bio absorbable Seamguard, W.L Gore and Associ-
ates, Flagstaff, AZ) have been investigated in clinical trials of colorectal surgery [4-7]. The 
fibrin glue study included 223 patients undergoing laparoscopic rectal surgery but did 
not show a significantly decrease in AL [7]. Also, in the largest, randomized, controlled 
trial including 258 patients with application of Gore®Seamguard® did not show a de-
crease in the rate of AL [6].
The use of a synthetic, bio-absorbable reinforcement material for the anastomosis has 
considerable advantages over non- or semi-absorbable staple line reinforcement and 
may help to decrease anastomotic leakage while avoiding the risk of strictures [1, 4]. 
N-butyl-2-cyanoacrylate (CA) is a biodegradable tissue adhesive. In our previous ex vivo 
porcine study and in vivo rat studies, CA had the greatest mechanical strength in either 
normal anastomoses, incomplete ‘insufficient’ anastomoses, and anastomoses in a 
bacterially contaminated field, compared to other tissue adhesives [8]. Besides the good 
adhesiveness of CA to the colonic surface, CA also enhanced the anastomotic healing 
by influencing the amount of anti-inflammatory macrophages, and no adverse foreign 
body reaction could be observed [9, 10].
The promising results from these previous experimental studies suggest that CA may 
be used safely to reinforce colorectal anastomoses. The objective of the present study 
was to investigate if the application of CA could prevent anastomotic leakage defined 
as either fecal peritonitis or macroscopic dehiscence of the anastomosis in a validated 
porcine model of a partially ischemic colo-colonic anastomosis.
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METHODS
Study design
This study was a prospective, randomized, controlled animal experiment evaluating the 
effectiveness of N-butyl-2-cyanoacrylate, to prevent colo-colonic AL in pigs with a par-
tially ischemic colo-colonic anastomosis using AL as the primary outcome parameter. All 
experiments were performed with approval of the Erasmus University Medical Center 
Animal Care Committee in accordance with national law regarding the protection of 
animals, approval number DEC-3167;105-13-07. The manuscript was written according 
to the Animal Research: Reporting In Vivo Experiments (ARRIVE) guidelines.
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Figure 1. A. sigmoid after ligation of mesentery arteries (10cm), B. sigmoid after dissection of serosa, C. 
sigmoid after transection, D. proximal cutting edge secured around the anvil, E. lower cutting edge secured 
around the fully extended trocar, F. click anvil on distal part of the stapler, application of glue or not and 
anastomosis was made by hand suture, G. gap of 2.1cm in anastomotic leakage model, H. anastomosis after 
removal of stapler device, with glue, I. anastomosis after removal of stapler device, without glue.
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Experimental animals
Twenty-four female domestic pigs (Yorkshire x Landrace), with an average weight of 40.7 
± 3.0 kg, were purchased from a licensed breeder in The Netherlands. The sex of the 
pigs was chosen based on previous literature [11, 12]. The pigs were randomly divided 
into four groups of six animals per group; the randomization occurred based on the 
assigned ear number of the pigs by the breeder. The pigs were operated in pairs, and the 
animal with the lowest ear number was assigned to a glue group. In the next session the 
opposite order was used with the animal with the lowest ear number assigned to a non-
glue group. All animals were housed in pairs and had an acclimatization period of one 
week prior to operation. Pigs were fed 2 kg of pig feed daily and had free access to water.
Anesthesia and operative procedure
The animals were fasted 1 day prior to surgery but with free access to fluid. Preop-
eratively, the animals were sedated with tiletamine/zolazepam (5 mg/kg), xylazine (2.25 
mg/kg), and atropine (0.03 mg/kg) intramuscularly (IM). Colon preparation was achieved 
by administration of sodium phosphate enema (Colex Klysma, Tramedico BV, the Neth-
erlands) directly after induction of anesthesia to allow easier transrectal introduction of 
the empty circular stapler. An ear vein was used for intravenous fluid administration of 
500ml of 5% glucose throughout the procedure. General anesthesia was maintained by 
intubation and ventilation with O2/N2 (1/3 v/v) enriched with 1-3% isoflurane. Animals 
received a single IM dose of procaïnebenzylpenicilline/ dihydrostreptomycine (per ml. 
200.000 I.E./200mg; 0.05 ml/kg) as antibiotic prophylaxis, and buprenorphine (0.015 mg/
kg) for analgesia. Depth of anesthesia was monitored by regular checking for absence of 
pain-reflexes and with cardiac monitoring.
A midline laparotomy was conducted after standard aseptic preparation of the surgical 
field, and the distal colon was exposed. Subsequently, the mesenteric branches were 
ligated over a length of 10 cm and the mesentery was cleared from the serosa of the 
colon in the same area to achieve an ischemic 10 cm segment. Before and after ligation 
of the mesenteric vessels, the Local Hemodynamic Index (LHI) was measured with a 
miniaturized, Dynamic Light Scattering (mDLS) device (Elfor, Elfi-Tech Ltd.) to evaluate 
the degree of ischemia [13].
In all groups, the distal colon was transected at approximately 40 cm from the anal verge. 
The colo-colonic anastomosis was constructed in a hand sewn, end-to-end fashion after 
applying the CA. In attempt to both standardize and facilitate application of the CA we 
used a circular 28 mm stapler, with the staples removed (Chex™ CS surgical staplers, 
Arseus Medical, distributor of Frankenman International Limited, HongKong)[12]. To ap-
proximate the edges and to apply the CA glue between both on the serosal surface, the 
204
stapler assured inversion of the mucosa and application of the CA directly onto the sero-
sal surface. Before performing a hand sewn anastomosis as follows, the proximal colon 
was secured around the anvil with a purse-string suture (4.0 PDS, Johnson & Johnson, 
Medical BV, the Netherlands). The cartridge of the stapler was inserted transanally, and 
the distal end of the colon was secured with a purse-string suture. The circular stapler 
was connected and partially closed with the proximal and distal ends 5 mm apart. In 
the CA-groups (II and IV), 0.3 mL of CA (Histoacryl® Flex, N-butyl-2-cyanoacrylate, B. 
Braun, Melsungen, Germany) was applied between the two ends of the colon parts, and 
the stapler was then closed completely. In the control groups (I and III), the stapler was 
closed without application of CA. In all groups, the anastomosis was then constructed 
with a single-layer, continuous, hand suture (4.0 PDS) before removal of the stapler. In 
group III and group IV, the anastomosis was constructed insufficient: before removal of 
the stapler, a gap of 21 mm length was left on the anti-mesenterial side according to the 
validated porcine AL model of Nordentoft et al [11].
The abdominal cavity was lavaged with 500 ml of 0.9%NaCl. The abdominal wall was 
closed in one layer, similar to a ‘mass closure’, with an absorbable monofilament (Mono-
syn 2.0, B. Braun, Melsungen, Germany). The abdominal skin was closed with a continu-
ous dermal suture (Vicryl 2.0, Ethicon, Somerville, NJ). After the operation, the animal 
was extubated and placed into a warm recovery booth. A fentanyl patch (25mcg/h) was 
applied for postoperative analgesia for three days. Animals were allowed to drink im-
mediately and were given access to solid food the next morning.
Follow up
During the 7 day postoperative period the researchers were blinded for the allocated 
treatment. The animals were weighed daily, and their health was scored based on a 
short version of the pig health scoring system proposed by Husa et al. (supplementary 
data; Table 1)[14]. On postoperative day (POD) 7, all pigs were anesthetized and re-
laparotomy was performed to evaluate the integrity and condition of the anastomosis. 
AL was defined as either fecal peritonitis or dehiscence of the anastomosis. In order 
to assess the severity of AL including abscess formation around the anastomosis, the 
grading system according to Wu et al. was used: 0 = no leakage, 1 = abscess formation 
only at the side of the anastomosis, 2 = presence of fecal peritonitis with or without 
abscess formation, and 3 = leakage-related death [15]. The abdomen was examined for 
presence of other distant abscesses, contaminated fluid, or other forms of inflammation 
in the area of anastomosis, other pathologicprocesses in the abdominal cavity and the 
incidence and the extent of adhesions. Abscess formation was scored according to the 
following scoring system: 0 = no abscess; 0.5 = one very small abscess; 1 = several small 
abscesses; 2 = medium abscess; 3 = large or several medium abscesses; 4 = one very 
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large or several large abscesses [16, 17]. Adhesion severity was recorded using the Züh-
lke score [18]. Abscesses and adhesions where scored separate for both the anastomotic 
site and other intra-abdominal locations. Anastomotic bursting pressure (ABP) was de-
termined by insufflation of air in the closed clamped segment of the colon in a saline 
filled abdomen, and the ABP and location was noted. The anastomotic segment was 
harvested for histologic examination, and the animal was euthanized using a sodium 
pentobarbital solution (Euthasol® 200mg/ml; 100mg/kg IV).
Histology
After measuring the ABP, we collected the entire anastomosis and opened it at the anti-
mesenteric side. A 1x1cm sample of the anastomosis was collected for histology. After 
fixation in 10% neutrally buffered formalin, dehydration and embedding in paraffin the 
specimen was cut in 5µm sections and mounted on glass slides. The paraffin sections 
were stained with hematoxylin and eosin (H&E), and scored using the Ehrlich and Hunt 
numerical scale [19]. Inflammatory cell infiltration, angiogenesis, fibroblast activity, and 
collagen deposition at the anastomotic site were evaluated. Each parameter was graded 
from 0 to 4 as follows: 0 = no evidence, 1 = occasional evidence, 2 = light scattering, 3 = 
abundant evidence, 4 = confluent cells or fibers. Two independent ’blinded’ investiga-
tors (G.B. and K.L.), scored all samples.
Statistical analysis
Statistical analysis was performed with SPSS 21.0 (IBM software, USA). Data are presented 
as mean (S.D.) or number and percentage. The Mann-Whitney U test or the one-way 
analysis of variance was performed with the Kruskal-Wallis test for non-parametric pa-
rameters. The Levene’s test was used to test equality of variances. All reported p values 
were two-sided; a p-value < 0.05 was considered to indicate statistical significance.
RESULTS
Perfusion data
To evaluate standardization of the ischemic anastomosis, we measured the LHI at the 
anastomotic site. A similar anastomotic perfusion was found among different groups, 
indicating a standardized ischemic condition (supplementary data; Table 1).
General observations
All operations were performed with an empty stapler device and all ‘donuts’ were com-
plete. No mortality occurred in any of the groups. Postoperative weight loss occurred up 
to POD 3 or 4 in all groups, and on POD 7 the weight loss was fully compensated with 
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a higher weight compared to the day of surgery. There were no statistically significant 
differences in weight between any of the four groups. The health scores in the CA groups 
were more favorable than those of the control groups during the first 4 postoperative 
days (supplementary data; Table 2).
Intra-abdominal observations
The ISCH and ISCH-AI groups had significantly higher AL scores; 0.8 ± 0.4 and 1.5 ± 0.8 
vs. 0.2 ± 0.4 (CA-ISCH) and 0 in the CA-ISCH-AI group respectively, (ISCH vs CA-ISCH: p 
= 0.027 and ISCH-AI vs CA-ISCH-AI: p = 0.006). Anastomotic dehiscence was recorded 
in four of six animals in the ISCH-AI group (67%) compared to none in the other three 
groups. These four animals had a low but measurable ABP as the dehiscence was covered 
by an abscess. Anastomotic abscesses were observed in one animal in the CA-ISCH-AI 
group , none of the CA-ISCH group and 83% (5/6) in the ISCH group (p = 0.005) and 67% 
(4/6) in the ISCH-AI group (p = 0.030) (Figure 2).
Adhesions around the anastomosis were present in all animals. The average adhesion 
score was greater in the ISCH groups when compared with the CA-ISCH groups (4.2 ± 
1.3 vs 1.7 ± 0.8; p = 0.019). Complete covering of the anastomosis by strong adhesions 
were only seen in both none-CA groups (Figure 2). The anastomoses reinforced with CA 
did not show any stricture of the anastomosis. In contrast, 25% (3/12) of the control pigs 
developed a stricture of the anastomosis.
Distant intra-abdominal abscesses occurred in 67% (8/12) of pigs in the control groups 
(ISCH and ISCH-AI). In the CA-ISCH group 50% (3/6) of the animals had a distant abscess, 
one intra-abdominal and two located in the abdominal wall. In the CA-ISCH-AI group 
17% (1/6) had an intra-abdominal abscess (Figure 2).
Anastomotic Bursting Pressure (ABP)
The mean ABP was 167 ± 53.9 mmHg in the ISCH group versus 213 ± 43 mmHg in the 
CA-ISCH group (p= NS). The majority (67%) of bursts occurred in native tissue proximal 
or distal to the anastomosis. In the insufficient anastomosis groups, the mean ABP for 
the ISCH-AI group was 145 ± 102 mmHg versus 187 ± 19 mmHg in the CA-ISCH-AI group. 
Although this difference did not reach levels of statistical significance, the variance of 
the ABP in the CA-ISCH-AI group was significantly lower than in the ISCH-AI (p = 0.005). 
The anastomotic bursting pressures and bursting locations are shown in Figure 3.
Histology
On HE-stained paraffin sections, the inflammatory cells, angiogenesis, fibroblasts, and 
collagen cells were scored. The CA-ISCH-AI group scored the least inflammation and 
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Adhesions around the anastomosis were present in all
animals. The average adhesion score was significantly higher
in the ISCH groups when compared with the CA-ISCH groups
(4.2 � 1.3 versus 1.7 � 0.8; P ¼ 0.019). Complete covering of the
anastomosis by strong adhesions was only seen in both
none CA groups (Fig. 2). The anastomoses reinforced with CA
did not show any stricture of the anastomosis. In contrast,
25% (3/12) of the control pigs developed a stricture of the
anastomosis.
Distant intra-abdominal abscesses occurred in 67% (8/12)
of pigs in the control groups (ISCH and ISCH-AI). In the CA-
ISCH group, 50% (3/6) of the animals had a distant abscess,
one intra-abdominal and two located in the abdominal wall.
In the CA-ISCH-AI group, 17% (1/6) had an intra-abdominal
abscess (Fig. 2).
Anastomotic bursting pressure
Themean ABP was 167� 53.9 mmHg in the ISCH group versus
213� 43mmHg in the CA-ISCH group (P¼nonsignificant). The
majority (67%) of bursts occurred in native tissue proximal or
distal to the anastomosis. In the insufficient anastomosis
groups, the mean ABP for the ISCH-AI group was
145 � 102 mm Hg versus 187 � 19 mm Hg in the CA-ISCH-AI
group. The ABPs and bursting locations are shown in Figure 3.
Histology
On hematoxylin and eosinestained paraffin sections, the in-
flammatory cells, angiogenesis, fibroblasts, and collagen cells
were scored. The CA-ISCH-AI group scored the least inflam-
mation andmost collagen formation compared with the other
groups. The CA-ISCH group showed the greatest angiogenesis
score, but also a greater collagen score compared with the
ISCH group. None of these scores were statistically significant
Fig. 2 e Comparison of the number and severity of abscesses on the anastomotic site and intra-abdominally, between the
different groups. Both glue groups (CA-ISCH and CA-ISCH-AI) show a significantly lower abscess number and score,
compared with respective control groups. Also the abscesses elsewhere were significantly lower in the glue AL group (CA-
ISCH-AI) than in the control groups.
Fig. 3 e The ABPs are shown in this figure; every data point
represents an individual animal. Open symbols represent
the bursting pressure at the anastomotic site. Closed
symbols represent the bursting pressure at native tissue,
either proximal or distal from the anastomosis. The mean
ABP was higher in the in the CA-ISCH group compared
with ISCH, although not significant. The animal from group
ISCH-AI with an ABP of 0 mm Hg had fecal peritonitis.
b o e r s em a e t a l � g l u e p r e v e n t s a n a s t omo t i c l e a k a g e 5
Figure 2. Comparison of the number and severity of abscesses on the anastomotic site and intra-abdomi-
nally, between the different groups. Both glue groups (CA-ISCH and CA-ISCH-AI) show a significantly lower 
abscess number and score, compared to respective control groups. Also the abscesses elsewhere were 
significantly lower in the glue anastomotic leakage group (CA-ISCH-AI) than in the control groups.
Adhesions around the anastomosis were present in all
animals. The average adhesion score was significantly higher
in the ISCH groups when compared with the CA-ISCH groups
(4.2 � 1.3 versus 1.7 � 0.8; P ¼ 0.019). Complete covering of the
anastomosis by strong adhesions was only seen in bo
none CA groups (Fig. 2). The anastomoses reinforced with CA
did not show any stricture of the anastomosis. In contrast,
25% (3/12) of the control pigs developed a stricture of the
anastomosis.
Distant intra-abdominal abscesses occurred in 67% (8/12)
of pigs in the control groups (ISCH and ISCH-AI). In the CA-
ISCH group, 50% (3/6) of the animals had a distant abscess,
one intra-abdominal and two located in the abdominal wall.
In the CA-ISCH-AI group, 17% (1/6) had an i tra-abdominal
abscess (Fig. 2).
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213� 43mmHg in the CA-ISCH group (P¼nonsignificant). The
majority (67%) of bursts occurred in native tissue proximal or
distal to the anastomosis. In the insufficient anastomosis
groups, the mean ABP for the ISCH-AI group was
145 � 102 mm Hg versus 187 � 19 mm Hg in the CA-ISCH-AI
group. The ABPs and bursting locations are shown in Figure 3.
Histology
On hematoxylin and eosinestained paraffin sections, the in-
flammatory cells, angiogenesis, fibroblasts, and collagen cells
were scored. The CA-ISCH-AI group scored the least inflam-
mation andmost collagen formation compared with the other
groups. The CA-ISCH group showed the greatest angiogenesis
score, but also a greater collagen score compared with the
ISCH group. None of these scores were statistically significant
Fig. 2 e Comparison of the number and severity of abscesses on the anastomotic site and intra-abdominally, between the
different groups. Both glue groups (CA-ISCH and CA-ISCH-AI) show a significantly lower abscess number and score,
compared with respective control groups. Also the abscesses elsewhere were significantly lower in the glue AL group (CA-
ISCH-AI) than in the control groups.
Fig. 3 e The ABPs are shown in this figure; every data point
repr sents an individual animal. Open symbols represent
the bursting pressure at the anastomotic site. Closed
symbols represent the bursting pressure at native tissue,
either proximal or distal from the anastomosis. The mean
ABP was higher in the in the CA-ISCH group compared
with ISCH, although not significant. The animal from group
ISCH-AI with an ABP of 0 mm Hg had fecal peritonitis.
b o e r s em a e t a l � g l u e p r e v e n t s a n a s t omo t i c l e a k a g e 5
Figure 3. The anastom tic bursti g pressures (ABP) are shown in this figure; every da a point represents 
an individual animal. Ope  ymbols r present the bursting pres ure at the anastomo ic site. Closed sym-
bols represent the bursting pressure at native tissue, either proximal or distal from the anastomosis. The 
mean ABP was higher in the in the CA-ISCH group compar d to ISCH, although not significant. The animal 
from group ISCH-AI with an ABP of 0 mmHg had fecal peritonitis.
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most collagen formation compared to the other groups. The CA-ISCH group showed 
the greatest angiogenesis score, but also a greater collagen score compared to the ISCH 
group. None of these scores were statistically significant (supplementary data; Table 3). 
There were no multinucleated giant cells seen in any of the groups as a sign of foreign 
body reaction.
DISCUSSION
This experimental study on colorectal anastomotic leakage in an ischemic and insuf-
ficient porcine model showed that cyanoacrylate tissue adhesive can reduce anasto-
motic leakage scores and anastomotic abscess formation, while adhesion formation was 
reduced in comparison to the control (no cyanoacrylate) groups.
During the last decades colorectal surgery has improved by perioperative standardiza-
tion. However, many risk factors for AL, such as age, gender and comorbidity, are patient 
dependent and can hardly be avoided. Several changes in techniques and perioperative 
protocols such as standardization of the anastomosis, by for example a stapler device, 
could not reduce the anastomotic leakage rate. Several intraluminal devices have been 
developed to reduce colorectal AL [20]. Despite positive results from some clinical stud-
ies the use of these protective devices has not been widely implemented [21-23].
Staple line reinforcement is a relatively new method for colorectal surgery, although it 
is well recognized in the field of bariatric and pulmonary surgery [24-29]. The available 
investigational and clinically used staple line reinforcement materials in gastrointestinal 
surgery consists of a large range of different biologic and non-biologic materials [4, 
30-34]. Most of the experimental studies showed reduced leakage rates, but one study 
showed an increased leakage rate in the reinforcement group [35]. Reliable clinical data 
is lacking as only a few clinical pilot studies on Bio-absorbable Seamguard (BSG) were 
published. These studies showed a lower reduced incidence of AL between 0%-3.4%, 
although the groups are very small. BSG is more biocompatible than compared to the 
other reinforcement materials [4, 5, 36]. Previous data on the use of cyanoacrylate for 
colorectal anastomotic reinforcement is only reported in experimental animal studies.
The majority of these animal studies have been performed in rats [8, 37]. Our own pre-
vious rat studies showed that the occurrence of AL could be significantly reduced by 
application of tissue adhesives. Cyanoacrylate (Histoacryl flex®) showed very promising 
results with an increase of anastomotic strength and reduction of abscess formation 
[8-10]. The CA used in this study is strong, inert, and, moreover, it stays flexible after 
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polarization, representing advantageous properties that facilitate its application on a 
difficult surface like the colon. An important limitation of Histoacryl flexible® (N‐butyl‐2‐
cyanoacrylate monomer with myristic acid and triacetin) is the lack of CE approval for 
intra-abdominal use, at this moment it is only CE approved for topical use. However, 
another cyanoacrylate variant Glubran 2® (N-butyl cyanoacrylate with metacryloxisulfo-
lane) is CE certified for internal and external use.
A limitation of rat studies is that these species have the ability to withstand severe 
abdominal infections, while mice and pigs seem to have a more comparable response 
to humans [11, 38]. Although, only four pig studies have been carried out since 1994 
regarding this subject [12, 39-41]. Paral et al. compared Glubran 2® with Dermabond®, 
two types of CA. After 14 days follow up all anastomoses constructed with Glubran 2® 
healed with no sign of pathology, but the Dermabond group showed stenosis of the 
anastomosis [12]. In this study the anastomosis was constructed under optimal condi-
tions in young healthy animals [16]. The most recent study published in 2014, showed 
that the glued colon anastomoses without sutures or staples were resistant to lower 
intraluminal pressures than stapled anastomoses, but the glued anastomoses did resist 
significantly higher pressures than the physiological intraluminal pressures in the colon 
[41].
Strengths of this study include the use of a high-risk colorectal anastomosis leakage por-
cine model in combination with CA. All animals were allocated in the different groups 
by randomization and operated under the same standardized and sterile circumstances. 
The use of a large-size animal is more comparable to human surgical procedures. The 
use of a stapler aids application of the glue and standardization of the hand-sewn anas-
tomosis. Therefore these results may be applied to both stapled and hand-sewn anas-
tomosis. However, the method of application is also the biggest challenge. It is difficult 
to reach the dorsal part of a low colorectal anastomosis or to apply the adhesive on an 
intra-corporal anastomosis during laparoscopic surgery. For practical use it is preferable 
that, for example, CA will be incorporated within the circular stapler.
Absorbable staple line reinforcement is preferred over non-absorbable materials because 
of the lower foreign body reaction. Cyanoacrylate is a biodegradable tissue adhesive, 
and is therefore expected to elicit only a low inflammatory response. Our histological 
data showed no multinucleated giant cells as a sign of foreign body reaction. Histo-
logical investigation also showed a trend for more collagen formation in the CA-groups. 
Type 1 macrophages (pro-inflammatory macrophages) impair collagen deposition by 
nitro oxide production. There is always a balance between type 1 macrophages and 
type 2 macrophages (anti-inflammatory). Previous studies showed that cyanoacrylate 
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induces more type 2 macrophages and it is plausible that this occurred in this study too 
[9]. The application of only a small dosage of N-butyl-2-cyanoacrylate could also have 
resulted in less inflammation, using 0.3 ml of glue, representing half of the dosage used 
in another porcine study [12].
Our study demonstrates that reinforcement of the colonic anastomosis with N-butyl-
2-cyanoacrylate glue and prevents leakage in a high-risk colorectal anastomosis. No 
anastomotic dehiscence and only one small abscess occurred in the CA groups. Further-
more, no undesirable effects, like stricture, were observed. This porcine study strongly 
supports the introduction of future clinical studies on the application of cyanoacrylate 
glue for the prevention of colorectal AL.
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SUPPLEMENTARy DATA
Supplementary Table 1. Median values of Local Hemodynamic Index (LHI).The ischemic condition was 
similar in all groups; p=NS.
Local Hemodynamic Index (LHI) mean ± S.E.M.
ISCH CA-ISCH ISCH-AI CA-ISCH-AI
Time points during surgery
ascending; before ligation 530 ± 76 643 ± 44 727 ± 67 676 ± 48
decending; before ligation 534 ± 59 636 ± 37 862 ± 151 696 ± 92
ascending; after ligation 503 ± 50 923 ± 168 993 ± 234 700 ± 67
decending; after ligation 549 ± 69 541 ± 38 767 ± 158 712 ± 194
Anastomosis 516 ± 115 597 ± 91 657 ± 73 628 ± 79
Supplementary Table 2. Clinical observations record sheet adapted with modifications from Husa et al. A 
record sheet was completed each observation day.
Pig ID Stools Behavior Appetite Ambulation
1 1 2 3 4 1 2 3 4 1 2 3 1 2 3
2 1 2 3 4 1 2 3 4 1 2 3 1 2 3
3 1 2 3 4 1 2 3 4 1 2 3 1 2 3
- 1 2 3 4 1 2 3 4 1 2 3 1 2 3
- 1 2 3 4 1 2 3 4 1 2 3 1 2 3
normal daily score = 4; max. score = 14 extracted from Husa et al.
Explanation
Stool consistency; 1 = normal, 2 = semi-formed, 3 = diarrhea, 4 = diarrhea with blood or tissue
Behavior; 1 = normal, 2 = lethargic, 3 = huddled, 4 = moribund
Appetite; 1 = normal, 2 = diminished, 3 = anorexic
Ambulation; 1 = normal, 2 = lame, 3 = down
Supplementary Table 3. Histological evaluation of anastomotic healing on postoperative day 7, values 
are mean. The p values of overall comparisons were all > 0.05.
mean histological score
ISCH CA-ISCH ISCH-AI CA-ISCH-AI
inflammation 2.3 2.7 2.5 1.8
angiogenesis 1.5 2.5 2.2 1.7
fibroblast activity 2.3 2 2.5 2.3
collagen 1.5 2.2 2.3 2.3
p = NS between the groups
Histologic scoring
0 = no evidence; 1 = occasional evidence; 2 = light scattering; 3 = abundant evidence; 4 = confluent cells or fibers
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ABSTRACT
Activation of macrophages is critical in the acute phase of wound healing after implan-
tation of surgical biomaterials. To understand the response of macrophages, they are 
often cultured in vitro on biomaterials. Since a wide range of biomaterials is currently 
used in the clinics, we undertook a systematic review of the macrophage polarization in 
response to these different surgical biomaterials in vitro. Beside the chemistry, material 
characteristics such as dimension, pore size, and surface topography are of great influ-
ence on the response of macrophages. The macrophage response also seems to depend 
on the differences in sterilization techniques that induce lasting biochemical changes 
or residues of chemicals and their byproducts used for sterilization. Regarding tissue-
based biomaterials, macrophages on human or porcine dermis, strongly cross-linked 
by chemicals elicit in general a pro-inflammatory response with higher amounts of 
pro-inflammatory cytokines. Synthetic biomaterials such as polyethylene, PET + PAAm, 
PET + PAANa, PFPE with large posts, PEG-g-PA, and PDO always seem to elicit an anti-
inflammatory response in macrophages, irrespective of origin of the macrophages, e.g. 
buffy coats or full blood. In conclusion, in general in vitro models contribute to evaluate 
the foreign body reaction on surgical biomaterials. Although it is difficult to simulate 
complexity of host response elicited by biomaterials, after their surgical implantation, 
an in vitro model gives indications of the initial foreign body response and allows the 
comparison of this response between biomaterials.
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INTRODUCTION
A wide range of biomaterials are used as implantable medical devices, notably for soft 
tissue repair. These materials have their own characteristics with regards to composition, 
mechanical strength, topography, porosity, and chemistry. Implantation of biomaterials 
is always associated with tissue damage, more or less important, according to the inva-
siveness of the surgical procedure, i.e. surgical treatment of the disease and biomaterial 
delivery. Initially, the body response most often starts with blood coagulation followed 
by wound healing. This process is characterized by protein adsorption to the biomate-
rial, followed by recruitment of cells including macrophages already 60 minutes after 
implantation of the material. In response to the cytokines and chemokines produced by 
the macrophages, cells involved in wound healing are attracted [1]. The inflammatory 
response is very important following surgical tissue damage and material implantation, 
also called foreign body reaction.
Activation of macrophages is critical in the acute phase of wound healing [2,3]. Mac-
rophages can be roughly divided into pro-inflammatory macrophages, also called M1 
macrophages, and anti-inflammatory macrophages, also called M2 macrophages [4,5]. 
The balance between M1 and M2 plays a critical role in the phagocytosis of pathogens, 
the clearance of apoptotic cells and the healing and remodeling of injured tissues [6].
Almost immediately after implantation, macrophages are recruited to biomaterials. De-
pending on the biomaterial specific characteristics, these macrophages will determine 
the type and intensity of the host-response [6,7]. The eventual success of an implantable 
medical device strongly depends on this response.
The host-response after implantation is inter alia guided by soluble factors such as cyto-
kines and growth factors, as communication agents between cells, active in the wound 
healing process. Several studies point out the cytokine classification according to their 
role in the foreign body response [8-10]. These soluble factors are, among other cell 
types, produced by macrophages and play pivotal roles in wound healing and serve as 
useful markers of M1/M2 activation [7,10-12].
The pivotal role of macrophages in the wound healing process, including tissue repair or 
regeneration supported by biomaterials, is a strong incentive to interrogate the macro-
phage response, elicited by biomaterials, in well-defined in vitro conditions, with reason-
able prediction of the complex foreign body reaction by using simplified single cell ap-
proaches. For this purpose, human monocyte-derived macrophages, human monocyte 
cell lines, mouse bone marrow-derived macrophages and murine macrophage cell lines 
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are used as culture models. In these models, it is examined whether biomaterials elicit a 
pro-inflammatory, anti-inflammatory, pro-wound healing or an anti-wound healing re-
sponse by macrophages. These models support the first step to analyze materials before 
use in the clinic. As nicely reviewed by Sridharan et al. [1] many different properties of 
the material influence the polarization of the macrophage, among others the mechani-
cal properties, topography, and surface chemistry. Since many types of biomaterials are 
used in many different culture models with a large variety of read-out parameters, the 
purpose of this review was to provide an overview of which biomaterial leads to which 
response, in particular regarding the differentiation and activation of the macrophages 
and the associated production of soluble factors.
MATERIAL AND METHODS
Search methods
This systematic review was conducted in accordance to the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Search strategy and study selection
On the 29th of June 2015 a systematic literature search was performed using Medline, 
EMBASE, Cochrane, PUBMED, Google Scholar, and Web-of-Science libraries, [appendix 
A]. There were no restrictions used during the search based on the publication year, 
publication language and type of study. Two researchers (G.B. and N.G.) screened all 
titles and abstracts of the identified articles independently for their relevance. From all 
articles that possibly met the inclusion criteria, the full-text version was retrieved and 
assessed for inclusion. Disagreement was resolved by discussion or requesting advice 
from a third author (Y.B.J).
An article was eligible for inclusion when it reported on macrophages and their response 
to biomaterials in an in vitro model. Presentations, reviews and letters to the editor were 
not included. All references from the selected articles were screened for further possible 
inclusions.
Data extraction and analysis
The extracted data are presented in separate tables. The following information was 
retrieved from each study: first author, year of publication, culture model, biomaterial, 
and cytokine expression. A meta-analysis could not be performed due to the lack of 
sufficient comparative studies and the important variability of the in vitro macrophage 
models (e.g. cell origin and isolation procedure, culture conditions, markers).
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Appendix A We used the following search strategy in the Embase, and the searching 
strategy was modified in other databases accordingly.
(‘tissue adhesive’/exp OR ‘adhesive agent’/de OR ‘surgical mesh’/de OR ‘surgical 
equipment’/de OR ‘tissue scaffold’/de OR biomaterial/de OR (adhesive* OR glue* 
OR bioglue* OR tachocomb* OR bucrilate* OR enbucrilate* OR cyanoacryl* OR 
mesh* OR 4DDOME OR AIGISRx OR AlloDerm OR AlloMax OR ‘Bard Composix EX 
patch’ OR ‘BIO-A Tissue Reinforcement prosthesis’ OR CollaMend OR DermaMatrix 
OR DualMesh OR ‘Evolution P3EM’ OR FasLata OR FlexHD OR FortaGen OR ‘IntePro 
Lite’ OR InteXen OR NEOVEIL OR ‘Optilene Mesh LP’ OR ‘Parietex composite’ OR 
Pelvicol OR Pelvisoft OR Pelvitex OR PerFix OR ‘Peri-Strips Dry’ OR PeriGuard OR 
Permacol OR Physiomesh OR Strattice OR Surgisis OR TIGR OR Timesh OR ‘TiMESH 
light’ OR Tutomesh OR Tutopatch OR Ultrapro OR Ventralex OR Veritas OR Vivosorb 
OR Vypro OR X-Repair OR XenMatrix OR scaffold* OR biomaterial* OR biocom-
patib* OR Hemocompatib* OR Haemocompatib* OR resorbable OR (implant* 
NEAR/3 integrat*)):ab,ti) AND (‘macrophage culture’/de OR ‘monocyte culture’/
de OR ((macrophage/exp OR ‘macrophage activation’/de OR monocyte/de OR 
(macrophag* OR monocyte*):ab,ti) AND (‘in vitro study’/exp OR monoculture/
de OR (‘in vitro’ OR culture* OR monocultur*):ab,ti))) NOT ([Conference Abstract]/
lim OR [Conference Paper]/lim OR [Review]/lim OR [Conference Review]/lim OR 
[Letter]/lim OR [Note]/lim OR [Editorial]/lim) AND [english]/lim
RESULTS
Search
After the exclusion of 2904 duplicates we identified 4275 references. After screening 
the titles and abstracts, we excluded another 4169 articles. The other 106 articles were 
regarded relevant and evaluated as full text. After careful reviewing the full text, another 
90 were excluded. In addition seven articles were included via references, resulting in 23 
included articles (Figure 1).
Culture models/ experimental conditions
All included studies cultured monocytes or macrophages on biomaterials. However, 
substantial differences were found in cell culture conditions between the studies. Mono-
cytes isolated from a human buffy coat or human peripheral blood were used in 19/23 
of the studies [7,8,11,13-28]. In the other four studies, one used monocytes derived from 
mouse bone marrow [4], two used the RAW 264.7 cell line (mouse leukaemia monocyte 
macrophage cell line)[9,29], and the other two used the THP-1 human monocyte cell 
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line [10,30] (Table 1). In most of the studies, no additional factors were added to the 
culture medium. However, some also added soluble factors to the media. Medium with 
LPS (lipopolysaccharides) was the most common, but media also contained LPS/ IFN-γ 
(interferon gamma, IL-4 (interleukin), IL-4/IL-13 or MCP (monocyte chemotactic protein) 
-1/IL-6/IFN-γ. The culture time varied from 2 hours to 14 days, but the majority cultured 
for 1, 3, 7 and/ or 10 days.
 
 
Figure 1. Study selection for relevant articles
Biomaterials
Biomaterials can be divided into three groups namely the non-biodegradable polymers 
(synthetic), biodegradable polymers (synthetic), and biologic materials [31]. In total 35 
different materials were used in the included articles (Table 2).
Non-biodegradable synthetic polymers
Expanded polytetrafluoroethylene (ePTFE) and polytetrafluoroethylene (PTFE) are 
commonly applied hernia mesh and vascular grafts materials. PTFE, also known as 
Teflon®, is naturally hydrophobic and non-porous. ePTFE is stretched and nano-porous 
and was introduced under the trademark GORE-TEX®, in 1969. Monocytes (precursors 
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of macrophages) on PTFE produced low amounts of IL-1β and high amounts of TNF 
(tumor necrosis factor)-α and IL-6 in the first days of culture. IL-10 levels increased during 
culture time, it was mainly produced between culture day 2 and 6[11,16]. After a culture 
time for 8-10 days the production of TNF-α and IL-10 decreased, while IL-8 increased 
after 8 days of culture [16]. GM-CSF (granulocyte-macrophage colony-stimulating fac-
tor) was secreted during the whole culture time (1-10 days) [11,16,18]. Macrophages 
on PTFE also produced Platelet-Derived Growth Factor-BB (PDGF-BB), and Matrix Metal-
loproteinase (MMP) 9 but VEGF (vascular endothelial growth factor) was undetectable 
[26]. Macrophages on ePTFE produced more pro-inflammatory cytokines (IL-1α, IL-1β, 
IL-6, TNF-α) and chemokines (MCP-1, MIP1-β, MCP-3) in association with an increase of 
the pore size of the material [18]. In contrast, immortalized human monocyte cell line 
(THP-1) cultured on ePTFE induced an anti-inflammatory and pro-wound healing profile 
characterized by a high IL-10 production in another study [10].
Table 1. Included studies cultured monocytes or macrophages on biomaterials.
Author year cells
Almeida et al. 2013 human buffy coat
Ballotta et al. 2014 human buffy coat
Bartneck et al. 2010 human peripheral blood
Bartneck et al. 2012 human peripheral blood
Bhardwaj et al. 2001 human buffy coat
Bhattacharjee et al. 2013 human peripheral blood
Bota et al. 2010 human peripheral blood
Brodbeck et al. 2002 human peripheral blood
DeFife et al. 1995 human peripheral blood
Fearing et al. 2014 THP-1 cell line*
Garg et al. 2013 mouse BMD (bone marrow-derived) Mφ
Gretzer et al. 2003 human buffy coat
Grotenhuis et al. 2013 human buffy coat
Jones et al. 2007 human peripheral blood
Oliveira et al. 2012 human buffy coat
Orenstein et al. 2009 human peripheral blood
Orenstein et al. 2009 human peripheral blood
Orenstein et al. 2010 human peripheral blood
Schachtrupp et al. 2002 human buffy coat
Schutte et al. 2007 THP-1 cell line*
Spiller et al. 2014 human buffy coat
Van den Beucken et al. 2007 RAW 264.7 & J744A.1#
Wagner et al. 2003 human peripheral blood
* THP human leukemic monocyte #RAW / J744 murine macrophage cell line
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Current surgical applications of polyethylene terephthalate (PET) are i.e. surgical 
meshes, vascular grafts, heart valves and sutures. Macrophages on PET produce pre-
dominantly pro-inflammatory cytokines, MCP-3, TNF-α, IL-6, IL-1β, MIP-1α [7,8,32] and 
pro-inflammatory chemokine IL-8 [32].
PET is also used in combination with different ‘coatings’. These coatings affect biomaterial 
adherent monocyte/macrophage cytokine expression through modification of surface 
chemistry. Different coatings are used: PET + poly(styrene-co-benzyl N,N-diethyldithio-
carbamate) (BDEDTC; hydrophobic), PET + BDEDTC + polyacrylamide (PAAm; hydrophilic 
and neutral), PET + BDEDTC + sodium salt of poly(acrylic acid) (PAANa; hydrophilic and 
anionic), PET + BDEDTC + methyl iodide of poly [3-(dimethylamino)propyl]acrylamide 
(DMAPAAmMeI; hydrophilic and cationic), and PET + absorbable, continuous and hydro-
philic collagen film (Parietex™ Composite). Macrophages on PAAm and PAANa surfaces 
reacted anti-inflammatory with a higher IL-10 production and lower IL-8 production 
than when cultured in PET without coating during the culture time from day 3 till day 
10[8,32]. Monocytes adherent to PAAm produced the most IL-6, IL-1β, IL-10, IL-8, and 
MIP-1β at all-time points, compared to the other coatings in combination with PET [32]. 
Macrophages cultured for 3 to 7 days, produced the highest concentrations of IL-1β on 
PAAm and least on BDEDTC. MIP-1β concentrations were greatest with PAANa at day 3. 
DMAPAAmMeI promoted a decrease of IL-10 and IL-1RA in macrophages, but it did not 
influence on the expression levels of IL-1β, TNF-α and IL-6[7,30]. BDEDTC, PAAm, PAANa, 
and DMAPAAmMeI let the IL-1β, TNF-α and IL-6 expression levels relatively unchanged 
at the end of culture time [8,32]. Parietex™ Composite (Covidien) induced high levels of 
pro-inflammatory and anti-inflammatory proteins [7].
Macrophages cultured on polyethylene (PE), with versatile use such as catheters and joint 
prosthesis, produced low amounts of cytokines in general but the balance was more to-
wards anti-inflammatory and pro-wound healing cytokines [10,19]. Both THP-1 cell line 
monocytes/ macrophages and macrophages isolated from human buffy coats cultured 
on polyurethane (PU), often used in blood contact applications, produced high levels of 
anti-inflammatory and pro-wound healing cytokines [10,16]. Perfluoropolyether (PFPE) 
is a non-degradable homopolymer that shows chemical inertness, lipophobicity and has 
very low surface energy [14]. This material was tested with different micro topographies 
and the effect on the response of macrophages. Different surface topographies resulted 
in different cytokine production by macrophages. An M1 surface marker, 27E10, had an 
enhanced expression in response to closely packed small posts, comparable to when 
macrophages were stimulated with LPS. In contrast, macrophages cultured on PFPE with 
large posts expressed the M2 surface marker CD163 the most. Large posts also resulted 
in significantly the highest M2-M1 index based on macrophages surface markers [14].
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Poly(propylene) (PP) is also commonly used mesh and suture materials in surgery. 
Both an anti-inflammatory reaction characterized by high levels of CCL-18 and IL1-RA 
amongst others and a pro-inflammatory reaction characterized by production of IL-8, 
IL-6, and IL-1β by macrophages seeded both for 24h or 3 days on PP were observed 
[7,27]. When combined with polyglactin 910 materials (Vypro II®, Ethicon), monocyte/
macrophages also released high amounts of TNF-α, IL-6, and low amounts of IL-10 after 
5 days of culture, which indicates a pro-inflammatory response [11].
Poly(ethylene glycol):poly(acrylate) PEG-g-PA is also modified with cell adhesion pro-
moting peptides (YRGDS and YEILDV, peptides recognized by integrins) to modulate the 
host cell response [27]. Culturing macrophages on PEG alone resulted in low production 
of TNF-α, IL-1β, IL-6, and IL-8. Macrophages on peptide modified PEG-g-PA produced 
even lower levels of TNF-α and IL-6 [27].
Poly-D-lysine (PDL) and poly(allylamine hydrochloride) (PAH), both synthetic polymers, 
were coated with DNA and seeded with two different cell line macrophages. All experi-
ments showed decreased levels of TNF-α compared to the cultured polymers with LPS 
stimulated murine macrophages (density of 1 x 105 cells/cm2)[9]. The cytokine secretion 
of IL-1β, IL-10, and TGF-β1 was not different between macrophages cultured on PDL 
and PAH with or without LPS stimulation [9]. Monocytes on silicone cultured for 10 days 
produced high GM-CSF and IL-8[16]. TNF-α and IL-10 were produced at high levels the 
first 2-6 days, where after the production decreased [16].
Biodegradable synthetic polymers
Synthetic biodegradable polymers were first used as biodegradable sutures in the 1960s. 
Synthetic biodegradable implants are mostly used in the clinic as soft / hard tissue rein-
forcement materials or temporary barriers / wound supports. Their purpose is to avoid 
a chronic foreign body reaction [33]. These polymeric biomaterials are based on lactic 
acid and glycolic acid, as well as other monomers, including dioxanone, trimethylene 
carbonate e-caprolactone as homopolymers and copolymers.
Polylactic acid (PLA) induces production of IL-6, IL-12/23 and IL-10, these cytokines are 
both pro-inflammatory and anti-inflammatory, it seemed like that human monocytes 
cultured on PLA exhibited a heterogeneous profile [13].
Poly(D,L-lactide-co-glycolide) (PLGA) represents a major class of materials widely used 
in surgical applications and tissue engineering [15]. Bartneck et al. generated 3D nano-
fibrous meshes in different porosities PLGA/ sP(EO-stat-PO) and a 2D NCO-sP(EO-stat-PO) 
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hydrogel. NCO-sP(EO-stat-PO) and sP(EO-stat-PO) are ethylene oxide derived polymers, 
used for preventing unspecific protein adsorption and cell adhesion.
Macrophages on the 2D materials formed clusters with an elevated release of IL-1β and 
TNF-α. Macrophages produced more IL-8 and CCL-4 (pro-angiogenic chemokines) on 
the more covered 3D nanofibers PLGA/ sP(EO-stat-PO)[15].
Macrophages seeded on a copolymer of glycolic acid and trimethylene carbonate, 
also known as GORE® BIO-A® Tissue Reinforcement (WL Gore Assoc), produced very 
low pro-inflammatory cytokine levels [24]. Polydioxanone (PDO) polymer is developed 
for biodegradable wound closure sutures. Bone marrow-derived macrophages were 
cultured on different PDO diameter fibers and pore sizes. An increase of the fiber/pore 
size resulted in an increased expression of anti-inflammatory and angiogenic markers as 
VEGF, TGF-β and FGF2[4].
The impact of mechanical cues on adherent monocytes on poly-e-caprolactone bisurea 
(PCL-U4U) was investigated. It has been demonstrated that strain affects macrophage 
response in terms of signaling and differentiation. Moderate strain (7%) elicits polariza-
tion towards a reparative M2 profile and enhance the expression of genes participating 
in the immune response [28]. Poly(urethane urea) (PUUR) elicited very small amounts of 
TNF-α and IL-10 [20].
Biologic materials
Biologic materials are either decellularized tissues such as human or porcine skin or por-
cine small intestine submucosa (SIS), or fabricated scaffolds or meshes made of natural 
molecules such as collagen, chitosan, silk, or keratin. The decellularized tissues can have 
additional chemical cross-links to alter the degradation speed [34].
After 7 days of culture CollaMend™ FM Implant (Bard/ Davol), a moderately chemi-
cally cross-linked porcine dermis, mostly elicited a pro-inflammatory response in macro-
phages with high IL-1β, IL-6, IL-8 and VEGF production [25]. Macrophages on Permacol™ 
(Covidien), a slightly chemically cross-linked porcine dermal matrix, produced high 
IL-1β, IL-6, IL-8 and VEGF levels after 7 days of culture [25]. But in other settings, low 
levels of both pro-inflammatory and anti-inflammatory proteins after 3 days of culture, 
were released by macrophages, in presence of Permacol™[7]. There were no differences 
in culture method between the two studies. AlloMax™ Surgical Graft (Bard / Davol) and 
FlexHD® (Ethicon), non-chemically crosslinked decellularized dermis but of human in-
stead of porcine origin, also induced mainly pro-inflammatory reactions with high IL-1β, 
IL-6, IL-8, and VEGF cytokine production [23,24]. AlloDerm® Regenerative Tissue Matrix 
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(LifeCell) (non-chemically crosslinked decellularized human dermis) induced a lower 
pro-inflammatory response than the other decellularized human dermis, characterized 
by lower expression of IL-1β, IL-6, IL-8, and VEGF [23,24]. Macrophages seeded on the 
non-cross-linked porcine dermis, Strattice™ (LifeCell), or on the non-cross-linked porcine 
small intestine submucosa, Cook® Biodesign® Surgisis® (Cook), produced low levels of 
IL-1β, IL-6, IL-8, and VEGF [25].
Macrophages cultured on collagen coatings expressed mostly M1 surface markers 
(CD86+) and express both M1 and M2 markers [30,35]. These macrophages produced 
also high levels of pro-inflammatory cytokines. Another collagen-based biomaterial is 
Avitene™ UltraFoam™ Collagen Sponge (Bard / Davol; bovine source collagen sponge). 
Macrophages cultured on this gel did not produce IL-1β, and IL-6 production was only 
seen at day 1 and was lower produced at day 3, indicating that the response of the 
macrophages was not pro-inflammatory [17].
Other noncommercial biopolymers have been investigated. Bhattacharjee et al. studied 
the macrophage responses against silk-fibroin and silk-sericin based 2D films, and 3D 
silk-fibroin scaffolds [17]. These scaffolds are used for tissue engineering and drug de-
livery. The 3D fibroin scaffold induced gene expression of pro-inflammatory genes and 
accordingly the production of IL-1β and IL-6. Silk-sericin films also induced IL1-β gene 
expression [17].
Two other biologic biomaterials are keratin and chitosan. Keratin has been described for 
applications such as tissue regeneration, hemostasis, and wound healing. A low foreign 
body reaction against keratin was described characterized with predominantly M2 
(CD206+) macrophages, high levels of IL-10 and low levels of IL-1β and IL-6[30]. Chitosan 
(a natural polysaccharide composed of randomly distributed β-(1-4)-linked D-glucos-
amine and N-acetyl-D-glucosamine) induced an M2 phenotype in one study based on 
low TNF-α that decreased with time and high IL-10 and TGF-β1 levels cytokines [22]. In 
another study chitosan induces a predominant M1 response based on high production 
of TNF-α and IL-12/IL-23 and low expression of IL-6, especially in the 3D geometry [13]. 
Oliveira et al. cultured on chitosan films instead of 3D geometry [13].
DISCUSSION
Macrophages are key components of tissue repair and remodeling in wound healing. 
Their polarization appears to depend on the type of biomaterial and their characteristics. 
The release of a variety of cytokines and chemokines is decisive for the differentiation 
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Table 2. This table present the reviewed biomaterials and their predominant reaction. This table shows 
results coming from different macrophage models, not necessarily equivalents. The results are adapted 
generally from 1 study.
BIOMATERIAL Predominant reaction of macrophages 
in contact with biomaterial
Low/ high 
cytokine 
production
Ref.
Polytetrafluoroethylene (PTFE) Mainly pro-inflammatory High 10, 15
ePTFE Pro-inflammatory and anti-inflammatory High/high 9, 17, 25
Polyethylene terephthalate (PET) Mainly pro-inflammatory High 6, 7, 20
PET + BDEDTC Mainly pro-inflammatory High 7, 20
PET + BDEDTC + PAAm Mainly anti-inflammatory High 7, 20
PET + BDEDTC + PAANa Mainly anti-inflammatory High 7, 20
PET + BDEDTC + DMAPAAmMeI Mainly pro-inflammatory High 7, 20
Parietex™ Composite Pro-inflammatory and anti-inflammatory High/high 6
Polyethylene Mainly anti-inflammatory Low 9, 18
Polyurethane Pro-inflammatory and anti-inflammatory High/high 9, 15, 18
Perfluoropolyether (small posts) Mainly pro-inflammatory High 13
Perfluoropolyether (large posts) Mainly anti-inflammatory High 13
Polypropylene (PP) Pro-inflammatory and anti-inflammatory Low/low 6, 26
PP + polyglactin Mainly pro-inflammatory High 10
Poly(ethylene glycol):poly(acrylate) Mainly anti-inflammatory Low 27
Poly-D-lysine-PAH Mainly pro-inflammatory Low 8
Silicone Pro-inflammatory and anti-inflammatory High/high 15
Polylactic acid (PLA) Pro-inflammatory and anti-inflammatory High/high 12
Poly(ethylene oxide) (PEO) Mainly pro-inflammatory High 14
Bio-A Mainly pro-inflammatory Low 23
Polydioxanone (PDO) Mainly anti-inflammatory High 3
Poly-e-caprolactone bisurea Mainly anti-inflammatory High 27
Poly(urethane urea) (PUUR) Pro-inflammatory and anti-inflammatory Low/low 19
Collamend™ Mainly pro-inflammatory High 24
Permacol™ Mainly pro-inflammatory/ Pro-
inflammatory and anti-inflammatory
High/low 6, 24
Allomax Mainly pro-inflammatory High 22, 23
FlexHD Mainly pro-inflammatory High 22, 23
Alloderm Mainly pro-inflammatory Low 22, 23
Strattice™ Mainly pro-inflammatory Low 24
Surgisis® Mainly pro-inflammatory Low 24
Collagen coating Mainly pro-inflammatory High 28
Ultrafoam Mainly pro-inflammatory Low 16, 25
Silk Mainly pro-inflammatory High 16
Keratin Pro-inflammatory and anti-inflammatory Low/high 28
Chitosan Pro-inflammatory and anti-inflammatory Low/high 12, 21
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and activity of monocytes [36]. Here, we reviewed the macrophage response on differ-
ent materials in vitro used in tissue repair and regeneration and provided an overview of 
commonly seen macrophage responses to these biomaterials.
Based on the literature review, we have shown that the dimensions of the cultured mate-
rial is of great influence on the response of macrophages. This was (mostly) investigated 
in PFPE, ePTFE, chitosan and polydioxanone. The association was however different 
between increasing fiber/ pore size and the polarization or release profile of macro-
phages. Two synthetic biomaterials showed the opposite effect of pore size. Bartneck 
et al. showed a higher pro-inflammatory effect when the pore size was smaller in PFPE 
[14]. Bota et al. saw a higher pro-inflammatory effect of macrophages cultured on ePTFE 
when the pores are larger [18]. Almeida et al. saw the same effect, on scaffolds based 
on chitosan, a biologic material [13]. In contrast, Garg et al. cultured macrophages on 
polydioxanone, a synthetic biodegradable material, and they showed that large pores 
induced M2 phenotype and a decreased M1-marker expression. However in this study, 
mouse bone marrow-derived macrophages were used instead of human macrophages. 
In an in vivo study with biodegradable pHEMA ( 2-hydroxyethyl methacrylate) hydrogel 
scaffolds it was also shown that pore size affect macrophage response. Pore size of 34 
µm was shown to reduce fibrous encapsulation, however more M1 cells were found 
than at those scaffolds with a larger pore size of 160 µm, this indicate that the initial M1 
response is necessary [37].
As expected, macrophages on moderately chemically cross-linked human or porcine der-
mis responded in general pro-inflammatory with higher amounts of pro-inflammatory 
cytokines than the macrophages cultured on non-chemically cross-linked or slightly 
chemically cross-linked materials. This was also seen in in vivo studies were Collamend™ 
FM Implant (Bard/ Davol) induced a chronic foreign body response and downstream 
encapsulation [38,39]. This mainly pro-inflammatory response lead to chronic fibrosis 
[40]. Unfortunately, in all in vitro studies on these biologic materials, were only investi-
gated IL-1β, IL-6, IL-8 and VEGF, known for their mainly pro-inflammatory response, no 
anti-inflammatory cytokines were measured. A recent review presented that moderately 
to strongly cross-linked collagen materials can alter normal wound healing. In particular, 
residues of chemical crosslinks in the material were associated with a M1 macrophage 
response, and inhibition of M2 macrophage polarization [34].
Chitosan, another biopolymer, showed a predominant M1 response with a very low IL-6 
production [13]. The same effect was seen on the collagen gel; mainly pro-inflammatory 
cytokines were produced, but no production of IL-1β [17]. This can be considered a pleio-
tropic function of IL-6 and IL-1β. It is known that IL-6 can act either pro-inflammatory or 
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anti-inflammatory, depending on the environment [41]. IL1-β is a key cytokine that is 
important for wound healing, activating and recruiting fibroblasts, resulting in expres-
sion of extracellular matrix components like collagen, elastin and glycosaminoglycans 
[42-44].
Some materials induced different responses in different experiments such as acellular 
human dermis from different companies. This could be due to the differences in steriliza-
tion techniques that induce lasting biochemical changes or residues of the chemical 
used for sterilization; gamma radiation is used for AlloMax™ Surgical Graft (Bard Davol), 
FlexHD® (Ethicon)is sterilized by detergents, disinfectants and ethanol, and the steriliza-
tion process of AlloDerm® Regenerative Tissue Matrix is proprietary. AlloDerm® induced 
the least of the pro-inflammatory cytokines. Also the methods of decellularization and 
processing of the materials were different which can be an additional explanation for 
the different foreign body responses, notably explained by chemical residues, used for 
decellularization and fat removal.
Comparing all the responses of the different materials, it seems that polyethylene, PET 
+ PAAm, PET + PAANa, PFPE (large posts), PEG-g-PA, and PDO always elicited an anti-
inflammatory response in macrophages, irrespective of origin of the macrophages.
In vitro testing of macrophage response to biomaterial can be an initial means of assay-
ing biocompatibility. Macrophages are certainly great drivers of the acute inflammation 
reaction, but not only. Also neutrophils (polymorphonuclear leukocytes, PMNs) charac-
terize the acute inflammatory response. Mast cell degranulation with histamine release 
and fibrinogen adsorption is also known to mediate acute inflammatory responses to 
implanted biomaterials [45,46]. For a complete in vitro model, these factors should also 
take into account. For example, Surgisis® is known to strongly activate PMNs, particularly 
neutrophils [47]. Bryan et al. show a strong release of Reactive Oxygen Species by Surgi-
sis® versus Alloderm® and Permacol™, in animal models [48].
In general, in vitro models are useful in the first step to evaluate the foreign body reac-
tion on surgical biomaterials. Although it is difficult to simulate the environment during 
a surgical procedure, an in vitro model gives an indication of the initial foreign body 
response even in an environment that simulates an infection by for instance addition 
of LPS. Grotenhuis et al. proved this by simulating a bacterial infection in their in vitro 
model, but the macrophage response remained biomaterial dependent [49]. In this 
perspective it will be useful to test for example other surgical biomaterials like tissue 
adhesives that are used in the clinic.
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Because of the complexity of host response to foreign body material it is difficult to pre-
dict the in vivo outcome from in vitro assays. Wolf et al. developed an in silico analysis by 
using an in vitro assay that characterized the dynamic inflammatory response of human 
monocyte derived macrophages to biomaterials in combination with quasi-mechanistic 
analysis [50]. This approach can be used to better predict the in vivo response. More 
sophisticated systems, like multi cellular approaches combining macrophages with 
fibroblasts, endothelial cells, stem cells, aiming at recreating a better mimicking system, 
should certainly be useful for the in-depth investigation of the behavior of materials in 
vivo [51].
Simple models as single cell approaches should be used for screening approaches, 
enabling the direct comparison of materials. Macrophage models can gain even higher 
interest by including monocytes from specific patient groups, like obesity, which may 
react differently to materials.
CONCLUSION
With this review, we provided an overview of in vitro responses of macrophages to many 
different biomaterials. Some materials performed comparable in different studies and 
it seems clear which response these biomaterials elicit in macrophages. Other mate-
rials behaved differently in different culture set-ups. Therefore all physical properties 
(e.g. stiffness, pore size, strain, topography, surface chemistry) of the biomaterial must 
be announced, because these features can induce different macrophage behavior 
[1,40]. Each step in cell culture is critical, the macrophage isolation, activation of the 
macrophage before culture or not, time duration of cell culture since it conditions the 
phenotype/ differentiation of cells, and the type of culture medium, minimal changes 
in culture methods can cause the different outcome [2,36,52,53]. In vitro culture models 
using macrophages on biomaterials are a valuable addition to the development of new 
biomaterials. Based on this review there is however to be a need for standardized culture 
models and a systematic comparison to the in vivo response.
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ABSTRACT
Macrophages play a key role in the foreign body response. In this study it was investigated 
whether obesity affects the acute response of macrophages to biomaterials in vitro and 
whether this response is associated with biomarkers in blood. CD14+ monocytes were 
isolated from blood from obese and age and gender matched lean persons. Monocyte 
subsets were determined based on CD14 and CD16 on their surface. C-reactive protein 
(CRP) was measured in peripheral blood. The response of monocyte-derived macro-
phages to polypropylene (PP), polylactic acid (PLA), polyethylene terephthalate (PET) 
monofilament, and PET-multifilament (mPET) in culture was based on cytokine produc-
tion. More IL-6 (for PET), less CCL18 (all materials) and IL-1ra (for PLA) was produced by 
macrophages from obese patients than lean subjects. Body mass index, serum CRP and 
to a lesser extend percentages of monocyte subtypes correlated with IL-6, TNFα, CCL18, 
and IL-1ra production. Taken together, monocyte-derived macrophages of obese pa-
tients respond more pro-inflammatory and less anti-inflammatory to biomaterials than 
macrophages from lean subjects, depending on the material. These results are a step 
towards personalized medicine for the development of a model or even a blood test to 
decide which biomaterial might be suitable for each patient.
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INTRODUCTION
Biomaterials are often used in several surgical disciplines such as urology, gynaecol-
ogy and general surgery [1]. The foreign body response to implanted biomaterials is 
crucial for adapting the material in the human body. Macrophages play a key role in the 
foreign body reaction to biomaterials [2]. For regenerative biomaterials, an initial pro-
inflammatory (M1) response is necessary for recruiting inflammatory cells to encourage 
the foreign body response, which are necessary events for wound healing including 
ingrowth. However, a prolonged M1 response results in fibrous capsule formation and 
extended inflammation. Therefore, a subsequent transition to the anti-inflammatory 
macrophages (M2), which promotes tissue repair and remodeling, is generally presumed 
to be the preferred modification [3]. Achieving the desired outcome is individual and 
biomaterial dependent.
In general, obesity seems to be an important factor for adverse outcomes after surgery. 
Observed complications are surgical site infections, impairment of cutaneous wound 
healing, wound failure, anastomotic leakage, and fascia dehiscence [4-6]. These compli-
cations are major risk factors to develop incisional hernia or a recurrent incisional hernia 
after repair [7, 8]. Potential factors that increase wound complications by obesity include 
intrinsic tenuous anatomic properties, poor vascularization, and cellular and molecular 
alterations. Inflammatory mediators such as tumor necrosis factor alpha (TNFα), inter-
leukin 6 (IL-6), leptin, and angiotensin increase simultaneously with increasing mass of 
adipose tissue and adipocyte size [4]. These factors negatively affect wound healing and 
are most likely produced by many types of cells than macrophages alone. Obesity is also 
positively correlated with oxidative stress which can lead to decreased oxygen tension 
and impaired fibroblast proliferation and collagen synthesis [4].
Due to obesity, macrophages undergo a phenotypic switch from M2 to M1, which leads 
to a chronic low-grade systemic inflammation [9-13]. Monocytes, the precursors of mac-
rophages, can be divided into subsets, according to their expression of the cell surface 
antigens CD16 (Fcg receptor III) and CD14 (a receptor for bacterial lipopolysaccharide 
(LPS))[14]. The classical monocyte has high CD14 (CD14++) cell surface expression and 
is CD16 negative (CD16-). The non-classical monocyte also expresses CD14 at its surface 
but at an approximately ten times lower level than the classical monocyte (CD14+), and 
is positive for CD16 (CD16++). The intermediate monocyte expresses CD14 at a high level 
(CD14++), and CD16 at an approximately ten times lower level than the non-classical 
monocyte (CD16+). In general, monocytes expressing CD16 have a high phagocytic 
capacity and produce more pro-inflammatory cytokines such as TNFα and IL-6, and are 
therefore considered pro-inflammatory [15]. The classical CD14++/CD16- subset is the 
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predominant population and accounts for approximately 90% in healthy persons. It has 
been suggested that obesity leads to a shift from classical towards intermediate and 
non-classical monocytes [16, 17].
Previous in vitro models have shown that culturing macrophages isolated from healthy 
donors on different biomaterials leads to a biomaterial-specific reaction [18] and that 
even in a contaminated in vitro model, surgical biomaterials still elicit differential re-
actions in macrophages [19]. These in vitro models did not take into account patient 
specific characteristics, such as age, smoking, diabetes or obesity. Obesity is a growing 
healthcare issue in the clinics and a subgroup of these patients does receive a biomate-
rial for several reasons like abdominal wall hernia with an increased risk of unwanted 
reactions to the biomaterial or delayed wound healing [4, 5]. Therefore, the aims of this 
study were to investigate how obesity affects the acute host response of macrophages 
to biomaterials in vitro and to examine whether this in vitro response can be predicted 
beforehand by determining monocyte subsets in the blood or by measuring the systemic 
inflammation marker CRP that is a common used clinical parameter for inflammation.
METHODS
Study population
In total we included 20 obese patients and 20 age and gender matched healthy, lean 
(BMI 18-25 kg/m2) volunteers. Obese patients with a BMI >30 kg/m2 were included at 
the department of bariatric surgery at the Maasstad Hospital, Rotterdam. Exclusion 
criteria for both groups were smoking, diabetes mellitus, use of immunosuppressive 
drugs, autoimmune disease or chronic inflammatory disease, and medical history such 
as previous surgery or having a prosthesis (e.g. vascular implants, mesh, osteosynthesis 
material). This study was approved by the Medical Ethical Committee of the Erasmus 
University Medical Center, Rotterdam, Netherlands, in accordance with the Dutch law 
on medical research in humans. Permit number MEC-2014-221, NL47780.078.14. Written 
informed consent was obtained from all patients.
Biomaterials
Four types of biomaterials were selected for use in all experiments: polypropylene (PP; 
0.9 g/cm3), polyethylene terephthalate multifilament (mPET; 1.34 g/cm3), polyethylene 
terephthalate monofilament (PET; 1.34 g/cm3) and polylactic acid (PLA; 1.25 g/cm3) (Fig-
ure 1). All materials were provided as yarns braided in the same conformation. All tested 
materials were braided according to a similar pattern and with same volumic density, 
corrected by the g/cm3 values by each material. The braided materials are created of a 
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mix of micro- and macro-porosity that favors cell attachment, particularly for monofila-
ments, and even more particularly, for polypropylene monofilaments.
Monocyte isolation and seeding on biomaterials
Peripheral blood mononuclear cells (PBMC) were isolated from 30 mL blood of obese 
patients and healthy volunteers by gradient density separation using Ficoll-Paque PLUS 
(GE Healthcare Life Sciences, Little Chalfont, UK). The blood from the obese patients was 
obtained preoperatively to bariatric surgery. Monocytes were isolated by CD14+ selection. 
Briefly, the blood was diluted 1:1 with PBS (Gibco; Carlsbad, USA) supplemented with 0.1% 
BSA (Sigma-Aldrich, St. Louis, USA), applied on top of a Ficoll layer, and centrifuged at 
900 x g for 30 minutes to acquire separation of layers. The interphases were collected and 
washed twice with PBS/0.1% BSA before a 20 minute incubation at 4⁰C with anti-human 
CD14 MicroBeads (Miltenyi Biotec, Bergisch Gladbach, Germany). Positive selection was 
performed by Magnetic-acitvated cell sorting (MACS). The isolated CD14+ monocytes 
were kept in suspension in X-VIVOTM 15 medium (Lonza, Verviers, Belgium) containing 
20% heat inactivated fetal calf serum (FCS; Lonza), 50 µg/mL gentamicin (Gibco) and 1.5 
µg/mL amphotericin B (Fungizone; Gibco), from now on referred to as ‘culture medium’, 
until seeding. Prior to seeding, the biomaterials were pre-conditioned in non-heat in-
activated FCS for 2 hours at 37⁰C with agitation. After pre-conditioning, the monocytes 
were seeded by rotation onto the biomaterials for 2 hours at 37⁰C at 20 rpm (VWR tube 
rotator, Radnor, Pennsylvania, USA). The materials were exposed to 850,000 monocytes 
per yarn at a concentration of 500,000 monocytes/mL. After seeding, the materials were 
carefully transferred to 96-well plates (Corning Costar, NY, USA) and cultured in 125 µL cul-
ture medium per well. Per patient, four different materials in triplicate were cultured. The 
culture system is shown in Figure 1. After 2 days of culture, the materials were transferred 
to new wells and medium was refreshed to only take into account the biomaterial adher-
ent cells. Twenty-four hours after refresh, the medium was collected while keeping the 
three samples separate, centrifuged for 10 minutes at 300 x g and stored at -80⁰C for later 
cytokine quantification. The macrophages adhering to the biomaterials were lysed in 125 
µL PBS/0.1% Triton-X (Sigma-Aldrich) and stored at -20⁰C before DNA quantification. The 
remaining CD14+ monocytes that were not used for seeding were stored in 20% dimethyl 
sulfoxide (DMSO)/FCS in liquid nitrogen for flow cytometric analysis.
Protein adsorption by the biomaterials
To evaluate potential adsorption of the proteins by the materials, the materials were 
pre-conditoned for 2 hours in non-heat inactivated FCS with agitation, followed by 2 
hours incubation in X-VIVO/20% FCS in a tube rotator at 37°C. Next, the materials were 
transferred to well plates and incubated in X-VIVO/20% FCS for 2 days. After this period, 
the materials were transferred to new well plates and incubated in medium containing 
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either 1 ng/mL IL-6 (Peprotech), 250 pg/mL CCL18 (R&D Systems), 1.25 ng/mL IL 1RA 
(R&D Systems), 500 pg/mL TNFα or no cytokine. After an additional incubation day, the 
media were harvested, centrifuged at 300 x g and stored at -80°C until cytokine quan-
tification. The use dosages were based on the detection ranges of the enzyme-linked 
immunosorbent assays (ELISAs) that were used to determine cytokine concentrations.
Figure 1. Experimental flow of our study, including pictures of the yarns and how the yarns were placed 
in the culture wells. CD14 = cluster of differentiation 14, PP = polypropylene, PLA = polylactic acid, PET = 
monofilament polyethylene terephthalate, and mPET = multifilament polyethylene terephthalate.
Cytokine quantification
Enzyme-linked immunosorbent assays (ELISAs) were performed according to manu-
facturer’s instructions to quantify the concentrations of CCL18, IL-1ra, IL-6, and TNFα 
(R&D Systems, Minneapolis, MN, USA) released in the cell culture supernatants. These 
selected cytokines were chosen based on our previous research in which CCL18, IL-1ra, 
IL-6, and TNFα were the most discriminative for the different macrophages phenotypes 
[18, 20]. All measurements fitted within the standard curve, for every material and cyto-
kine different dilutions had to be made of the culture medium, ranging from a 3 to 100 
times dilution. C-Reactive Protein (CRP) levels in the plasma were determined using the 
standard technique at the hospital’s laboratory (Dimension Vista® System, Flex reagent 
cartridge, Siemens Healthcare Diagnostics Products, Germany) and expressed in mg/L. 
CRP is a very common used parameter in all hospitals to detect early systemic inflamma-
tion, also prior to surgery, especially in obese patients.
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DNA quantification
Since cell attachment was different between materials we normalized the protein con-
tent in the culture media to the amount of DNA on the biomaterial as an indication for 
the cell number. By normalizing for DNA, we adjust for variation in cell number allow-
ing to determine the production of cytokines per cell, not influenced by the number 
of cells that adhered to the material. DNA was quantified with a modified CYQUANT® 
cell proliferation assay (Invitrogen, Carlsbad, California, USA), in order to normalize the 
cytokine production for the number of cells. In short, the samples were sonicated for 30 
minutes at 48 kHz to completely disintegrate the cells. Next, a solution containing 250 
IU heparin (LEO Pharma, Ballerup, Denmark) and 125 µg RNAse (Sigma-Aldrich) were 
added to the suspensions and incubated for 30 minutes at 37°C. Finally, 0.375 µL Cy-
QUANT GR dye was added to each sample and fluorescence was immediately measured 
on a SpectraMax Gemini micro plate reader (Molecular Devices, Sunnyvale, USA) at 480 
nm excitation and 520 nm emission.
Flow cytometric analysis
Monocytes were thawed from -80°C and re-suspended at 500,000 cells/mL in FACSFlow 
solution (BD Biosciences) and stained for 30 minutes at 4°C with antibodies against hu-
man CD14 conjugated with APC-H7 and CD16 conjugated with PE (both BD Biosciences), 
according to the manufacturer’s guidelines. Unstained cells were used as negative 
control. Flow cytometric analysis was performed using the FACSJazz™ (BD Biosciences), 
and data were analyzed using FlowJo (FlowJo v7.6.4/v10; Ashland, OR, USA). As can be 
seen in supplementary Figure 1, cells changed in shape and granularity (A and C), and 
most likely because of cell death, less cells were stained with either of the two antibod-
ies after freezing and thawing. Percentages of monocytes subsets remained however 
comparable (B and D).
Statistical analysis
Statistical analysis was performed with SPSS 21.0 (IBM Inc., Chicago, USA). Basic charac-
teristics are presented as mean ± standard deviation (SD) and data related to cytokines 
are presented as mean and standard of mean (S.E.M.). An independent T-test was used 
for the age and BMI due to normal distribution of these parameters. Mann Whitney U 
analysis was used for statin use. To compare cytokine levels between macrophages 
obtained from lean and obese subjects and compare cytokine levels between the dif-
ferent materials within the obese and control group, a Kruskal-Wallis analysis followed 
by a post-hoc Mann Whitney U analysis was performed. An M1/M2-index per material 
was calculated based on the cytokine production of pro-inflammatory (M1) cytokines 
IL-6 and TNFα and anti-inflammatory (M2) cytokines CCL18 and IL-1ra. The mean of the 
relative M1 cytokine levels per patient to the overall M1 cytokine levels of all patients, 
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was divided over the mean of the relative M2 cytokine levels per patient to the overall 
M2 cytokine production of all patients, as shown in the following formula.
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To determine correlations, a non-parametric Spearman test was performed. All reported 
p-values were two-sided; a p-value < 0.05 was considered to indicate statistical signifi-
cance. Since the analyses were exploratory and the groups sizes small, no adjustment for 
multiple testing was performed.
RESULTS
As a result of our inclusion criteria, BMI was significantly different between the included 
lean and obese subjects. Age, gender and the use of statins were not significantly differ-
ent between the two groups (Table 1).
Table 1. Patient characteristics lean group vs obese patients.
lean (n=20) obese (n=20) p-value
BMI (kg/m2) 22.9 ± 2.6 43.8 ± 6.5 <0.001
gender (male/ female) 2/18 2/18 1.0
age (years) 41.8 ± 13.1 41.3 ± 13.5 0.916
use of statins 0/20 2/20 0.154
Values are means (SD), p-value was estimated by using independent sample T-test
Obesity influenced cytokine production by macrophages on biomaterials
The production of IL-6 and TNFα as indicators for a pro-inflammatory response and CCL18 
and IL-1ra as indicators for an anti-inflammatory response were measured. Macrophages 
from obese patients produced significantly more IL-6 than macrophages from lean sub-
jects when cultured on PET (144.0 pg IL-6/ng DNA vs 102.0 pg IL-6/ng DNA, p = 0.022). 
No significant differences were seen for the other materials regarding IL-6 production 
(Table 2 and Supplementary Figure 2A). TNFα production was not significantly different 
between the groups for any of the tested materials (Table 2 and Supplementary Figure 
2B). CCL18 production was significantly higher for all materials in the lean group than in 
the obese group (Table 2 and Supplementary Figure 2C). IL-1ra production was higher 
in the lean group than in the obese group when cultured on PLA (34.6 pg IL-1ra/ng 
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DNA vs 15.5 pg IL-1ra/ng DNA, p = 0.026) but not on the other materials (Table 2 and 
Supplementary Figure 2D).
Table 2. The average production of IL-6, TNFα, CCL18, and IL-1ra corrected for DNA by macrophages on 
the different materials.
cytokine material
cytokine production by macrophages (pg protein/ng DNA)
p valuelean (mean ± SD) obese (mean ± SD)
IL-6 PP 116.6 ± 97.2 172.4 ± 114.1 0.106
PLA 109.2 ± 67.1 157.4 ± 146.8 0.247
PET 102.0 ± 73.9 144.0 ± 58.4 0.022
mPET 39.2 ± 23.9 68.7 ± 64.0 0.140
TNFα PP 7.9 ± 8.3 5.9 ± 4.9 0.300
PLA 5.0 ± 4.4 3.3 ± 3.1 0.119
PET 3.6 ± 3.8 3.3 ± 1.5 0.417
mPET 1.0 ± 0.9 0.7 ± 0.5 0.421
CCL18 PP 0.8 ± 0.7 0.2 ± 0.3 < 0.001
PLA 1.4 ± 0.9 0.4 ± 0.4 0.002
PET 1.6 ± 1.3 0.5 ± 0.6 0.002
mPET 0.7 ± 0.6 0.3 ± 0.3 0.007
IL-1ra PP 49.4 ± 52.2 24.4 ± 16.8 0.128
PLA 34.6 ± 28.5 15.5 ± 9.0 0.026
PET 32.3 ± 22.6 20.2 ± 13.6 0.071
mPET 18.0 ± 18.4 10.0 ± 12.3 0.057
Bold values denote statistical significance
No IL-6, TNFα, CCL18, and IL-1ra were detectable in medium with serum alone and thus 
also no difference was seen after incubation of the material in medium with serum but 
without adherent cells. When the proteins of interest were spiked in the culture medium, 
adsorption of these proteins was seen to the materials, with the most adsorption of all 
four proteins to PP, and PLA in the case of IL-6 (Figure 2).
The DNA concentration as an indication for the number of attached macrophages to the 
biomaterials, was not significantly different between the lean and obese patients in all 
biomaterials (Supplementary data Figure 3A). Absolute protein production per individual 
is shown in supplementary Figure 2B-D. When comparing the effect of the materials on 
macrophages within the obese and lean group and per material, PP induced higher levels 
of IL-6, TNFα, and IL-1ra than the other materials, especially when compared to mPET. 
Less clear differences between materials were seen for CCL18 production (Figure 3).
To compare overall response of the different materials in lean and obese subjects, an M1/
M2 index was calculated for each condition. The M1/M2 index was significantly higher 
of the obese group than for the lean subjects for PP (p < 0.001), PET (p = 0.001), and 
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mPET (p = 0.003) but not for PLA. No differences regarding the M1/M2 index were seen 
between materials for the lean subjects. In obese patients, PLA resulted in the lowest 
M1/M2 index, and mPET the highest (Figure 4).
Serum CRP and BMI correlate with cytokine production by macrophages
The average C-reactive protein level in lean subjects was 1.3 ± 1.8 mg/L versus 15.6 ± 
17.1 mg/L in obese patients, p = 0.004 (Supplementary Figure 4). CRP concentration 
positively correlated with BMI (Table 3). A positive correlation was also seen between 
CRP and IL-6 production in response to the material for all materials, but only significant 
for PP and mPET. A significant negative correlation was seen between serum CRP con-
centration and CCL18 production by macrophages in response to PP, PLA, and mPET and 
between BMI and CCL18 production by macrophages in response to PP, PLA, and mPET. 
CRP also negatively correlated with IL-1ra production in response to PP, PLA, and mPET. 
CRP or BMI did not correlate with TNFα production (Table 3).
Figure 2. Measurements of IL-6 (A), TNFa (B), CCL18 (C), and IL-1ra (D) in the culture medium with and 
without the incubation of the biomaterials and with and without spiking of the protein of interest. White 
bar indicates measurements in medium with or without incubation of the materials. Black bars indicate 
measurements in medium alone or after incubation with the material in the presence of the spiked pro-
teins. Bars represent n= 6 + sd for every bar.
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Differences in monocyte subsets between lean and obese patients
The percentages of classical monocytes (CD14++CD16-), intermediate monocytes 
(CD14++CD16+), or non-classical monocytes (CD14+CD16++) in peripheral blood were not 
statistically significantly different between lean and obese subjects (Table 4). However, 
the percentages of intermediate monocytes correlated positively with IL-6 for PLA and 
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Figure 4. Cytokine production corrected for DNA compared per material, in lean subjects or in obese sub-
jects. Number of patients per cytokine and per material are indicated in the bars or just above the error bar.
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Figure 5. M1/M2 index between materials. Bars represent the mean, error bars the SD, p-values indicate 
significant differences. A base 2-log scale is used for the Y-axis. PP = polypropylene, PLA = polylactic acid, 
PET = monofilament polyethylene terephthalate, and mPET = multifilament polyethylene terephthalate. 
The number of patients included per material, per group are indicated in the bars.
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negatively with the CCL18 protein production for PET and mPET, and with IL-1ra for 
mPET. The percentages of non-classical monocytes correlated negatively with CCL18 
production when macrophages were cultured on mPET. No statistically significant cor-
relations were seen between percentages of monocyte subsets and TNFα production 
by the macrophages cultured on any of the biomaterials (Table 5A). For PP and mPET 
the M1/M2 index significantly correlated with the percentage of classical monocytes. 
Intermediate monocytes significantly correlated negative with the M1/M2 index for 
mPET. Supplementary Figure 1 shows that the percentages of monocyte subsets are 
unaffected before and after thawing.
Table 3. Correlations between CRP concentration in peripheral blood, BMI of all subjects, and cytokine 
production by the macrophages.
material
CRP BMI
r p- value r p-value
CRP - - - 0.64 < 0.001
IL-6 PP 0.37 0.046 0.27 0.111
PLA 0.20 0.310 0.22 0.198
PET 0.40 0.035 0.27 0.146
mPET 0.53 0.003 0.22 0.186
CCL18 PP -0.45 0.012 -0.44 0.006
PLA -0.56 0.002 -0.37 0.028
PET -0.36 0.063 -0.39 0.017
mPET -0.54 0.002 -0.30 0.068
IL-1ra PP -0.36 0.05 -0.15 0.391
PLA -0.45 0.015 -0.20 0.245
PET -0.35 0.075 -0.22 0.211
mPET -0.54 0.013 -0.22 0.267
TNFα PP -0.17 0.382 -0.18 0.295
PLA -0.15 0.438 -0.24 0.16
PET 0.14 0.492 0.02 0.903
mPET -0.17 0.476 -0.30 0.143
Bold values denote statistically significant p-values
Table 4. Percentages of peripheral blood monocytes subsets in lean (n = 9) and obese (n = 8) subjects. 
Values are mean +/- sd.
% of monocyte lean obese p-value
classical (CD14++CD16-) 90.9 ± 5.3 77.4 ± 22.0 0.290
intermediate (CD14++CD16+) 2.2 ± 3.4 7.9 ± 13.4 0.336
non-classical (CD14+CD16++) 4.0 ± 3.8 12.9 ± 13.7 0.211
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Table 5. Spearman correlation between percentages of CD14++CD16- (classical), CD14++CD16+ (intermedi-
ate), or CD14+CD16++ (non-classical) monocyte subsets and production of cytokines by cultured macro-
phages on the four different materials. The Spearman correlation coefficients (r) define the relationship 
between monocyte subsets from peripheral blood and the production of IL-6, CCL18, IL-1ra, and TNFα) by 
macrophages cultured on PP, PLA, PET, and mPET. Table 5B shows the correlation between the percentages 
of monocyte subsets with the M1/M2 index for the four different materials. PP = polypropylene, PLA = 
polylactic acid, PET = monofilament polyethylene terephthalate, and mPET = multifilament polyethylene 
terephthalate.
A 
CD14++CD16- CD14++CD16+ CD14+CD16++
material r p- value r p-value r p-value
CRP - -0.42 0.120 0.35 0.198 0.35 0.203
BMI -0.16 0.535 0.12 0.636 0.31 0.231
IL-6 PP -0.17 0.541 0.27 0.334 0.26 0.355
PLA -0.43 0.086 0.53 0.028 0.41 0.103
PET -0.54 0.038 0.51 0.052 0.47 0.079
mPET -0.36 0.158 0.38 0.133 0.26 0.323
CCL18 PP 0.28 0.321 -0.13 0.639 -0.23 0.405
PLA 0.16 0.549 -0.32 0.107 -0.18 0.370
PET 0.21 0.451 -0.40 0.045 -0.36 0.073
mPET 0.24 0.353 -0.50 0.007 -0.39 0.039
IL-1ra PP 0.12 0.676 -0.43 0.108 0.18 0.516
PLA 0.16 0.529 -0.29 0.252 0.04 0.889
PET 0.28 0.334 -0.65 0.011 -0.03 0.911
mPET 0.13 0.658 -0.53 0.052 0.16 0.594
TNFα PP -0.37 0.173 0.17 0.550 0.42 0.121
PLA -0.35 0.171 0.37 0.141 0.21 0.428
PET -0.46 0.084 0.30 0.283 0.30 0.296
mPET -0.41 0.167 0.01 0.986 0.42 0.152
B Spearman correlation between percentages of monocyte subsets and M1/M2 index
CD14++CD16- CD14++CD16+ CD14+CD16++
material r p-value R p-value r p-value
M1/M2 PP -0.59 0.020 0.36 0.182 0.48 0.069
PLA -0.40 0.112 0.37 0.144 0.35 0.174
PET -0.45 0.092 0.26 0.341 0.27 0.328
mPET -0.51 0.038 0.58 0.016 0.41 0.098
Bold values denote statistically significant p-values
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DISCUSSION
The use of biomaterials has become common in regenerative medicine. The reaction of 
primary human macrophages to biomaterials has been shown in vitro to be biomaterial 
specific, even when an inflammatory situation is simulated [18, 19]. However, the person-
dependent foreign body response has not been taken into account in these models. In 
the current explorative study, we investigated the effect of obesity, a growing problem 
in the Western world, on the response of macrophages to biomaterials and found that 
on average macrophages from obese patients respond more pro-inflammatory to 
biomaterials as indicated by higher IL-6 and lower CCL18 and IL-1ra production than in 
macrophages from lean persons that were cultured on the same materials. In addition, 
we found that BMI, serum CRP and percentages of monocyte subsets in the peripheral 
blood correlate with the response of the macrophages to the biomaterials in vitro, and 
that these correlations were biomaterial specific. In addition, we showed that macro-
phages derived from monocytes from obese patients still respond pro-inflammatory, 
even when they are not in an obese environment anymore. To our knowledge, this is 
the first study that investigated the differences in macrophage response to biomaterials 
between lean and obese patients.
Obese patients included in this trial had no insulin resistance and therefore, according 
to the WHO criteria, no metabolic syndrome [21]. Because of the strict inclusion and 
exclusion criteria, such as no smoking, no implants, and the absence of diabetes mellitus 
we assume that the different responses to the biomaterials between lean and obese 
patients is the result of obesity only and not because of a difference in the presence of 
diabetes or previous operations in which biomaterials were used. However, certain risk 
factors that are unknown at the moment might have influenced our measurements and 
have resulted in the large variation that is sometimes observed in the cytokine measure-
ments. Although these patients do not have a metabolic syndrome, 50% of them had 
a CRP level >10 mg/L, indicating systemic low-grade inflammation. CRP levels in the 
serum correlated positively with IL-6 production by the macrophages on PP and mPET 
and negatively with CCL18 and IL-1ra levels on PP, PLA and mPET in vitro, showing that 
CRP has a pro-inflammatory effect on macrophages. This was supported by an in vitro 
study, where it was shown that CRP polarizes human macrophages to an M1 phenotype 
[22]. A shift from classic monocytes in the peripheral blood to intermediate or non-
classic monocytes has been seen before as a result of obesity [11, 23, 24], of which the 
latter two subsets are regarded as the pro-inflammatory subsets with increasing CD16 
positivity [11, 23, 24]. We did not observe a statistically significant shift when comparing 
the presence of these subsets between lean persons and obese patients. This can be 
due to the fact that the inclusion criteria were strict and only obese patients without 
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a metabolic syndrome were included. In addition, the numbers of patients from who 
we were able to obtain a sufficient number of monocytes to perform additional flow 
cytometric analysis next to culture with biomaterials were low and thus resulting in a 
low power. Interestingly however, when comparing percentages of monocyte subsets in 
the peripheral blood with the cytokine production of monocyte-derived macrophages 
on biomaterials in vitro, CCL18 and IL-1ra production by macrophages on mPET and 
PET in vitro were correlated with the percentages of the different monocyte subsets in 
the peripheral blood. The percentages of classical monocytes correlated positively with 
CCL18 and IL-1ra levels produced by macrophages in culture, the percentages of the 
more pro-inflammatory intermediate and non-classical subsets correlated negatively 
with CCL18 production in culture. CCL18 is a chemokine that is predominantly made by 
anti-inflammatory macrophages [18, 25], indicating that the initial presence of classical 
monocytes is associated with the differentiation towards anti-inflammatory macro-
phages. As could be seen from the individual levels of IL-6, CCL18 and IL-1ra, not all 
obese patients had macrophages producing high levels of IL-6 and low levels of CCL18 
or IL-1ra. No corrections for baseline production of the cytokines of interest were made 
however, because in our opinion, this best represents the in vivo situation. Even though 
no corrections were made, differences were still seen between the effects of different 
biomaterials on cells of the same patient. This underlines potential patient specific 
responses even when obesity already changed the metabolic status of the patient and 
these responses can be explained by serum CRP levels and percentages of monocyte 
subsets in the blood. The production of TNFα in our culture system was not influenced 
by obesity, this might be explained by the short time detection range of TNFα [26]. Based 
on our data, it seems that PLA followed by PP and PET, are more preferable for obese 
patients and that all tested materials can be more or less equivalently be used for lean 
for lean patients, assuming that a pre-dominant anti-inflammatory reaction is preferred. 
Although the choice of material may be better guided by the inflammatory reaction at 
the individual patient level rather than at the comorbidity category such as obesity. As 
shown in previous clinical studies, no enormous undesirable behavior of multifilament 
PET mesh (e.g. Parietex™ Composite mesh) for hernia repair in obese patients has been 
reported till now, therefore the clinical impact might be moderate [27, 28]. Nevertheless 
the patients outcome can always be improved with careful and personalized selection 
of meshes.
The polymers used in this study are commonly used for materials for soft tissue repair. 
The host-response to materials is not only material dependent but also the porosity, 
topography, and surface of the material influence the biocompatibility [3, 29-31]. The 
many different properties of the material influence the polarization of the macrophages 
[3]. In the current study, the materials were braided in the same way, but because of 
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different diameters of the individual fibers between the materials, the topography 
was not exactly the same. Therefore the length of the knitted yarn was adjusted to the 
diameter to achieve the best possible comparable material appearance. Interestingly, 
PET and mPET resulted in different M1/M2 indexes, especially when macrophages of 
obese patients were cultured on the materials. This demonstrates that indeed not only 
the polymer but also the architecture of the material is important for elicited responses. 
In this study, PP did not elicit an anti-inflammatory effect based on the cytokines 
measured. This underlines again that not only the polymer itself is important for the 
reaction the material elicits, but also the architecture of the material since in our earlier 
studies we have used meshes instead of yarns [18, 19]. Braided yarns were chosen in 
the current study to make the macrophage-biomaterial contact more optimal necessary 
for the low numbers of patient cells available for this study. After spiking of IL-6, TNFα, 
CCL18, and IL-1ra in the culture medium, adsorption was seen, and varying between the 
materials. Since PP had the most adsorption of our proteins of interest, the values for 
PP (and for PLA in the case of IL6) are most likely an underestimation. However, most 
of the associations and comparisons are made within a biomaterial and a cytokine, not 
comparing two different cytokines or materials with each other. These comparisons and 
associations are therefore unaffected in our opinion by the adsorption of the protein 
of interest. However, the difference in adsorption to each material, and especially the 
high adsorption to PP, might overshadow the differences in reactions elicited by the 
materials.
After implantation, the biomaterial eventually will be in contact with macrophages, but 
it will also be surrounded by non-adherent macrophages and extracellular matrix. We 
however specifically chose not to included non-adherent macrophages in our experi-
mental set-up. The biomaterials were cultured plates made of tissue culture polystyrene 
(TCPS), also a polymer. By transferring the materials with their adherent cells to new 
wells, the medium contained mainly the cytokines from the macrophages adhering to 
the yarns. TCPS most likely will have a totally different effect than the extracellular matrix 
that normally surrounds an implanted biomaterial. In fact, we have seen that collagen 
indeed exerts different effect on macrophages than polymers [18, 19]. Therefore, we 
believed that including cytokine production from macrophages adhering to the TCPS 
would make the system even more artificial.
The proteins IL-6, TNFα, CCL18, and IL-1ra were selected as indicators of pro-inflammato-
ry and anti-inflammatory responses. We are aware that these cytokines do not represent 
the full spectrum of mediators produced during the foreign body response. However 
previously, we have seen that these mediators are most discriminative between pro-
inflammatory and anti-inflammatory macrophages [18, 25]. Studies to determine the 
253
14
Chapter 14 | Monocyte subsets correlate with response of macrophages to biomaterials 
actual in vivo response to the biomaterial and correlating this with the parameters in 
the peripheral blood are necessary to draw more firm conclusions about the predictive 
value of monocyte subset percentages and serum CRP levels for the reaction biomateri-
als elicit in a certain patient.
CONCLUSION
Monocyte-derived macrophages of obese patients respond more pro-inflammatory 
and less anti-inflammatory to biomaterials than macrophages from lean subjects and 
this response depends on the type of biomaterial. This variation in cytokine production 
by the macrophages was associated by the percentages of monocyte subsets in the 
peripheral blood, serum CRP levels, or BMI of the patient. The results of this in vitro study 
offer possibilities and could stimulate future research towards personalized medicine, 
eventually leading to a model that can be used to test biomaterials for tissue repair and 
tissue engineering using patient’s own cells prior to implantation of a biomaterial. In 
addition, our results offer the prospect that monocyte subsets in the blood or serum 
CRP might be measured prior to surgery to predict which biomaterial might be suitable 
for each patient. Studies indeed examining the clinical outcome after implantation of a 
biomaterial in relation to serum CRP, BMI, and monocyte subsets are however needed 
to confirm this.
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SUPPLEMENTARy DATA
Supplementary Figure 1. flow cytometric analysis of fresh (A, B), and frozen monocytes (C, D). Forward 
scatter (FSC) and sideward scatter (SSC) show size and granularity of the cells (A, C) and monocyte subsets 
were determined based on the presence of cluster of differentiation 14 (CD14) and CD16 (B, D).
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Supplementary Figure 2. A: IL-6, B: TNFα, C CCL18, D IL-1ra production by macrophages seeded on dif-
ferent materials corrected for DNA, lean vs. obese groups shown per material. Every dot represents a single 
donor. The line indicates the mean, p-values indicate a statistically significant difference. Bars represent the 
mean, whiskers the SD. Ratios underneath the graphs indicate the male/female ratio per measurement and 
per material. PP = polypropylene, PLA = polylactic acid, PET = monofilament polyethylene terephthalate, 
and mPET = multifilament polyethylene terephthalate.
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Supplementary Figure 3E.
Supplementary Figure 3. A. The amount of DNA as indication of the number of attached macrophages to 
the biomaterials. DNA is shown as ng/mL for polypropylene (PP), polylactic acid (PLA), monofilament poly-
ethylene terephthalate (PET), and multifilament polyethylene terephthalate (mPET) for the lean (open bars) 
and obese (dotted bars) donors. Bars represent mean ± S.E.M. n = 20 donors/ group, three samples/ per 
material/ per donor, p-value indicates a significant difference. Figure 3B, C, D, E Comparing macrophages 
from lean and obese donors cultured on different materials regarding B) IL-6 production and C) TNFα pro-
duction and D) CCL18 production and E) IL-1ra production in ng/ml after 3 days of culture. Every dot rep-
resents a single donor. Line and whiskers indicate mean ± S.E.M., p-values indicate a statistically significant 
difference. PP = polypropylene, PLA = polylactic acid, PET = monofilament polyethylene terephthalate, and 
mPET = multifilament polyethylene terephthalate.
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Supplementary Figure 4. C-reactive protein (CRP) levels in mg/L in plasma of lean subjects vs. obese 
patients. The middle line in box represent the median and whiskers the minimum and maximum; lean (0-7 
mg/L) and obese (0-75 mg/L).
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In the best case scenario no patient would have a complication after surgery. Unfor-
tunately, to date postoperative complications still happen very often after abdominal 
surgery, in a recent study a non-lethal complication rate of 33.5% in patients was found, 
while 15% of the patients had two or more complications [1]. Some complications can 
be general for surgery, others are specific to particular operations, like for example 
anastomotic leakage after colorectal surgery. Postoperative complications cause high 
morbidity, mortality, longer hospital stays, and increase costs. Therefore it would be 
ideal to avoid complications and when a complication happens, detect this as soon as 
possible to prevent from worse.
PREDICTION AND EARLy DETECTION OF COLORECTAL ANASTOMOTIC 
LEAkAGE AND POSTOPERATIVE ILEUS
Of course prevention is better than detection and cure, but when a complication 
happens, obviously early detection is crucial. Therefore it still is important that also 
preoperative risk factors are considered before choosing the best personalized surgical 
procedure. Sufficient blood supply to the wound is considered essential for anastomotic 
healing. Perioperative identification and monitoring of the vascularization of the colon 
is essential. These days most surgeons still mainly judge the perfusion of the anastomo-
sis by eyesight. And unfortunately in most cases the preoperative vascular status of the 
patients is not available.
In Chapter 2 the focus was on the amount of calcium/ atherosclerosis in the arteries that 
provide the blood supply of the anastomosis after left-sided colorectal surgery, because 
CAL rates are higher in this type of surgery. It was hypothesized that a high amount of 
calcium was associated with a higher leakage rate, because of its correlation with tissue 
ischemia and poor micro-circulation. Komen et al. investigated this hypothesis for colon 
anastomosis in as well right/ left sided colectomy, low anterior resections, and rectum 
resections [2]. The study of Komen et al. showed that the atherosclerotic calcifications in 
the left and right common iliac arteries are an independent risk factor for CAL. Our study 
however indicates that calcified atherosclerosis in the large abdominal arteries does not 
influence the perfusion of the anastomotic edges and is not related with the incidence 
of anastomotic leakage. The microperfusion at the cutting edges of the anastomosis, 
which is extremely important for tissue healing, is not only determined by the large 
arteries but also by the presence of a sufficient collateral network, which was not inves-
tigated in our study. Further research should also focus on the local tissue perfusion of 
the anastomosis itself.
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To date, CAL is usually detected between day 5 and day 8 postoperatively based on clini-
cal presentation, more than half of the detected leakages requiring reoperation. Many 
leakage cases are not detected until too late with this current strategy [3-5].
In Chapter 3, a novel miniaturized dynamic light scattering (mDLS) device to carry out 
postoperative evaluation of anastomotic microcirculation was used. In this study we 
evaluated whether the perfusion data correlates with anastomotic healing to determine 
whether blood flow measurement with the mDLS device may aid in the diagnosis of 
failed healing of the anastomosis prior to the clinical symptoms. Our data suggested 
that postoperative blood flow evaluation with an mDLS device at the anastomotic site 
indeed provides useful information regarding anastomotic healing and may facilitate 
detection of anastomotic leakage in colorectal surgery. Till now there are no devices 
that provide real-time monitoring information about the perfusion of the anastomosis 
postoperatively. There are only studies that investigated the perfusion during the con-
struction of the primary anastomosis for example with Indocyanine green fluorescence 
angiography (ICG-FA)[6].
In addition to CAL, postoperative ileus (POI) is another important complication following 
colorectal surgery. Both complications are caused by local and systemic inflammatory 
response.
In Chapter 4, a prospective cohort study was carried out to investigate whether systemic 
inflammatory markers may aid to the early detection of anstomotic leakage, infectious 
complications or prolonged POI. Perioperative blood samples of patients who under-
went colorectal surgery were collected. Based on our results, it seems that only in severe 
complications such as anastomotic leakage and surgical site infections but not PPOI, the 
overwhelming inflammatory response can be detected in a systematic manner in clinical 
settings. The diagnostic value of systemic levels of IL-6 yields better diagnostic value 
than CRP in predicting postoperative infections. In literature there are only two studies 
that describe the value of systemic cytokine levels and the link between CAL, showing 
no significant difference in the cytokine levels between patients with or without CAL [7, 
8]. On the contrary, peritoneal levels of proinflammatory cytokines increase in the first 
postoperative days in CAL patients and also in POI patients [9-11]. Therefore, it seems 
like that postoperative peritoneal cytokine levels are more sensitive to predict PPOI than 
systemic levels.
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PREVENTION OF POSTOPERATIVE ILEUS
Previous research revealed that surgical procedures trigger two different phases of POI: 
an early neurogenic phase and a late inflammatory phase. Prevention of POI and early 
detection are important because it affects the patients’ recovery. Many interventions, 
such as early mobilization and nutrition, fluid restriction, prokinetic agents, epidural 
anesthesia, and analgesia are used for the management of POI [12].
Recently there is an increasing number of studies that investigated the effect of gum-
chewing on the prevention and reduction of POI. A recent Cochrane review showed 
some benefits of gum chewing postoperatively [13]. Gum-chewing mimics the cephalic 
phase of digestion and stimulates the gastrointestinal motility via the vagal pathways. 
Asao et al. first demonstrated that gum chewing stimulated bowel motility and aided to 
early recovery from POI in surgical patients [14].
In Chapter 6 it was hypothesized that a combination of chewing gum with nicotine 
stimulates the vagal nerve in two ways in a non-invasive way. Activation of the vagal 
nerve increases bowel motility by controlling inflammatory cell recruitment via the 
cholinergic anti-inflammatory pathway [15]. In the near future the first results of our 
study investigating this hypothesis will be presented.
COLORECTAL ANASTOMOTIC LEAkAGE: PREVENTION AND DETECTION
Colorectal surgery is the cornerstone for colorectal cancer however, despite new 
techniques colorectal anastomotic leakage (CAL) is still a common and most feared 
complication after colorectal surgery, with an occurrence in the colon of 3-7% and in the 
rectum of 13-18% [16-19], and a mortality rate of 0.8-27% [20, 21].
CAL is considered to be of multifactorial origin, the etiology of CAL being based on three 
main components: 1) communication between the intraluminal and extraluminal parts 
of the colon, 2) infection at the anastomotic site, and 3) healing disturbances that cause 
delay in healing of the anastomosis [22, 23]. Numerous risk factors are described for CAL, 
the risk factors being in line with the etiology of CAL. For example in a recent systematic 
review and meta-analysis 23 studies were described involving in total 110.272 patients 
in which the perioperative risk factors were evaluated [19]. In general these factors can-
not be influenced and are patient related. The review showed that the anatomical level 
of anastomosis, gender, and preoperative radiotherapy are the main risk factors for CAL. 
Also very high and very low Body Mass Index (BMI) is associated with worse surgical 
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outcome [24-26]. Steroid treatment is also associated with impaired wound healing and 
therefore a higher risk of CAL [27-29].
Almost all patient-related risk factors cannot be influenced prior to surgery. Though, it is 
possible to change or adjust the technique that is used to perform the anastomosis. Re-
sults in the literature show that an inverting, continuous single-layer anastomosis with 
slowly absorbable monofilament material or using a stapler seems preferable [30]. There 
is no evidence that hand-sewn anastomosis is better than stapling the anastomosis is. 
Actually there is little known about the distance between the bites, how much tension 
should be given on the suture, and how much the distance should be to the anastomotic 
edge [30]. Even by standardizing the anastomotic technique by using a stapler device, 
becoming more and more common over the last four decades, the percentage of CAL 
did not decrease.
This thesis focuses on improving the anastomotic strength and healing of the anasto-
mosis by applying hyperbaric oxygen therapy on the anastomosis (Chapter 7), applying 
stem cell sheets around the anastomosis (Chapter 8), or using tissue adhesives at the 
anastomotic site (Chapters 9-11).
In Chapter 7 the role of hyperbaric oxygen therapy (HBOT) to improve anastomotic heal-
ing and lower the infection rate at the anastomotic site were investigated. Oxygenation 
is important for tissue repair. The mechanism of HBOT is still not fully understood, but 
it is known that oxygen stimulates collagen synthesis, matrix deposition, angiogenesis, 
epithelialization, and the eradication of bacteria [31-33]. The blood supply and perfu-
sion of the preserved parts of the bowel proximally and distally to the anastomosis and 
especially around the cutting edge, significantly affects the outcome of the operation 
[34]. The increased oxygen pressure (100% oxygen under pressure) results in a three 
times more diffusion of oxygen from the plasma into the tissues increasing the diffu-
sion distance. Perioperative application of HBOT in rats with an ischemic anastomosis, 
prevents anastomotic dehiscence, increases the anastomotic strength, and reduces 
anastomotic adhesions. The mechanism behind these observations is probably partly 
due to the inhibition of pro-inflammatory cytokines like TNF-α and IL-1β, produced 
by M1 macrophages [35, 36]. This hypothesis was supported by the fact that more M2 
macrophages were observed at the anastomotic site at the histological level in rats that 
underwent HBOT, and significantly less M1 macrophages.
Other approaches to prevent anastomotic leakage or enhance anastomotic healing 
are using foreign body materials like tissue adhesives or using own cells or biological 
materials.
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In Chapter 8, a study was described in which adipose tissue derived stem cells (ACS) 
were used, assembled to form a sheet, to apply on the colorectal anastomosis promoting 
wound healing. This is not the first study applying stem cells on the colonic anastomosis 
[37-39], although ours is the first study that applied stem cells as a sheet of one cell 
layer thick. The other studies showed improved intestinal regeneration and increased 
angiogenesis after intraperitoneal injection of ASC, however there were no differences 
found in CAL [38, 39]. In our study, the ASC sheets prevented anastomotic leakage as 
shown by a lower leakage score, less abscess formation, and slightly higher ABP. As with 
the cyanoacrylate, in this study with ASC sheets more M2 macrophages were found in 
the ASC group compared to the rats without ASC application.
Reinforcement of the anastomotic site is another strategy to prevent CAL. This is already 
used in pulmonary, vascular, and bariatric surgery [40-43], although not yet in colorectal 
anastomosis. The application of semi-absorbable or bio-absorbable materials reinforces 
the anastomosis by sealing the gaps between the staples, reducing the bleeding, and 
improves the resistance to tensile forces. Over the years different materials have been 
tested for linear staple reinforcement. Only two studies described circular reinforcement, 
one with semi-absorbable bovine pericardium strips and the other with polyglycolic 
acid:trimethylene carbonate [44, 45]. Also the C-seal: a biodegradable sheath that is 
attached to the inner surface of the bowel, just proximally the colorectal anastomosis 
in order to prevent intestinal contents leak intra-abdominally seemed not to lead to the 
optimal solution [46]. Several studies with protective intraluminal stents did not solve 
CAL either, the main disadvantage of stents being migration [47].
Therefore in Chapters 10-12 focus was aimed at the prevention of communication 
between the intraluminal and extraluminal parts of the colon by application of tissue 
adhesives. The use of tissue adhesives to prevent CAL in experimental studies is not new: 
already in the 1960s’ the first experimental studies started. Most of these were animal 
studies performed on rats or pigs, describing the use of fibrin glue or cyanoacrylate 
glue [48, 49]. The use in clinical studies is only recent: only one study in 2010 has been 
described with the use of fibrin glue, although no advantage of the glue has been re-
ported [50]. In addition there is a wide variation between the used animal models and 
the amount and type of glue in the described studies. By comparing the mechanical 
strength and rheology of 12 different existing tissue adhesives was chosen we thought 
best for prevention of CAL [51]. After this study three glues were selected that had the 
most potential for preventing CAL: TissuCol (fibrin glue), Histoacryl Flex (cyanoacrylate), 
and Duraseal (polyethylene glycol adhesive). Eventually, based on another study from 
our group, cyanoacrylate glue was selected as the one to focus on. Cyanoacrylate is 
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one of the strongest adhesives with mild clinical and immune-histopathological effects, 
making it promising as a colonic sealant [52].
Research regarding cyanoacrylate application in intestinal and colorectal anastomosis 
was reviewed in Chapter 9. The conclusion of this review was indeed that application of 
cyanoacrylate seemed promising, although there was a great inconsistency and lack of 
detailed information on how the different animal studies were performed. Partly caused 
by this conclusion, our study group tried to set a gold standard for animal research in 
CAL and developed a new colorectal anastomotic leakage rat model. This rat model was 
of great value to perform research in this field [53].
In addition to strengthen the anastomosis with tissue adhesive it can also prevent 
infection of the anastomosis when the anastomosis is conducted in an contaminated 
environment.
Therefore, in Chapter 10 TissuCol (fibrin glue), Histoacryl Flex (cyanoacrylate), and 
Duraseal (polyethylene glycol adhesive) and their influence on the anastomotic healing 
in a contaminated environment were evaluated. Cyanoacrylate did not only prevented 
CAL, but histologically there was also an association with anti-inflammatory M2 mac-
rophages. M2 macrophages play an important role in the foreign body response to 
biomaterials by the production of anti-inflammatory cytokines. On the anastomotic site 
pro-inflammatory M1 macrophages were less common. M1 macrophages produce pro-
inflammatory cytokines like TNF-α and are associated with impaired collagen deposition. 
Anti-inflammatory cytokines induce regenerative processes, one of these processes 
being activated by IL-6 which inter alia induces regeneration of the epithelium in the 
intestine [54].
Patients with IBD/ colitis have also, like patients with peritonitis, a higher risk of CAL 
and severe infectious complications postoperatively, especially when they still use high 
doses of corticosteroids.
In Chapter 11 the same positive effect of anastomotic healing by application of cyano-
acrylate glue was found, compared with TissuCol (fibrin glue) and Duraseal (polyethyl-
ene glycol adhesive) in an IBD-rat model. In this experimental study a switch from M1 
macrophages to M2 macrophages was also observed.
In Chapter 12 by performing a porcine study, the use of Histoacryl Flex® (cyanoacrylate) 
became more translational for human practice. A high risk porcine model was used 
with ischemic anstomosis and a leakage model to make sure that the risk of CAL was 
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high, even for the young pigs. In this porcine study the advantages of small amounts of 
cyanoacrylate applied at the anastomotic site, became once again very clear. Our study 
demonstrated that reinforcement of the colonic anastomosis with cyanoacrylate glue is 
feasible and prevents leakage in a high-risk colorectal anastomosis. No anastomotic de-
hiscence and only one small abscess occurred in the cyanoacrylate groups. Furthermore, 
no undesirable effects like stricture formation were observed as also shown in other 
porcine studies without negative results [55]. In our study there were no more negative 
signs of the foreign body response compared to anastomosis without glue.
Based on Chapter 9-12 it was concluded that cyanoacrylate not only strengthens the 
colorectal anastomosis, but also seals the anastomosis to prevent micro-leakage. Fur-
thermore it seals the anastomosis to prevent from getting infected by the envrionment, 
for example when peritonitis develops during operation and last but not least, cyanoac-
rylate modulates the desirable inflammatory part of wound healing response by shifting 
the macrophage phenotype from M1 (pro-inflammatory) to M2 (anti-inflammatory) 
[56-58].
Another approach, instead of using foreign body material like tissue adhesives, could be 
to use of own cells or biological materials.
In Chapter 7, 8, 10 and 11, a lower anastomotic leakage rate was associated with a 
higher number of M2 macrophages at the anastomotic site, compared to anastomosis 
without HBOT, stem cells, or application of cyanoacrylate glue.
Monocytes and macrophages are among the first responders to ischemic, traumatic or 
surgical injury and are required for successful tissue regeneration [59]. These monocytes 
differentiate into macrophages based on the environment. This innate immune response 
is highly dynamic. Macrophage functional diversity is described as a continuum from 
inflammatory (M1) to anti-inflammatory or pro-regenerative macrophages (M2), and 
plasticity is believed to be retained in order to rapidly respond to micro-environmental 
changes [60].
In our studies M2 macrophages or anti-inflammatory macrophages seem to play an im-
portant role in the healing of the anastomosis. M2 macrophages are protentially impor-
tant in promotion of wound healing and tissue remodelling, taking part in dampening 
of inflammation, and angiogenisis [61-63]. These wound healing macrophages express 
high levels of arginase-1 in response to IL-4, allowing M2 to generate precursors for col-
lagen and fibroblast stimulating factors with regard to extracellular matrix deposition. 
M2 macrophages also suppress inflammation though secretion of IL-10 [60].
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The inflammatory response can also be influenced by biomaterials. Foreign materials un-
avoidably elicit a biological response when implanted. This response can be influences 
by physical properties such a topography, porosity, surface chemistry, and degradation 
mode [64]. By engineering biomaterial properties, the biological response can be tuned 
to maximally promote repair, while not prolonging the inflammatory response [60].
THE USE OF BIOMATERIALS
In surgery many varieties biomaterials are used to regenerate or replace tissue. Every 
biomaterial induces a foreign body response after implantation into the body.
In Chapter 9-11 it was shown that the material can influence the macrophage pheno-
type, this earlier being shown in in vitro models by our group [65, 66]. Depending on the 
material, macrophages can differentiate towards cells promoting or preventing healing. 
Modulation of the inflammatory response is used in strategies to reduce inflammation 
resulting in a more favorable outcome, the extend to which a material is able to induce 
these favorable aspects being a measure for success of the biomaterial [56].
Each individual responds in a different way to biomaterials regarding the foreign body 
response and although medicine is more and more personalized still techniques and 
materials are used in surgery chosen based on what is the best for a general group of 
patients. Since the behavior of macrophages alters in reponse to biomaterials we in-
vestigated whether it is possible to predict the foreign body response to a biomaterial 
beforehand, defining an individual profile and then deciding which material to use in 
surgery for that individual.
In Chapter 13 it was shown that there are many different materials used for regenera-
tive medicine, cells responding in their own specific way to each material. Furthermore, 
every individual response is unique.
In Chapter 14 the individual response to different commonly used polymers was shown 
in an in vitro model. First healthy and obese patients were compared. Obesity is known 
to negatively influence the immune reaction. The inflammatory response between 
healthy and obese patients on 4 different types of materials were compared. Monocyte-
derived macrophages of obese patients responded more pro-inflammatory and less 
anti-inflammatory to biomaterials than macrophages from lean subjects the response 
depending on the type of biomaterial. This variation in cytokine production by the 
macrophages was associated by the percentages of monocyte subsets in the peripheral 
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blood, serum CRP levels, or BMI of the patient. Obesity is a growing healthcare issue and 
is associated with surgical complications including cutaneous wound helaing, wound 
failure, and fascial dehiscence [67]. Obesity initiates a low-grade inflammatory response 
and inflammatory mediators in the plasma increasing with adipose tissue mass including 
TNF-α, IL-6, and TGF-β [68]. In adipose tissue there is also a shift from anti-inflammatory 
M2 macrophages to M1 macrophages [69]. Besides the cellular alterations there is also 
a higher oxidative stress in subcutaneous adipose tissue, this relative hypoperfusion 
causing disfunctioning of fibroblasts to synthesize collagen which is essential for wound 
healing [70]. In our study the results showed that macrophages derived from monocytes 
from obese patients still respond pro-inflammatory, even when being not in an obese 
environment anymore. This is an important finding because this makes it possible to 
continue in vitro studies for future research studies aiming at personalized medicine, 
eventually leading to a model that can be used to test biomaterials for tissue repair and 
tissue engineering using patient’s own cells prior to implantation of a biomaterial to 
decide which matierial is the best for that specific individual.
FUTURE PERSPECTIVES
The prevention and early detection of major postoperative complications of abdominal 
surgery is not simple. It is a multifactorial process determining whether a patient will de-
velop a postoperative complication or not. In this thesis three important postoperative 
complications have been researched: incisional hernia (IH), prolonged postoperative 
ileus (PPOI), and colorectal anastomotic leakage (CAL).
The use of biomaterials e.g. meshes in medicine is well known to prevent from IH. How-
ever each biomaterial induces an inflammatory response, which can lead to complica-
tions like wound healing problems. Therefore It would be ideal if one can anticipate on 
the patients personal foreign body response prior to implanting the material. This can 
be done by using an in vitro model with patients’ own cells cultured on the materials to 
be implanted. Monocytes of the individual who needs to undergo the operation can be 
isolated from periferal blood. These monocytes can be cultured on the most common 
used materials for that specific operation. Depending on the foreign body response of 
the cultured monocytes (macrophages) to the material, the ‘best’ material can be cho-
sen. A more anti-inflammatory response of the macrophages is preferable to promote 
tissue healing. It would even be more ideal if from the monocyte subsets in the blood 
of the patient the foreign body response can be predicted. If this is possible, the process 
of culturing the material, a time-consuming proceeding, can be omitted. In this respect 
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personalized medicine, moreover: personalised surgery, is necessary to improve patient 
outcome in the future.
For prevention of CAL several targets can be defined in the future: 1) improvement of 
anastomotic healing by application of tissue adhesives, HBOT or stem cells, 2) reinforce-
ment of the anastomosis by application of tissue adhesives, 3) protect the anastomosis 
from infection on the extraluminal site by tissue adhesives.
Based on the experimental research studies presented in this thesis, it is justified to 
perform a clinical study with application of cyanoacrylate glue on the colorectal anas-
tomosis in a controlled manner. Application of the very liquid tissue adhesive on the 
colon anastomosis without spill and without spending a lot of time is a challenge. A 
technical device to assist in the application would be preferable in clinic. For example 
incorporation of the tissue adhesive in a circular stapler that is used for the anastomosis 
would be ideal, this will not cost not much extra operation time and no extra procedure 
is necessary. At the moment prototypes of such a device are in development.
Especially the colorectal anastomosis that is at high risk, for example in a patient who 
needs to be operated in an acute setting with peritonitis, extra prevention of the anasto-
mosis is welcome therefore this patient group will be perfect to test cyanoacrylate glue 
in a clinical study.
Application of HBOT in the clinic will be more challenging especially starting the 
treatment preoperatively. However patients who would have a greater risk of ischemic 
anastomosis can be detected preoperatively e.g. smoker, patients with atherosclerosis, 
diabetic mellitus, cardiovascular disease. If HBOT can be applied and researched in this 
specific group and the clinal outcome will be improved, application of HBOT can be 
considerd in a larger group of patients.
The use of stemcell sheets to facilitate anastomotic healing is still experimental but also 
promising. These days bioscaffolds are also used to improve tissue healing. Preformed 
grafts, for example SIS grafts made of porcine small intestine submuca, showed amazing 
results in literature and have been rigorously tested to confirm biocompatibility. SIS are 
cell-free scaffolds with collagen matrix that demonstrated the ability for constructive 
remodeling of missing of damaged tissue, for example in esophageal defects or bladder 
augmentation [71, 72]. Hence, SIS seems to be an interesting candidate to be researched 
to prevent anastomotic leakage. The cost of these bioscaffolds being high, they are of 
shelf available. However, a major advantage of using patients own adipose tissue stem 
cells to form a sheet that can be applied on the anastomosis during colorectal surgery 
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would be ideal to avoid the foreign body response like with regard to other biomaterials. 
Of course the production process should be less time consuming and more efficient to 
become a cost-effective additional preventive therapy.
Future research regarding the relationship between abdominal atherosclerosis and the 
risk of CAL should concentrate on the relationship between abdominal calcifications 
and the severity of abdominal artery stenosis and the perfusion of the colon and/or 
rectum during surgery. Furthermore, visualization of the collateral network around the 
anastomosis may provide extra information on the onset of ischemia leading to CAL. 
According to the perfusion of the anastomosis, this miniaturized device can be further 
developed in a sensor performing realtime measurements of the anastomosis. This prin-
ciple is ideal to use as an objective evalution monitoring the microvasularisation during 
and after performing the anastomosis and providing the clinician more information 
than only the symptoms of CAL. The mDLS device that was tested can be integrated in 
a smart sensor to observe the real-time status of the anastomosis postoperatively. Such 
sensor should be placed near the anastomosis sending information via Bluetooth to a 
computer device. There are also studies that monitor the anastomosis accurately by the 
use of a smart drain [11, 73]. In this respect measurements of cytokines and bacteria in 
drain fluid can indicate early CAL and PPOI [11, 74, 75].
For conclusion, nowadays it is extremely difficult to find any funding for research on the 
still far too frequently occurring major complications of abdominal surgery as themes 
like oncology, cardiovascular disease, transplantation or Alzheimer disease are far more 
prominent and better known in public. One of the reasons for this might be represented 
by a certain degree of reticence on complications in general, still existing within the pro-
fessional field. In the age of transparency and quality of care efforts to improve surgical 
care via the avoidance of complications should be considered paramount by the surgi-
cal community overtly and also generously supported by the industry and government.
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SUMMARy
In this thesis the focus was on three major complications after abdominal surgery: 
incisional hernia (IH), prolonged postoperative ileus (PPOI), and colorectal anastomotic 
leakage (CAL). The results were summarized in three parts: Part 1 focused on prediction 
and detection of these surgical complications; Part 2 describes different methods to 
prevent complications; Part 3 analyzed also prevention of major surgical complications 
with a focus on patients at risk.
Part 1
In Chapter 2 it was investigated if the amount of calcification in the major abdominal 
arteries can be used as a prognostic factor for colorectal anastomotic leakage. In this 
case-control study it was demonstrated that the abdominal calcium score and calcium 
volume in the aortoiliac trajectory as determined by CT-scan analysis, are not correlated 
with anastomotic leakage for left-sided colon anastomosis.
In Chapter 3 was the perioperative anastomotic perfusion measured with a miniaturized 
Dynamic Light Scattering (mDLS) device, aiming to determine whether anastomotic 
perfusion correlated with the anastomotic healing process in a rat colectomy model. 
This study demonstrated that postoperative perfusion-monitoring can assist the detec-
tion of anastomotic leakage earlier.
In Chapter 4 cytokine levels in the blood from patients who underwent oncological 
colorectal surgery were studied to detect infectious complications earlier. Cytokine 
levels of patients with infectious complications were compared with patients without 
complications. This study showed that perioperative changes of IL-6 levels on postop-
erative day 1 and 3 had a better diagnostic value compared to leucocyte count and CRP 
changes. However, POI cannot be predicted with inflammatory cytokines.
In Chapter 5 an overview of the literature about clinical endpoints, early detection, 
and differential diagnosis of POI was given. This overview showed that the best clinical 
endpoint of POI is defecation and eating of solid food. A CT-scan is the most valuable 
radiologic diagnostic method to differentiate between POI or other diagnosis.
Part 2
In Chapter 6 the hypothesis regarding vagal nerve stimulating by chewing nictone 
gum to prevent PPOI was described in detail. For more than ten years several studies 
have been published investigating the use of chewing gum and reduction of POI. Chew-
ing of chewing gum stimulates the vagal nerve. The vagal nerve is one of the twelve 
290
cranial nerves. The vagal nerve is the most important nerve to stimulate the digestive 
tract stimulating gastric juice secretion and emptying of the stomach. Vagal nerve 
stimulation induces production of acetylcholine that stimulates production of gastric 
juices. Moreover, vagal nerve stimulation reduces the inflammatory response. Nicotine 
also stimulates the vagal nerve. Therefore it seemed logical to combine nicotine with 
chewing gum to gain a stronger stimulating effect on the vagal nerve to reduce POI. To 
research this hypothesis a human randomized controlled trial should performed.
In Chapter 7 the use of hyperbaric oxygen therapy (HBOT) to improve the healing of the 
anastomosis was researched in a rat model. In this rat model a partial colon resection 
was combined with an ischemic anastomosis, half of the animals received perioperative 
HBOT compared with no treatment. No anastomotic dehiscence was seen in the HBOT 
groups, compared to 37.5% and 28.6% dehiscence in the control group on postoperative 
day 3 and 7, respectively. Histological research of the anastomosis showed significantly 
more type 2 macrophages (anti-inflammatory).
In Chapter 8 another approach to prevent anastomotic leakage by means of stimulating 
the healing was investigated. This innovative study explored the therapeutic potential 
of adipose tissue derived stem cells (ASC) applied as a sheet on the anastomosis for 
preventing dehiscence of sutured colorectal anastomoses. ASC sheet application 
significantly enhanced healing of colorectal anastomoses with decreased incidence 
of dehiscence and abscess formation. The increased numbers of anti-inflammatory 
macrophages and T-cells might have contributed to promotion of the healing process. 
This preclinical study indicates that ASC sheet application may have a therapeutic role 
in promoting colorectal healing and prevention of anastomosis-related complications. 
Also in this study, the amount of type 2 macrophages around the anastomosis was 
increased compared to the control group,
In Chapter 9 a systematic review of the literature was given regarding the use of cyano-
acrylate glue to prevent anastomotic leakage in colorectal anastomosis. Although there 
were substantial heterogeneity and methodological bias in the experimental studies, 
the results were promising in this overview. Therefore, in the following chapters the 
focus was on prevention of colorectal anastomotic leakage with tissue adhesives.
Part 3
In Chapter 10-12 different tissue adhesives were tested in anastomotic leakage animal 
models. Special attention was paid to anastomosis that are at high risk for leakage, 
respectively a contaminated environment, IBD (inflammatory bowel disease), and isch-
emic anastomosis.
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In Chapter 10 three different types of tissue adhesives were tested in a rat model to 
be investigated if these sealants would prevent from leakage in a peritonitis model. 
These tissue adhesives: fibrin glue, cyanoacrylate glue, and polyethylene glycol glue 
were circularly applied on a sufficient sutured anastomosis. These three ‘glue groups’ 
were compared to each other and to a control group without glue. As expected anasto-
motic leakage and comprised anastomotic strength were observed in the animals with 
peritonitis. All three adhesives prevented occurrence of anastomotic leakage. Again 
histologic research of the anastomosis showed more type 2 macrophages in the best 
healed anastomosis. In this study the main role of the glue was sealing the anastomosis 
to prevent from contact of the intraperitoneal bacteria.
The promising data of Chapter 10 led to the next study presented in Chapter 11. In 
this chapter the focus was on another high risk patient group: patients with IBD like 
Crohns disease or colitis. When these patients have to undergo an operation they have 
an increased risk of anastomotic leakage.
In Chapter 11 the same tissue adhesives were used as in the previous chapter, but now 
in a surgical IBD model. This model caused compromised anastomotic healing with 
more abscess formation and a lower anastomotic bursting pressure because of inflam-
mation and ischemia. All the tissue adhesive groups yielded a higher bursting pressure. 
On postoperative day 7 there were only abscesses in the control group. Histoacryl 
Flex®, a cyanoacrylate glue, was the only tissue adhesive that showed significantly less 
intra-abdominal abscesses compared to the control group. Type 2 macrophages were 
significantly more present in the Histoacryl Flex® group.
In Chapter 12 the application of Histoacryl Flex® on a high risk porcine model was 
investigated representing a more translational study for human surgical procedures. In 
this ischemic and anastomotic leakage model the strength of cyanoacrylate glue was 
once again proved. Cyanoacrylate was effective and safe to prevent from leakage and 
with less adhesions, no stricture of the anastomosis, and no foreign body response to 
the glue shown with histological analysis.
In Chapter 13 the effect of different biomaterials to the macrophage response was 
described in a detailed overview of the literature. A wide range of biomaterials, for 
example tissue adhesives or meshes for hernia surgery, are used as medical devices. 
These materials have their own characteristics, and every material induce a foreign body 
response by activation of macrophages. This response can be influenced by the environ-
ment, but also by the material itself. This initial foreign body response to a material can 
be researched in an in vitro model. The used methods are very variable. We concluded 
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in this review that in vitro culture models using macrophages on biomaterials are a 
valuable addition to the development of new biomaterials. However there is a need for 
standardized culture models and a systematic comparison to the in vivo response.
In Chapter 14 the influence of obesity on macrophages and the acute response to 
biomaterials were investigated. This study showed that macrophages from patients 
with obesity respond more pro-inflammatory to biomaterials than macrophages from 
lean subjects. This response is biomaterial dependent. The results of this in vitro study 
offer possibilities and could stimulate future research towards personalized medicine, 
eventually leading to a model that can be used to test biomaterials for tissue repair and 
tissue engineering using patient’s own cells prior to implantation of a biomaterial.
In Chapter 15 the results of this thesis were discussed. Based on the described stud-
ies new perspectives were given for the prediction, detection, and prevention of three 
major abdominal surgical complications.
293
16
Chapter 16 | Samenvatting
SAMENVATTING
Jaarlijks ondergaan duizenden patiënten in Nederland een buikoperatie. Helaas gaat 
dit vaak gepaard met complicaties. Drie ernstige complicaties die vaak optreden zijn: 
littekenbreuk, postoperatieve ileus (POI: tijdelijk functieverlies van de darm na de 
operatie) en naadlekkage, dit betekent dat een nieuwe verbinding (anastomose: naad) 
tussen de darmuiteinden die tijdens de operatie gecreëerd is niet goed geneest en er 
daardoor ontlasting in de buikholte lekt. Het optreden van een dergelijk complicatie 
heeft meestal meerdere oorzaken. Veel factoren zijn patiënt gerelateerd en kunnen niet 
beïnvloed worden, enkele voorbeelden zijn: leeftijd, geslacht, eerdere buik operaties, 
co-morbiditeit, immuundeficiëntie en acute operaties. Sommige factoren zijn wel te 
beïnvloeden zoals voedingsstatus, overgewicht, ervaring van de chirurg en de gebruikte 
operatietechniek. Echter, meestal is er sprake van een multifactoriële oorzaak.
In dit proefschrift is met name aandacht besteed aan deze drie ernstige complicaties. 
De resultaten worden besproken in drie verschillende onderdelen: Deel 1 richt zich op 
de genoemde chirurgische complicaties en het voorspellen en detecteren daarvan. In 
Deel 2 worden preventiemethoden besproken om complicaties te voorkomen. Tot slot 
zijn in Deel 3 diverse onderzoeken naar preventie van complicaties bij patiënten die een 
verhoogd risico lopen uitgelicht.
Deel 1
In Hoofdstuk 2 is onderzocht of de mate van calcificatie van de aorta-iliacale vaten 
van invloed is op het risico van naadlekkage. De hypothese was dat des te ernstiger 
de calcificaties zijn, des te meer de bloedvoorziening van de darm te wensen over laat 
en daarmee een hoger risico op naadlekkage zal ontstaan. Uit deze studie bleek dat de 
mate van de hoeveelheid calcium in de arteriën (slagaders) geen directe voorspellende 
waarde op het ontstaan van naadlekkage heeft.
In Hoofdstuk 3 is de doorbloeding van de anastomose in een ratmodel gedurende 
en na de operatie van de dikke darm (colon) gemeten met behulp van een apparaat 
dat dynamische lichtverstrooiingen kan meten. Uit deze studie bleek dat met name 
ischemie (onvoldoende doorbloeding) van de anastomose gemeten ná de operatie kan 
voorspellen of er naadlekkage zal optreden.
In Hoofdstuk 4 is onderzocht of het mogelijk was om aan de hand van ‘biomarkers’ (o.a. 
cytokines in bloed) POI en infectieuze complicaties eerder te detecteren dan aan de 
hand van de klinische presentatie van de patiënt. Dit is onderzocht bij patiënten die een 
operatie van het colon of de endeldarm (rectum) hebben ondergaan in verband met 
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kanker. Hierbij bleek dat POI met behulp van systemische cytokine levels niet eerder 
voorspeld kan worden. Echter, een stijging van interleukine-6 (IL-6) in het bloed vanaf 
postoperatieve dag 1 naar dag 3, gaf een betere voorspellende waarde voor bijvoor-
beeld wondinfectie, longontsteking, naadlekkage en urineweginfectie in vergelijking 
met de voorspellende waarde van leukocyten (witte bloedcellen) of CRP.
In Hoofdstuk 5 is een overzicht gegeven van de literatuur over de definitie, vroegdetec-
tie en differentiaal diagnose van POI. Uit dit overzicht bleek dat POI het beste gedefini-
eerd kan worden aan de hand van de eerste ontlasting en het nuttigen van vast voedsel. 
Een CT-scan bleek het meest waardevolle onderzoek te zijn om te beoordelen of bij een 
patiënt inderdaad van POI sprake is.
Deel 2
In de afgelopen jaren zijn er vele studies verricht waaruit bleek dat het kauwen van 
kauwgom preventief werkt om POI te voorkomen dan wel te verkorten door stimulatie 
van de nervus vagus (één van de twaalf hersenzenuwen). De nervus vagus is de belang-
rijkste zenuw voor de aansturing van de maag en de regulatie van de productie van 
maagsappen. De nervus vagus produceert de stof acetylcholine (neurotransmitter) die 
ervoor zorgt dat de maagsapklieren actief zijn. Daarnaast is de inflammatoire respons 
verminderd door activatie van de nervus vagus. Nicotine zorgt ook voor stimulatie van 
de nervus vagus. Daarom ontstond het idee om nicotine met kauwgom te combineren 
om zo een versterkt stimulerend effect te verkrijgen. Deze hypothese is uitgebreid in 
Hoofdstuk 6 beschreven. Deze hypothese moet nog wetenschappelijk onderzocht 
worden in klinische studies.
In Hoofdstuk 7 zijn de effecten van hyperbare zuurstof therapie (HBOT) op de genezing 
van de darmanastomose in een ratmodel onderzocht. In dit model, waar een deel van 
het colon werd verwijderd en een ischemische anastomose werd aangelegd, ontving 
één gedeelte van de dieren wel HBOT en de andere groep niet. Het bleek dat bij de ratten 
die rond de operatie HBOT hadden ontvangen geen naadlekkage werd geconstateerd 
en de anastomose sterker was in vergelijking met de groep zonder HBOT. Bij histolo-
gisch onderzoek van de anastomose bleek dat type 2 macrofagen (anti-inflammatoire 
macrofagen) significant meer aanwezig waren.
In Hoofdstuk 8 is een andere methode onderzocht om de genezing van de anastomose 
te stimuleren en daarmee naadlekkage te voorkomen. In deze innovatieve studie is voor 
het eerst onderzocht of het bedekken van een colonanastomose met een stamcel-sheet 
de genezing van de anastomose bevordert en naadlekkage voorkomt. Naadlekkage van 
de anastomose werd op dag 3 na de operatie in de stamcel groep in 14% van de geval-
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len gezien tegenover 71% bij de ratten zonder stamcelapplicatie. Daarnaast werd ook in 
deze studie een verhoogd aantal type 2 macrofagen ter hoogte van de naad gezien ten 
opzicht van de controlegroep.
In Hoofdstuk 9 is beschreven welke studies er tot nog toe in de literatuur bekend zijn 
met betrekking tot het gebruik van cyanoacrylaatlijm ter preventie van naadlekkage bij 
colorectale anastomosen. Dit overzicht laat zien dat er veel variatie in de methode van 
het gebruik van diermodellen en soorten weefsellijmen bestaat. In de volgende hoofs-
tukken zijn verschillende weefsellijmen ter preventie van naadlekkage onderzocht.
Deel 3
In Hoofdstuk 10-12 zijn verschillende weefsellijmen getest in naadlekkagediermodel-
len. In deze studies lag de focus op hoog risico-anastomosen, respectievelijk in een ge-
contamineerd milieu, bij IBD (inflammatoire darmziekte) en ischemische anastomosen.
In Hoofdstuk 10 is het gebruik van 3 soorten weefsellijm getest in een rat model waarbij 
de colonanastomose in een gecontamineerd milieu was vervaardigd, het zogenaamde 
peritonitis model. Deze 3 weefsellijmen: fibrine lijm, PEG-lijm (polyethyleen glycol) en 
cyanoacrylaat lijm zijn uitgekozen op basis van eerdere studies. De lijm werd circulair 
op de anastomose aangebracht. De lijmgroepen zijn vergeleken met een controlegroep 
zonder lijm. Zoals verwacht bij dit peritonitis model bleek de anastomose minder sterk 
en een naadlekkage kwam vaker voor. Echter in de lijmgroepen kwam geen naadlekkage 
voor. Wederom werd er bij histologisch onderzoek een hoger aantal type 2 macrofagen 
gevonden bij de anastomosen zonder lekkage. In deze studie is aangetoond dat het 
sealen van de anastomose met lijm de anastomose beschermt tegen invloed van bacte-
riën van buitenaf. Het aanbrengen van lijm lijkt een veilige methode om naadlekkage te 
voorkomen in een gecontamineerd milieu.
De aansprekende resultaten uit het vorige hoofdstuk hebben er toe geleid tot een ver-
volgstudie waar de focus lag op een andere groep patiënten die ook een verhoogd risico 
op naadlekkage hebben: patiënten met IBD zoals de ziekte van Crohn of colitis ulcerosa.
In Hoofdstuk 11 zijn dezelfde lijmen ter preventie van naadlekkage gebruikt als 
in Hoofdstuk 10, maar dan in een chirurgisch IBD-ratmodel. In dit model ontstaan er 
pathologische veranderingen in de darm die patiënten met IBD ook hebben, zoals ont-
stekingen en ischemie. In deze studie werd ook gezien dat de lijmen beschermend zijn 
en dus naadlekkage voorkomen. Histoacryl Flex®, een cyanoacrylaat lijm, liet als enige 
weefsellijm significant minder abcessen zien in vergelijking met de controlegroep. Ook 
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hier werd bij histologisch onderzoek een significant aantal meer type 2 macrofagen 
geconstateerd.
In Hoofdstuk 12 is een varkensmodel beschreven dat de stap van proefdieronderzoek 
naar klinische studies verkleint. In dit ischemie- en naadlekkagemodel is wederom de 
werking van cyanoacrylaat lijm (Histoacryl Flex®) aangetoond. In de lijmgroepen werd 
geen naadlekkage geconstateerd, daarnaast werden er meer adhesies (verklevingen) 
in de groepen zonder lijm gevonden. Deze studie laat zien dat het gebruik van cyano-
acrylaatlijm veilig en effectief is om naadlekkage te voorkomen.
In Hoofdstuk 13 is een gedetailleerd overzicht gegeven van de literatuur over de ma-
crofaag respons op verschillende biomaterialen. Bij het gebruik van biomaterialen, zoals 
lijm of een mesh (matje) voor bijvoorbeeld het herstel van een littekenbreuk ontstaat 
altijd een vreemdlichaamreactie. Deze reactie kan beïnvloed worden door de omgeving, 
maar ook door het materiaal zelf. Macrofagen zijn nauw betrokken bij deze respons. 
Deze initiële respons op een biomateriaal kan goed onderzocht worden in een in vitro 
model (celkweek). Echter een systematische aanpak voor dit soort studies ontbreekt en 
de voorkeur gaat dan ook sterk uit naar het ontwikkelen van een gestandaardiseerde 
aanpak voor dit soort studies om verschillende in vitro studies met elkaar te kunnen 
vergelijken.
In Hoofdstuk 14 is de invloed van obesitas op de respons van macrofagen op verschil-
lende biomaterialen onderzocht. In deze studie is aangetoond dat patiënten met obesi-
tas een pro-inflammatoire respons hebben op biomaterialen in vergelijking met mensen 
zonder obesitas. Deze respons is biomateriaal afhankelijk. De macrofaag respons werd 
onderzocht door de productie van pro- en anti-inflammatoire cytokines te bepalen. 
Deze in vitro studie biedt mogelijkheden om een model te ontwikkelen om preoperatief 
te bepalen welk materiaal voor de individuele patiënt het meest geschikt is.
Hoofdstuk 15 bevat een algemene discussie over de belangrijkste bevindingen van dit 
proefschrift. Op basis van de beschreven studies worden nieuwe inzichten in voorspel-
ling, preventie en detectie van de belangrijkste abdominale chirurgische complicaties 
gepresenteerd.
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alsnog aan de slag als arts-onderzoeker bij de REPAIR. De ASAP trial moet toch nog een 
keer van de grond komen.
Mijn promotor, professor Kleinrensink, veel dank voor uw betrokkenheid bij de voltooi-
ing van mijn proefschrift. Uw positivisme en enthousiasme zullen me altijd bij blijven. 
Altijd tijd voor een praatje en een luisterend oor. En daarnaast, tijdens de beruchte 
REPAIR-vergaderingen, samen met professor Lange, altijd in voor een geintje. Helaas 
heb ik nooit een grote bijdrage kunnen geven aan de ronde ‘cultuur’. Bedankt voor uw 
steun en bijdrage.
Beste dr. Bastiaansen-Jenniskens, mijn co-promotor, beste Yvonne, eind 2013 kwam 
ik op gesprek. Samen bespraken we of het mogelijk was om een gezamenlijke project 
van de REPAIR met orthopedie naar de lichaamsvreemde reactie op biomaterialen te 
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waren altijd doeltreffend, kort en krachtig.  Heel erg bedankt voor deze gezellige en 
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voor jullie samenwerking en gezelligheid! Dear Zhouqiao, a special word to you, thank 
you for the time we spent together in the lab writing, discussing, drinking coffee, and 
operating. We worked together on a lot of manuscripts, thank you for the collaboration! 
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Beste collega’s bij de orthopedie, het was een warm welkom op de 16de, vanuit de kelder 
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te vragen, jij weet als geen ander hoe het is om onderzoek te doen bij de REPAIR, ook al 
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- NBTE, Lunteren (oral) 2014-2015 1.0 
- Wetenschapsdag Heelkunde Erasmus MC, R’dam (oral) 2014-2015 1.0 
- Wetenschapsdag arts-assistenten vereniging (oral) 2015 1.0 
(Inter)national conferences   
- Chirurgendagen, Veldhoven 2013/2015 1.0 
- Najaarsdag Heelkunde, Rotterdam 2014 1.0 
Other   
- Journal club 2014-2015 2.0 
- REPAIR 2012-2015 2..0 
2. Teaching/ supervising year ECTS
- Education medical students 2013-2014 2.0
- Examination of Basic Life Support medical students 2013-2015 1.0 
- Master theses 2013-2015 4.0 
Other
-
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CURRICULUM VITAE
Geesien Simone Anja ter Hoeve - Boersema werd geboren op 26 april 1985 te Groningen. 
Ze groeide op in Usquert, in het hoge noorden op het platteland van Groningen. Tijdens 
de gehele middelbare school periode tenniste ze op hoog nationaal niveau. In 2003 
behaalde ze haar middelbare school diploma op Het Hogeland College te Warffum. Via 
decentrale selectie begon ze in datzelfde jaar de studie Geneeskunde aan de Erasmus 
Universiteit te Rotterdam, waar ze in maart 2010 afstudeerde. Daarna werkte ze ruim 
twee jaar als ANIOS (arts assistent niet in opleiding tot specialist) chirurgie in het 
Amphia Ziekenhuis te Breda (dr. L. van der Laan). Vervolgens begon ze in september 
2012 als arts-onderzoeker bij de REPAIR onderzoeksgroep (prof. dr. J. Jeekel, prof. dr. G.J. 
Kleinrensink, prof. dr. J.F. Lange en dr. A.G. Menon), sinds 2014 werd ze ook betrokken 
bij onderzoek onder leiding van dr. Y.M. Bastiaansen-Jenniskens. Onderzoek verricht in 
deze periode heeft geleid tot dit proefschrift. In 2016 was ze werkzaam als ANIOS chirur-
gie in het Reinier de Graaf Gasthuis, te Delft (dr. M. van der Elst). Per 1 januari 2017 is ze 
begonnen als AIOS (arts in opleiding tot specialist) chirurgie in het Maasstad Ziekenhuis, 
te Rotterdam (dr. R.A. Klaassen).
